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 I 
Abstract 
All	 microorganisms	 require	 transition	 metals	 for	 key	 metabolic	 processes,	 thus	
during	infection	microbial	access	to	essential	metals	is	tightly	regulated	by	the	host	
in	 a	 process	 termed	 nutritional	 immunity.	 Iron	 acquisition	 is	 critical	 to	 the	
pathogenesis	 of	 the	 formidable	 human	 pathogen,	 Staphylococcus	 aureus,	 which	
utilizes	 heme-uptake	 systems	 and	 two	high	 affinity	 iron-scavenging	 siderophores,	
staphyloferrin	A	(SA)	and	staphyloferrin	B	(SB)	for	iron	acquisition.	In	this	study,	I	
identify	sbnI	as	encoding	a	transcription	factor	required	for	expression	of	genes	in	the	
sbn	operon,	the	biosynthetic	operon	for	SB	synthesis.	I	also	show	that	SbnI	is	a	novel	
hemoprotein,	where	 binding	 to	 heme	 abrogates	 its	 ability	 to	 bind	DNA.	 Thus	 this	
work	 proposes	 a	 novel	 mechanism	 in	 which	 S.	 aureus	 controls	 SB	 synthesis	 in	
response	 to	 heme.	 Although	 free	 iron	 is	 scarce	 in	 the	 host,	 copper	 at	 the	 host-
pathogen	interface	is	found	in	excess.	Copper	is	highly	reactive	and	in	macrophages	
is	imported	into	phagosomes	where	it	exerts	bactericidal	effects.	S.	aureus	flourishes	
within	 macrophages	 and	 therefore	 must	 resist	 copper-mediated	 killing.	 I	
demonstrate	that	the	USA300	strain	of	Community-Associated	MRSA	relies	on	CopAZ	
and	 CopBL	 for	 copper	 detoxification;	where	 CopA	 and	 newly	 identified	 CopB	 are	
copper-translocating	efflux	pumps,	CopZ	is	a	copper-binding	chaperone,	and	CopL	is	
a	novel	copper-responsive	lipoprotein.	Finally,	CopAZ,	in	accord	with	CopBL,	aid	in	S.	
aureus	survival	in	murine	macrophages.	This	study	examines	two	important	facets	of	
nutritional	 immunity	 and	 the	 virulence	 factors	 used	 by	 S.	 aureus	 to	 overcome	
obstacles	posed	by	the	host	in	maintaining	metal	homeostasis.		
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Chapter 1 
1 Introduction 
1.1 Staphylococci 
In	the	late	19th	century,	staphylococci	were	first	identified	as	causative	agents	in	wound	
infections	and	surgeons	 initially	named	 them	Coccobacteria	 septica,	 then	Micrococcus,	
and	only	years	 later	eventually	gave	the	name	Staphylococcus	(1).	The	Staphylococcus	
genus	 is	 comprised	of	over	80	 species	of	 catalase-producing,	 coccoid-shaped	bacteria	
that	are	found	in	a	wide	range	of	ecological	and	physiological	niches.	The	group	is	broadly	
and	 commonly	 categorized	 by	 the	 ability,	 or	 not,	 of	 species	 to	 produce	 coagulase,	 a	
secreted	polypeptide	that	activates	prothrombin	(2).	Many	staphylococci	are	 found	as	
commensals,	 such	 as	 the	 coagulase-negative	 (CoNS)	 skin	 commensal	 S.	 epidermidis.	
However,	this	genus	has	garnered	notoriety	due	to	the	ability	of	many	species	to	cause	
severe	to	lethal	infections,	such	as	those	caused	by	coagulase-positive	(CoPS)	S.	aureus.		
CoNS	 are	 the	most	 prevalent	 skin	 commensals	 on	 the	 human	body	 and	 are	 the	most	
frequently	identified	bacteria	in	clinical	samples	(3).	Until	1975,	CoNS	were	considered	
either	S.	 epidermidis	or	S.	albus	and	were	distinguished	 from	S.	aureus	based	on	their	
inability	to	clot	plasma	(4).	In	1981,	additional	CoNS	were	characterized	due	to	their	high	
prevalence	in	human	blood	samples	including	S.	haemolyticus,	S.	hominis,	S.	warneri,	S.	
simulans,	and	S.	 xylosus.	These	 CoNS	 appeared	 to	 originate	 from	 the	 skin	 and	 for	 the	
majority	of	cases	only	caused	internal	infections	in	humans	when	a	foreign	device	was	
present,	such	as	a	catheter	or	shunt	(5).	The	increasing	use	of	implanted	devices	has	led	
CoNS	 to	 be	 prevalent	 agents	 in	 nosocomial	 infections	 and,	 particularly	 in	
immunocompromised	individuals,	can	cause	severe	infections.	Notable	among	the	CoNS	
is	S.	lugdenensis,	known	to	cause	infrequent	but	aggressive	infectious	endocarditis,	with	
a	mortality	 rate	 reaching	42%	(6).	S.	 lugdenensis	stands	out	 from	 the	CoNS,	 as	 it	was	
initially	misidentified	as	S.	aureus	due	to	the	presence	of	a	membrane-bound,	coagulase-
like	 enzyme	 referred	 to	 as	 “clumping	 factor”,	 that	 caused	 false	 positive	 results	 in	
coagulase	tests	(7).		
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Although	most	commonly	found	as	commensals,	CoNS	have	an	array	of	virulence	factors.	
Nevertheless,	they	are	typically	less	virulent	than	CoPS	and,	like	their	CoPS	counterparts,	
can	 have	 widespread	 antibiotic	 resistance,	 and	 can	 form	 persistent,	 metabolically	
repressed	small	colony	variants	in	the	course	of	infection	(1).	Furthermore,	there	are	a	
number	of	CoPS	staphylococcal	species,	the	most	characterized	and	clinically	relevant	of	
them	 being	 S.	 aureus	 due	 to	 its	 high	 prevalence	 in	 human	 and	 domesticated	 animal	
infection.									
1.2 Staphylococcus aureus 
S.	aureus	 is	the	most	characterized	of	the	staphylococci.	Despite	living	commensally	in	
the	nasopharynx,	throat,	and	intestinal	tract	of	roughly	30%	of	the	population,	S.	aureus	
is	 also	 a	 human	 pathogen	 capable	 of	 causing	 severe	 diseases	 such	 as	 septicemia,	
necrotizing	 fasciitis,	 osteomyelitis,	 pneumoniae,	 and	 endocarditis	 (8–10).	 People	who	
are	 persistent	 or	 intermediate	 carriers	 of	 S.	 aureus	 are	 significantly	 more	 likely	 to	
develop	S.	aureus	infections,	with	numerous	studies	showing	the	infectious	strains	are	
often	 isogenic	 to	 the	 commensal	 (11).	 The	 ability	 of	 S.	 aureus	 to	 persist	 as	 an	
asymptomatic	commensal	and	then,	by	some	environmental	cue,	transition	to	pathogenic	
and	cause	symptoms,	has	given	S.	aureus	the	status	as	“pathobiont”	(11).				
Currently,	S.	aureus	is	the	most	frequent	cause	of	bloodstream	infections	in	Canada	and	
the	United	States,	the	most	common	agent	of	post-operative	infection,	and	responsible	
for	 10%	of	 all	 hospital	 acquired	 infections	 (HAI)	 (8,	 12–14).	 S.	 aureus	 is	particularly	
formidable	as	many	strains	have	acquired	antibiotic	resistance,	with	the	World	Health	
Organization	 ranking	 methicillin-resistant	 S.	 aureus	 (MRSA)	 among	 the	 seven	 most	
threatening	infectious	bacterial	agents	in	the	world	(14).		
1.2.1 S. aureus antibiotic resistance 
Treatment	options	 for	S.	aureus	 infections	are	 largely	restricted	to	antibiotics,	against	
which	 resistance	 is	 quickly	 spreading.	 First-line	 penicillin	 antibiotics	were	 effectively	
introduced	in	1940	to	treat	S.	aureus;	however,	as	early	as	1942,	resistance	to	β	-lactams	
began	 to	 spread	 among	 S.	 aureus	 strains	 rendering	 many	 penicillin-based	 drugs	
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ineffective	(15).	Methicillin	was	introduced	in	1959	and	was	greatly	effective	against	S.	
aureus	 infections;	 however,	 MRSA	 were	 first	 reported	 just	 two	 years	 later	 with	 the	
acquisition	of	the	mec	mobile	element	in	many	strains	(16).	The	mec	genes,	(mecA,	mecB,	
and	mecC),	which	are	now	widespread	among	CoNS	and	CoPS,	encode	novel	penicillin-
binding	protein	(PBP2a)	that	renders	these	strains	resistant	to	all	β-lactam	antibiotics	
(17).				
The	first	methicillin-resistant	strains	were	Hospital	Acquired	(HA)	MRSA,	and	were	first	
identified	in	the	1960’s	in	immunocompromised,	hospitalized	individuals	(13,	18,	19).	In	
the	 1990’s	 a	 new	 MRSA	 strain	 was	 identified	 outside	 of	 a	 hospital	 setting,	 called	
Community	Acquired	(CA)	MRSA,	and	CA-MRSA	now	comprise	between	30-50%	of	all	
MRSA	infections	in	Canada	(13,	20).	CA-MRSA,	compared	to	its	HA-MRSA	counterpart,	
can	 infect	 otherwise	 healthy	 individuals,	 are	 typically	 more	 virulent,	 and	 are	 not	
contained	 within	 the	 hospital	 environment	 as	 they	 are	 frequently	 found	 in	 the	
community	setting	(13,	18,	19).	With	these	recent	statistics,	S.	aureus	 infections	are	a	
severe	public	health	concern	and	financial	burden.	The	most	frequent	site	of	CA-	and	HA-
MRSA	infections	is	the	skin	and	soft	tissue	(so	called	skin	and	soft	tissue	infections	or	
SSTIs),	which	can	range	from	mild	to	severe.	About	1-4%	of	CA-MRSA	infections	are	of	
greater	 severity	 such	 as	 osteomyelitis,	 endocarditis,	 necrotizing	 pneumonia,	 urinary	
tract	 infections,	and	sepsis	(21).	One	CA-MRSA	strain,	USA300,	 is	 the	most	commonly	
isolated	 CA-MRSA	 strain	 worldwide	 and	 as	 such	 is	 incredibly	 adept	 at	 infection	 and	
transmission	 and	 is	 globally	 known	 for	 its	 enhanced	 virulence	 and	 antimicrobial	
resistance	(8,	22).	
1.2.3 CA-MRSA strain USA300  
In	North	America,	the	epidemic	spread	of	CA-MRSA	can	be	attributed	to	USA300,	where	
by	2004	this	single	strain	was	the	most	common	agent	for	SSTIs	in	the	United	States	(22).	
Its	 increased	 virulence	 can	 be	 attributed	 to	 the	 presence	 of	 novel	 genetic	 mobile	
elements;	 unique	 to	 this	 clone	 are	 the	SEK	 (sek)	 and	 SEQ	 (seq)	 enterotoxins,	 Panton-
Valentine	 leucocidin	 (PVL)	 toxin,	 and	 the	 arginine	 catabolic	 mobile	 element	 (ACME)	
cassette	(23).		
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It	is	generally	thought	that	USA300	acquired	the	ACME	genetic	island	through	horizontal	
gene	transfer	from	S.	epidermidis,	or	another	CoNS,	as	a	homologous	ACME	sequence	was	
identified	in	S.	epidermidis	(23).	The	ACME	cassette	is	a	30.9	kb	genetic	island	that	derives	
its	 name	 from	 the	arc	gene	 cluster	 that	 is	 comprised	 of	 genes	 necessary	 for	 arginine	
catabolism,	referred	to	as	the	arginine	deiminase	pathway	(ADI)	(23).		
As	 all	 sequenced	 S.	 aureus	 strains	 have	 a	 chromosomally-encoded	 arc	 operon,	 the	
acquisition	of	the	ACME	cassette	confers	USA300	with	two	sets	of	arc	genes.	Whereas	the	
chromosomal	 arc	 operon	 is	 expressed	 under	 anaerobic	 growth	 conditions,	 ACME-
encoded	arc	is	expressed	constitutively	under	conditions	of	both	anaerobic	and	aerobic	
growth	 (24–26).	 The	 ADI	 pathway	 involves	 the	 catabolism	 of	 arginine	 for	 use	 as	 a	
nitrogen	 source,	 and	 is	 a	 prevalent	metabolic	 pathway	 found	 in	 both	 eukaryotic	 and	
prokaryotic	species	(27);	although,	its	exact	role	in	bacterial	survival	has	not	been	fully	
elucidated.	The	arc	operon	contains	five	genes	in	total,	arcA,	arcB,	arcD,	arcC,	and	arcR:	
arcA,	 arcB,	 and	 arcC	 are	 catabolic	 enzymes,	 that	 break	 arginine	 into	 L-ornithine,	
ammonium,	carbon	dioxide,	and	one	molecule	of	ATP.	Arginine	is	transported	into	the	
cell	by	the	arginine/ornithine	antiporter	ArcD,	and	the	entire	operon	is	regulated	by	the	
transcriptional	regulators	ArcR	and	divergently	transcribed	gene,	argR	(24,	28).		
In	 addition	 to	 the	 arc	 operon,	 the	 ACME	 cassette	 also	 encodes	 a	 spermidine	
(Spd)/spermine	 (Spm)	 acetyltransferase,	 designated	 SpeG	 (25,	 26).	 Spd	 and	 Spm	 are	
polyamines,	low-molecular	weight,	aliphatic	molecules	that	exert	pleiotropic	effects	on	
bacteria,	including	inhibition	of	microbial	growth	(29).	In	addition	to	polyamines	already	
present	on	the	skin,	during	skin	colonization,	increased	arginine	catabolism	from	the	arc	
operon	 results	 in	 secretion	 of	 high	 levels	 of	 L-ornithine,	 which	 induces	 the	 host’s	
production	of	polyamines	(25).	ACME-encoded	SpeG	is	able	to	detoxify	the	polyamines	
Spd	and	Spm,	resulting	in	enhanced	growth	of	USA300	during	skin	colonization	(30,	31).	
Thus,	 it	 is	 generally	 believed	 that	 the	 ACME	 cassette	 confers	 USA300	 with	 a	
hypervirulent,	skin	colonization	phenotype.	However,	the	exact	role	of	the	ACME	cassette	
in	virulence	is	unclear,	as	USA300	ACME-deficient	strains	had	no	changes	in	virulence	in	
rat	models	of	necrotizing	pneumonia	or	dermonecrosis,	compared	to	isogenic	WT	(32).	
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Thus,	 the	 ACME	 cassette	 may	 be	 important	 for	 enhanced	 transmission	 and	 not	
necessarily	for	enhanced	virulence	at	later	stages	of	infection,	although	research	is	still	
ongoing.	The	ACME	cassette	is	unique	to	USA300;	however,	all	S.	aureus	strains	contain	
a	vast	array	of	virulence	factors	that	aid	in	colonization,	transmission,	and	infection	in	
the	host.		
1.3 S. aureus and host innate immunity 
To	 survive	 in	 the	 host,	 S.	 aureus	must	 evade	 being	 killed	 by	 the	 primary	 immune	
response.	 Integral	members	 of	 innate	 immunity	 are	 professional	 phagocytes,	 such	 as	
macrophages	and	neutrophils,	 that	 are	 critical	 to	bacterial	 clearance	during	 infection.	
Phagocytes	 have	 a	 large	 arsenal	 of	 antimicrobial	 effectors;	 however,	 remarkably,	 S.	
aureus	 is	 often	 able	 to	 survive	macrophage	 and	 neutrophil-mediated	 killing	 (33,	 34).	
Discussed	below	are	some	of	 the	effectors	employed	by	neutrophils	and	macrophages	
against	S.	aureus,	and	ways	in	which	this	pathogen	withstands	such	effectors.		
1.3.1 Phagocyte extravasation 
The	first	step	of	phagocyte-mediated	clearance	is	extravasation	to	the	site	of	infection.	
Microbes	 that	have	penetrated	 the	 skin	barrier	and	are	 localized	 to	 tissues	 cause	 the	
release	of	chemoattractants,	cytokines,	bacterial	products,	and	selectins	that	all	activate	
β2	integrins	on	the	surface	of	phagocytes	(33).	β2	integrins	bind	with	high	affinity	to	the	
intercellular	adhesion	molecule	1	 (ICAM-1)	of	endothelial	 cells.	Thus,	phagocytes	 that	
were	“rolling”	along	the	blood	vessel	wall	through	temporary	contact	of	glycoproteins	on	
the	 neutrophil	 and	 with	 P-	 and	 E-selectins	 on	 endothelial	 cells,	 suddenly	 become	
adherent	 through	 β2	 integrin/ICAM-1	 interaction.	 The	 result	 of	 this	 adherence	 is	 the	
extravasation	of	neutrophils	from	the	blood-stream	across	the	endothelial	layer	(35).		
S.	aureus	interferes	with	diapedesis	through	staphylococcal	superantigen-like	5	(SSL-5),	
which	blocks	interaction	of	phagocytes	to	P-selectin	glycoprotein	ligand-1	(PSGL-1);	this	
prevents	cell	adherence	and	the	“rolling”	phenomenon	needed	for	eventual	extravasation	
(36).	Furthermore,	SSL-5	thwarts	chemokine/chemokine	receptor	interaction	by	binding	
to	chemokines	through	a	highly	conserved	glucosaminoglycan	(GAG)-binding	site	(37).	
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Finally,	the	Eap	protein	of	S.	aureus	binds	to	ICAM-1	on	endothelial	cells,	which	inhibits	
the	 firm	 adhesion	 of	 neutrophils	 to	 the	 endothelium,	 preventing	 translocation	 of	
neutrophils	(33).				
1.3.2 Priming and activation of phagocytes 
Phagocytes	that	cross	the	endothelial	barrier	are	met	with	a	plethora	of	chemoattractants	
that	direct	them	to	the	site	of	infection,	and	proinflammatory	stimulants	that	prime	and	
activate	 them	 for	 killing.	 Priming	 of	 phagocytes	 is	 predominantly	 through	microbial	
factors.	Priming,	although	not	essential	to	phagocyte	function,	results	in	amplification	of	
neutrophil	 responses,	 including	 altering	 the	 composition	 of	 surface	 receptors	 and	
adhesion	 molecules,	 heightened	 oxidative	 burst	 and	 actin	 polymerization,	 and	
augmented	 degranulation	 of	 secretory	 vesicles	 and	 subsets	 of	 granules	 (38).	
Staphylococci	 release	 a	 number	 of	 molecules	 that	 can	 activate	 the	 transmembrane,	
glycoprotein	toll-like	receptors	(TLRs)	on	neutrophils;	these	include,	but	are	not	limited	
to,	bacterial	 lipoproteins	 that	 activate	 receptors	TLR1,	TLR2,	 and	TLR6,	 and	bacterial	
CpG-rich	DNA	that	activates	TLR9	(39).			
1.3.3 Phagocytosis and oxidative burst 
At	 the	 site	 of	 infection,	 phagocytes	 aid	 in	 bacterial	 clearance	 through	 engulfing	 the	
invading	pathogen	in	a	process	termed	phagocytosis.	Phagocytosis	is	enhanced	through	
the	opsonization	of	the	microorganism	through	components	of	the	complement	system,	
typically	immunoglobulins,	or	other	innate	immune	components	(38).	Phagocytosis	is	a	
receptor-mediated	process,	where	 receptors	on	 the	 surface	 of	 the	 phagocyte,	 such	 as	
TLRs	 that	 can	 recognize	 bacterial	 components,	 or	 immunoglobulin	 Fc	 receptor	 that	
recognizes	the	constant	region	of	IgG,	bind	to	molecules	on	the	bacterial	cell	surface	(38).	
The	result	of	this	binding	is	formation	of	cell	membrane	extensions,	or	pseudopods,	on	
the	 phagocytic	 membrane.	 Pseudopods	 form	 around	 the	 microorganism	 and	 then	
envelope	the	microbe	into	a	membrane-bound	vacuole	termed	the	phagosome.		
S.	aureus	inhibits	opsonization	through	staphylococcal	complement	inhibitor	(SCIN)	that	
blocks	 the	 C3	 convertase,	 or	 secretes	 the	 metalloprotease	 aureolysin	 to	 cleave	 and	
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inactivate	C3	(40,	41).	Additionally,	S.	aureus	uses	multiple	virulence	factors	to	bind	and	
activate	 clotting	 factors,	 such	 as	 fibrin,	 fibrinogen,	 fibronectin,	 and	 prothrombin,	 that	
form	around	the	bacteria	and	protect	the	cells	from	phagocytosis	by	forming	a	protective	
“shield”	(42).			
If	phagocytosis	of	S.	aureus	occurs,	phagocytosis	alone	is	not	sufficient	to	kill	microbes,	
as	 phagosomes	 still	 contain	 an	 appreciable	 amount	 of	 nutrients;	 therefore,	 it	 is	 the	
process	of	phagosome	maturation	in	the	macrophage,	or	fusion	with	preformed	granules	
in	the	neutrophil,	that	is	needed	to	kill	engulfed	bacteria	(33,	43).	Neutrophil	granules	
contain	enzymes	that	have	cytotoxic	effects	on	bacteria,	 these	 include:	 lysozymes	that	
degrade	 the	 cell	 wall,	 proteases	 that	 damage	 bacterial	 toxins	 and	 surface	 associated	
virulence	factors,	enzymes	such	as	myeloperoxidase	that	assist	in	metabolic	burst,	and	
antimicrobial	peptides	called	defensins	(44).		
Along	with	granule	 fusion	with	 the	phagosome,	neutrophils	 are	also	 characterized	by	
production	of	reactive	oxygen	species	(ROS),	in	a	process	defined	as	the	oxidative	burst.	
Reactive	oxygen	species	are	the	byproduct	of	the	stepwise	reduction	of	oxygen	to	water	
producing	the	active	 intermediates	superoxide	(HO2·),	hydrogen	peroxide	(H2O2),	and	
hydroxyl	radical	(OH·)	(45).	The	production	of	ROS	in	phagocytes	is	primarily	performed	
through	 the	 activity	 of	 the	 membrane-bound,	 multiprotein	 Nicotinamide	 Adenine	
Dinucleotide	Phosphate	(NADPH)-oxidase.	NADPH-oxidase	is	found	in	the	phagosomal	
membrane	and	catalyzes	the	production	of	superoxide	(O2-	),	which	serves	as	a	catalyst	
for	 other	 reactive	 oxidants.	 NADPH	 is	 typically	 dormant	 in	 polymorphonuclear	 cells	
(PMNs)	but	is	induced	in	the	presence	of	pro-inflammatory	cytokines	(46).	ROS	is	not	
only	released	into	bacteria-containing	phagosomes	but	can	be	excreted	extracellularly	
into	 the	 environment.	 The	 oxidative	 burst	 is	 deleterious	 to	 bacterial	 cells,	 causing	
damage	to	membranes,	DNA,	RNA,	and	proteins	(47).			
S.	 aureus	 has	 a	 number	 of	 protective	 strategies	 against	 ROS.	 Staphyloxanthine,	 the	
molecule	responsible	for	the	golden	pigment	of	S.	aureus,	shields	the	membrane	against	
peroxide	and	singlet	oxygen	(48).	Inside	the	bacterial	cell,	S.	aureus	synthesizes	enzymes	
that	help	 to	detoxify	ROS.	The	main	enzyme	responsible	 for	ROS	detoxification	 in	the	
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cytoplasm	is	catalase.	Catalase	scavenges	hydrogen	peroxide	and	converts	it	to	water	and	
oxygen	(49).	S.	aureus	also	encodes	alkyl	hydroperoxide	reductase	(ahpC)	and	surface	
factor	 promoting	 resistance	 to	 oxidative	 killing	 (SOK),	 both	 enzymes	 are	 involved	 in	
resistance	to	ROS	(45,	50).	In	addition,	S.	aureus	also	encodes	two	superoxide	dismutases,	
SodA	and	SodM	(51,	52).		
1.3.4 Calprotectin 
The	host	actively	sequesters	Mn2+	through	calprotectin	(Cp),	which	comprises	50%	of	the	
total	 proteinaceous	 content	 of	 the	 neutrophil	 cytoplasm.	 Calprotectin	 is	 upregulated	
during	 infection	 in	 neutrophils,	 as	 well	 as	 epithelial	 cells,	 and	 works	 to	 sequester	
essential	 transition	 metals	 Zn2+,	 Mn2+,	 and	 Fe2+	 (57–59).	 The	 process	 of	 withholding	
essential	micronutrients	from	invading	microbes	is	defined	as	nutritional	immunity,	and	
is	critical	to	bacterial	clearance.	Nutritional	immunity	results	in	decreased	survival	of	the	
pathogen;	it	was	shown	that	Cp-deficient	mice	had	increased	S.	aureus	bacterial	burden	
in	 the	 liver	 compared	 to	WT	mice	 (60).	 Calprotectin	 is	 a	 S100	 class	 protein	 that	 is	 a	
heterodimer	 of	 S100A8	 and	 S100A9	 and	 is	 a	 member	 of	 the	 EF-hand	 Ca2+	 binding	
proteins	(61,	62).		
Cp	 affects	 the	 pathogenesis	 of	 S.	 aureus.	 All	 staphylococci	 encode	 the	 superoxide	
dismutase	SodA;	however,	only	S.	aureus	possesses	SodM	(53).	Previously,	it	was	shown	
that	SodA	and	SodM	bind	to	Mn2+	as	an	essential	coordinating	metal,	where	SodM	can	
also	use	Fe2+	in	place	of	Mn2+	(54).	Manganese	is	an	important	micronutrient	in	resistance	
to	oxidative	burst,	where	it	is	not	only	essential	to	the	function	of	superoxide	dismutase,	
SodA,	but	itself	can	neutralize	ROS	(55).	Manganese	in	S.	aureus	is	taken	up	by	the	ABC	
transporter	MntABC	and	NRAMP-like	transporter	MntH	(56).	Deletion	of	both	mntC	and	
mntH	resulted	in	a	significant	decrease	in	bacterial	burden	in	the	liver	and	kidneys	(55).		
Because	of	 the	close	relationship	between	Mn2+	and	resistance	to	ROS,	S.	aureus	must	
overcome	metal	 sequestration	 by	 Cp	 to	 survive	 oxidative	 burst.	 This	 is	 achieved	 by	
upregulation	of	mnt	manganese	transporters	during	infection	and,	perhaps,	through	use	
of	the	Fe2+-containing	SodM	in	place	of	SodA	(55).	Additionally,	S.	aureus	also	steals	Zn+	
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from	Cp	through	use	of	the	zinc-binding	metallophore	staphylopine	(to	be	discussed	in	
greater	detail	in	section	1.5.5	)	(63).	
1.3.5 Neutrophil extracellular traps 
Neutrophils	 can	 expel	 their	 intracellular	 contents	 in	 what	 is	 defined	 as	 neutrophil	
extracellular	 traps	 (NETs).	 NETs	 comprise	 nucleic	 acid,	 granule	 proteins,	 and	 other	
cytosolic	 components	 that	 work	 to	 ensnare	 nearby	 microbes,	 preventing	 bacterial	
dissemination	and	sepsis.	Although	it	is	not	entirely	clear	what	causes	the	formation	of	
NETs,	 stimuli	 have	 been	 identified	 that	 include	 phorbol	 myristate	 acetate,	
lipopolysaccharide	(LPS),	 interleukin-8	(IL-8),	and	certain	bacteria	(33);	however,	 the	
greatest	activator	of	NET	formation	is	by	platelet	activation	through	TLR4	(64).	S.	aureus	
secretes	a	nuclease,	encoded	by	nuc,	that	degrades	NETs	(65);	the	degradation	product	
of	nuclease	activity	is	modified	by	S.	aureus	adenosine	synthase	A,	encoded	by	adsA,	to	
produce	2’-deoxyadenosine	 (dAdo)	 (66).	The	dAdo	molecule	was	 found	 to	be	 toxic	 to	
macrophages	and	thus	prevents	macrophage	recruitment	into	S.	aureus	abscesses,	where	
strains	that	lack	nuc	and	adsA	are	more	susceptible	to	macrophage	killing	in	vivo	(66).		
S.	aureus	has	many	ways	to	hinder	every	step	of	neutrophil-mediated	killing,	including	
neutrophil	chemotaxis,	activation,	priming,	and	phagocytosis	(33).	S.	aureus	is	also	fully	
capable	of	 flourishing	 inside	the	macrophage,	eventually	escaping	the	phagosome	and	
causing	macrophage	lysis	(67).	The	exact	mechanisms	involved	in	macrophage	survival,	
however,	are	not	fully	delineated	and,	like	neutrophil	evasion,	are	most	likely	the	result	
of	multiple	virulence	factors	working	in	concert.			
1.3.6 Additional key virulence factors of S. aureus  
Already	discussed	are	some	of	the	key	factors	used	by	S.	aureus	in	resistance	to	killing	by	
professional	phagocytes.	However,	S.	aureus	has	a	vast	array	of	virulence	factors	that	aid	
in	resistance	to	many	facets	of	the	innate	immunity.	Figure	1-1	and	the	following	sections	
highlight	just	some	of	these	key	virulence	mechanisms.		
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Fig	1-1.	Mechanisms	by	which	S.	aureus	subverts	host	immune	defenses.	The	S.	aureus	
cell	 wall	 is	 comprised	 of	 a	 thick	 peptidoglycan	 (PGN)	 layer	 that	 provides	 structural	
integrity	 and	 protection	 against	 osmotic	 pressure,	 and	PGN-anchored	 lipotechoic	 and	
teichoic	acid	that	regulate	autolysis.	DltABCD	and	MprF	modify	positive	charges	on	the	
cell	 wall	 and	 afford	 resistance	 to	 cationic	 antimicrobial	 peptides.	 Capsular	
polysaccharide	 gives	 an	 additional	 layer	 of	 protection	 from	 antimicrobials.	 Secreted,	
pore-forming	toxins,	a,	b,	d	(including	other	phenol-soluble	modulins)	g,	and	leukocidins	
cause	 lysis	 of	 target	 host	 cells.	 Exo-enzymes,	 such	 as	 V8	 protease,	 aureolysin,	 and	
phospholipase	C,	cleave	and	degrade	host	proteins	and	lipids.	Secreted	exotoxins	interact	
with	 MHC	 class	 II-T	 cell	 receptor	 complexes	 and	 cause	 non-specific	 activation	 and	
proliferation	of	T	cells.	Covalently	anchored	adhesion	determinants,	fibrinogen	binding	
protein,	fibronectin	binding	protein,	clumping	factor,	VonWillebrand	(VW)	factor	binding	
protein,	 and	 Efb	 bind	 to	 host	 factors	 such	 as	 fibrinogen,	 fibronectin,	 VW	 factor,	 and	
elastin.	Opsonization	by	phagocytes	is	hindered	by	Efb	and	staphylococcal	complement	
inhibitors	(SCIN)	that	bind	to	complement	factor,	C3,	and	inhibit	classic	and	alternative	
C3	convertases;	additionally,	protein	A	binds	to	Fc	domains	of	immunoglobulin	in	a	non-
opsonization	orientation.	Siderophores,	staphyloferrin	A	and	B,	and	Isd	protiens	aid	in	
acquisition	of	ferric	iron	and	heme,	respectively.	Essential	amino	acids	and	peptides	are	
transported	inside	the	cell	through	dedicated	transporters,	such	as	BrnQ.	Inside	the	cell,	
catalase	and	superoxide	dismutase	aid	in	detoxification	of	reactive	oxygen	species,	and	
penicillin	binding	proteins	provide	resistance	to	b-lactam	antibiotics.		
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Secreted virulence factors 
S.	 aureus	 secretes	 a	 number	 of	 exotoxins,	 perhaps	 the	 best	 known	 being	 α-toxin	 (α-
hemolysin),	a	293-amino	acid	protein	that	forms	distinguishing	β-sheet	conformations.	
α-toxin	is	a	receptor-mediated	toxin,	and	thus	receptor	ADAM10	is	required	on	the	target	
cell	for	proper	pore	formation,	although	it	has	been	suggested	that	high	concentrations	
of	α-toxin	may	diminish	the	need	for	ADAM10	(68).	Upon	binding	to	the	receptor,	α-toxin	
monomers	oligomerize	to	form	a	β-barrel	configuration	that	comprises	the	mature	pore	
in	the	cellular	membrane.	This	pore	allows	the	passive	transport	of	molecules	less	than	
2	kDa,	and	thus	the	cell	undergoes	osmotic	lysis	and	subsequent	necrosis	(69,	70).		
Other	pore-forming	toxins	produced	by	S.	aureus	are	γ-hemolysin	and	leukocidins.	Unlike	
α-toxin,	γ-hemolysin	and	leukocidins	are	comprised	of	a	hetero-octamer	comprised	of	4	
units	of	each	polypeptide,	defined	as	slow	(S)	and	fast	(F)	based	on	their	electrophoretic	
mobility	(68).	γ-hemolysin	has	two	different	S	components	(HlgA	and	HlgC)	that	pairs	
with	 the	 F	 component,	HlgB.	S.	 aureus	produces	 three	 different	 leukocidins,	 the	most	
characterized	 of	 these	 being	 the	 Panton-Valentine	 leukocidin	 (PVL)	 (71).	 PVL	 is	
comprised	of	LukS-PV	and	LukF-PV,	 the	other	 two	 leukocidins	are	LukED	and	LukGH	
(LukAB).	 Like	 α-toxin,	 the	 individual	 monomers	 of	 γ-hemolysin	 and	 leukocidins	
assemble	into	a	β-barrel	structure	that	forms	a	pore,	causing	lysis	of	the	target	host	cell.	
Toxins	 are	 generally	 observed	 in	 the	 supernatant	 of	 cells	 and	 function	 as	 a	 secreted	
factor.	 LukGH/AB,	 however,	 is	 anchored	 to	 the	 bacterial	 cell	 membrane	 (72–75).	 β-
hemolysin	differs	from	α-	and	γ-hemolysin	in	that	it	does	not	cause	cell	lysis	by	pore-
formation	but	degrades	sphingomyelin	in	the	target	cell	membrane	into	ceramide	and	
phosphorylcholine.	 This	 degradation	 is	 thought	 to	 alter	 membrane	 fluidity	 and	
destabilize	the	membrane	bilayer	(76).		
δ-hemolysin	 and	 other	 phenol-soluble	 modulins	 (PSM)	 are	 amphipathic,	 α-helical	
peptides	that	are	secreted	by	the	ABC	transporter	phenol-soluble	modulin	transporter	
(Pmt)	(77).	There	are	seven	PSMs	identified	in	S.	aureus,	broadly	characterized	as	short	
peptides	(~20	amino	acids),	one	of	which	is	δ-hemolysin,	and	are	referred	to	as	PSMα,	
and	long	peptides	(~40	amino	acids)	designated	PSMβ	(78).	Roughly	60%	of	CA-MRSA		
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secreted	protein	mass	is	comprised	of	PSMs,	and	as	such	they	are	key	virulence	factors.	
They	degrade	a	wide	array	of	eukaryotic	cells,	 including	osteoblasts,	endothelial	cells,	
epithelial	cells,	PMNs,	monocytes,	and	erythrocytes	(78–80).	A	S.	aureus	mutant	deficient	
in	PSMα	exhibited	a	severe	reduction	in	abscess	size	in	a	murine	skin	infection	model	
(78)	and	in	a	rabbit	skin	infection	model	(81);	moreover,	in	a	CA-MRSA	psmα	mutant,	
mice	had	a	significant	delay	in	morbidity	compared	to	mice	infected	with	the	isogenic	WT	
strain	in	a	murine	bacteremia	model	(78).	The	profound	cytolytic	activity	of	PSMs	may	
rely	on	other	secreted	virulence	factors,	as	PSM	activity	was	enhanced	in	the	presence	of	
β-toxin	(82),	PVL	(83),	and	antimicrobial	peptides	(84).	
Lastly,	S.	aureus	produces	immuno-stimulatory	superantigens	that	work	to	activate	large	
populations	of	T	cells	by	indiscriminately	binding	MHC	II	molecules	and	the	Vβ-region	of	
T	 cell	 receptors	 (TCRs)	 (85).	 The	 trimolecular	 complex	 of	 superantigen-MHC	 II-TCR	
induces	 large-scale	 T	 cell	 proliferation	 resulting	 in	 massive	 secretion	 of	 cytokines,	
referred	to	as	a	cytokine	storm.	This	results	in	extensive	damage	to	epithelial	cells	and	
capillary	 damage	 leading	 to	 hypotension	 and,	 in	many	 cases,	morbidity	 (86).	 A	 large	
number	of	superantigens	have	been	identified	in	staphylococci,	named	as	exotoxins	A-C	
(with	antigenic	variant	D	and	E)	and	G-Q.	However,	perhaps	the	most	well-known	is	toxic	
shock	syndrome	toxin-1	(TSST-1)	which,	as	its	name	suggests,	is	the	causative	agent	of	
toxic	shock	syndrome,	a	severe	toxigenic	state	marked	by	rapid	onset	of	fever	and	multi-
organ	failure	(87,	88).		
Secreted Exo-proteins 
Staphylococcus	aureus	produces	a	number	of	proteins	that	serve	as	secreted	virulence	
factors	 that	 can	 work	 to	 degrade	 host	 proteins,	 lipids,	 and	 interfere	 with	 signaling	
cascades.	As	previously	mentioned,	staphylococci	utilizes	coagulase	that	clots	plasma	by	
facilitating	the	conversion	of	fibrinogen	to	fibrin	by	activating	host	enzyme	prothrombin	
(89).	Staphylokinase	(Sak)	is	a	serine	protease	that	functions	as	a	plasminogen-activator	
and	causes	the	conversion	of	plasminogen	to	plasmin.	S.	aureus	also	produces	glycerol	
ester	 hydrolases	 and	 lipases	 that	 degrade	 triglycerides,	 and	 nucleases	 that	 aid	 in	
degradation	of	NETs	(90).				
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Surface-associated factors 
Cell	wall	anchored	(CWA)	proteins	are	linked	to	peptidoglycan	through	the	enzymatic	
activity	of	sortases.	Each	CWA	protein	has	a	carboxy-terminal	sorting	signal,	the	majority	
of	which	is	the	LPXTG	motif	recognized	by	sortase	A,	whereas	sortase	B	is	active	only	
during	iron-starvation	and	recognizes	a	NPQxN/P	motif	found	on	the	IsdC	protein	(91).	
The	sorting	signal	is	essential	for	secretion	and	anchoring	of	the	protein	to	the	cell	wall.	
Microbial	surface	components	recognizing	adhesive	matrix	molecules	(MSCRAMMs)	are	
a	large	family	of	surface-associated	factors	that	aid	in	infection	by	facilitating	adherence	
to	host	cells.	Many	MSCRAMM-family	proteins	contain	tandemly-linked	IgG-like	folds	in	
the	N-terminal	region	(92),	and	interact	with	host	clotting	factors	that	serve	to	protect	S.	
aureus	 from	primary	 immune	responses	(93).	Fibronectin	binding	proteins	(FnBPs)	A	
and	B	bind	to	fibronectin	on	the	surface	of	cells,	which	acts	as	a	bridge	to	integrin	α5β1,	
a	phagocytic	receptor.	This	interaction	with	integrin	α5β1	results	in	remodeling	of	the	
cytoskeleton	that	allows	internalization	of	S.	aureus	(94,	95).	Clumping	factors	A	and	B	
bind	 to	 fibrinogen	 and	 are	 responsible	 for	 platelet	 adhesion	 and	 aggregation.	 von	
Willebrand	 factor	 binding	 protein	 (vWbp)	 also	 activates	 prothrombin	 and	 can	 bind	
fibrinogen	and	von	Willebrand	factor	(2).	Serine-aspartate	repeat	proteins	(SdrC,	SdrD,	
and	SdrE)	are	adhesins	that	have	been	implicated	in	nasal	colonization	(96).	
Protein	A	(SpaA)	is	one	of	the	most	studied	S.	aureus	surface	proteins;	it	binds	to	the	Fc	
portion	of	 IgG,	 an	 immune	evasion	 tactic	 that	 impairs	opsonization	and	phagocytosis.	
Protein	A	 can	 also	 bind	 to	 von	Willebrand	 factor	 and	 complement	 protein	 C3,	which	
increases	 S.	 aureus	 adhesion	 to	 platelets	 (97).	 A	 second	 binder	 of	 immunoglobulin	
protein	 (Sbi)	 is	both	an	anchored	and	secreted	 Ig-binding	protein	 that,	 in	addition	 to	
antibody	 binding,	 works	 synergistically	 with	 extracellular	 fibinogen-binding	 protein	
(EfB)	to	bind	plasmin	and	leads	to	the	degradation	of	complement	proteins	C3a,	C3b,	and	
C3	(98).	In	addition,	most	S.	aureus	strains,	but	not	the	aforementioned	USA300	due	to	
mutations	 in	 cap5D	 and	 cap5E	 genes,	 produce	 a	 polysaccharide	 capsule,	 typically	
serotype	 5	 or	 8,	 that	 protects	 the	 cell	 from	 damaging	 host	 factors.	 The	 capsule	 is	
important	in	abscess	formation	(99,	100).			
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S. aureus biofilms 
Most	S.	aureus	strains	produce	biofilms,	which	are	comprised	of	cells	embedded	in	thick	
extracellular	polymeric	matrices	produced	by	sessile	microbial	communities	that	allow	
attachment	to	hard	surfaces	or	other	cells.	Biofilms	are	a	particular	threat	in	the	context	
of	medical	implants	or	catheters,	where	they	are	challenging	to	remove	and	protect	the	
cells	 from	 antibiotic	 treatment.	 They	 are	 generally	 comprised	 of	 host	 factors,	
polysaccharides,	 proteins,	 and	 extracellular	 DNA	 (eDNA)	 (101).	 S.	 aureus	 biofilm	
formation	on	hard	surfaces	is	largely	facilitated	by	the	accumulation-associated	protein	
(Aap),	autolysins	AtlA	and	AtlE,	and	wall	teichoic	acid	(WTA)	and	lipoteichoic	acid	(LTA)	
(92).	 Biofilms	 on	 cell	 surfaces	 predominantly	 consist	 of	 CWA	 proteins	 and	 secreted	
proteins	that	activate	and	bind	to	clotting	factors,	such	as	FnBPA	and	FnBPB,	ClfA	and	
ClfB,	and	SdrCDE	(102).	Additionally,	all	PSM	surfactant	peptides	are	capable	of	aiding	in	
biofilm	formation	and,	as	such,	are	critical	biofilm-structuring	factors.	As	viewed	using	
confocal	 laser-scanning	 microscopy	 (CLSM),	 psm	 mutants	 had	 significantly	 reduced	
biofilm	formation	compared	to	isogenic	WT	(103),	demonstrating	how	S.	aureus	utilizes	
virulence	factors	for	multiple	roles	during	infection.			
1.3.7 Regulation of virulence factors 
During	infection,	S.	aureus	tightly	regulates	expression	of	its	virulence	factors.	Adhesion	
proteins	are	largely	produced	in	the	early	phase,	or	establishment,	of	infection,	where	
manipulation	of	host	cells	and	clotting	factors	create	a	favorable	growth	environment.	
Toxins	and	enzymes	are	secreted	at	the	later	stages	of	infection	when	tissue	destruction	
and	 bacterial	 dissemination	 are	 necessary	 (104).	 Regulation	 in	 the	 cell	 is	 achieved	
through	two	broadly	categorized	families	of	transcriptional	regulators	i)	two-component	
systems	 (TCS),	 comprised	 of	 an	 environmentally	 “sensing”	 transmembrane	 histidine	
kinase	 and	 cytoplasmic	 response	 regulator	 and	 ii)	 SarA-family,	 single-component	
regulators	(105).					
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Accessory gene regulator (Agr) system 
The	majority	of	exoproteins	produced	by	S.	aureus	are	regulated	by	the	accessory	gene	
regulator	 (agr)	 system,	 which	 functions	 as	 a	 global	 regulator	 and	 activator	 of	 many	
virulence	genes	(106,107).	The	agrBDCA	operon	encodes	two,	divergent	transcriptional	
products,	RNAII	 and	RNAIII,	where	RNAII	 encodes	agrBDCA	 that	 are	 involved	 in	 cell-
density	 sensing.	AgrD	 is	 a	46-amino	acid	peptide	 that	 is	processed	by	 the	membrane	
protease	AgrB,	to	the	autoinducing	thiolactone	pepetide	(AIP),	7-9	amino	acids	in	length.	
AIP	is	a	quorum	sensing	molecule	and	is	constitutively	secreted	(108).	Quorum	sensing	
in	S.	aureus	relies	on	the	TCS	AgrCA	where	AgrC	is	a	transmembrane	histidine	kinase	and	
AgrA	is	the	cognate	response	regulator.		
At	 high	 cell-density,	 AIP	 is	 sensed	 by	 AgrC,	 which	 causes	 autophosporylation	 of	 an	
intracellular	histidine	kinase	domain,	which	then	phosphorylates	AgrA	causing	release	
of	AgrA	from	AgrC	allowing	transcriptional	activation	of	the	agr	operon.	RNAIII	carries	
the	open	reading	frame	for	δ-hemolysin	and	encodes	one	of	the	largest	regulatory	RNAs	
(109).	 Thus,	 the	 combined	 regulon	 of	 RNAIII	 and	 AgrA	 is	 hundreds	 of	 genes,	 many	
involved	 in	 virulence,	 that	 generally	 result	 in	 the	 upregulation	 of	 toxins	 and	
downregulation	 of	 surface	 proteins	 (110,	 111).	 Not	 surprisingly,	 agr	 is	 essential	 for	
virulence	in	vivo	(112–114).	
Staphylococcal accessory regulator (Sar) family 
The	transcription	of	RNAII	and	RNAIII	is	partially	reliant	on	another	regulatory	system,	
designated	the	staphylococcal	accessory	regulator	(sar).	The	sar	locus,	roughly	1.2	kb,	is	
comprised	 of	 three	 overlapping	 genes,	 sarA,	 sarB,	 and	 sarC,	 each	 having	 their	 own	
promoter	(115).	The	expression	of	both	sarA	and	sarB	is	required	for	full	expression	of	
agr,	and	SarA	has	been	shown	to	interact	with	both	RNAII	and	RNAIII	promoters.	SarA	is	
also	responsible	for	the	regulation	of	many	other	genes,	either	through	direct	binding	to	
the	gene	promoter,	 through	 indirect	 regulation,	or	 through	mRNA	stabilization	 (104).	
Phenotypically,	SarA	activates	expression	of	fibronectin	and	fibrinogen	binding	proteins	
and	toxins,	while	repressing	expression	of	protein	A	and	proteases	(105).		
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Another	notable	member	of	the	SarA	family	of	transcriptional	regulators	is	MgrA,	which	
is	a	regulator	of	autolysis	in	S.	aureus.	Autolysins	are	peptidoglycan	hydrolases	that	are	
specific	 for	various	structural	components	of	 the	peptidoglycan	wall	 (116).	 Important	
genes	 upregulated	 by	MgrA	 are	 capsule	 polysaccharides,	 serine	 proteases,	 sortase	 A,	
leukotoxins,	and	α-hemolysins,	although	RNAseq	of	an	mgrA	mutant	revealed	that	over	a	
hundred	genes	were	affected	by	MgrA	regulation	(117,	118).	MgrA	itself	is	upregulated	
by	the	autolysis-related	locus,	ArlRS	TCS	(118).	
Repressor	of	 toxins	 (Rot)	 is	 a	DNA-binding	protein	 that	belongs	 to	 the	SarA-family	of	
regulators.	Rot,	like	many	regulators	in	the	SarA	family,	performs	dual	regulation,	as	it	
both	 activates	 the	 expression	 of	 surface	 proteins	 and	 immunomodulators,	 such	 as	
Protein	 A	 and	 superantigens,	 and	 represses	 expression	 of	 exotoxins	 and	 secreted	
enzymes	(119).		
S. aureus exoprotein (Sae) regulator 
Sae	(S.	aureus	exoprotein	expression)	locus	encodes	the	TCS	SaeRS,	where	SaeS	 is	 the	
sensor	kinsase	and	SaeR	is	the	response	regulator.	Two	auxiliary	genes,	saeP	and	saeQ,	
encode	 lipoprotein	SaeP	and	transmembrane	protein	SaeQ	(120).	SaePQ	is	needed	for	
SaeS	phosphorylation	activity	by	forming	an	SaeSPQ	ternary	complex.	A	major	activation	
signal	 of	 the	 Sae	 system	 is	 the	 human	 neutrophil	 peptide	 1,	 2,	 and	 3,	 which	 are	
antimicrobial	 peptides	 produced	 by	 neutrophils	 and	 constitute	 30-50%	 of	 the	 total	
protein	 in	 azurophilic	 granules.	 A	 second	major	 activation	 signal	 is	 calprotectin,	 also	
produced	by	neutrophils,	that	sequesters	metals	zinc,	manganese,	and	iron,	and	thereby	
inhibits	S.	aureus	proliferation	 (120).	The	Sae	 system	activates	a	number	of	 virulence	
genes,	including	fbnA,	coA,	and	sbi,	and	represses	virulence	factors,	including	hla	and	hlb,	
and	its	regulation	is	growth-dependent	but	agr-independent	(120,	121).	
Regulation of biofilms 
The	formation	of	biofilms	in	S.	aureus	is	controlled	by	overlapping	regulatory	pathways,	
where	repression	or	inactivation	of	SarA	results	in	decreased	biofilms	and	inactivation	
of	 agr	 results	 in	 heightened	 formation	 of	 biofilms.	 Rot	 has	 been	 implicated	 as	 a	 key	
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regulatory	 factor	 in	 biofilm	 formation,	 and	 inactivation	 of	 ArlRS	 and	 MgrA	 leads	 to	
decreased	biofilm	formation	(118).			
During	 infection	and	the	battle	 for	survival,	S.	aureus	relies	on	a	plethora	of	virulence	
factors	to	ultimately	avoid	immune	destruction	and	acquire	essential	nutrients;	one	such	
essential	nutrient	is	iron.	Iron	homeostasis	in	S.	aureus,	and	in	the	host,	will	be	discussed	
in	sections	1.4	and	1.5.	
1.4 Iron 
All	organisms	require	certain	metals	to	survive.	The	function	of	transition	metals	in	the	
cell	 is	 broken	 down	 into	 three	 main	 functions:	 redox	 catalytic	 cofactors,	 non-redox	
catalytic	 cofactors,	 and	 non-catalytic	 functions	 (122).	 Although	 transition	metals	 are	
essential	to	the	cell,	at	high	concentrations	they	are	also	toxic,	as	they	readily	participate	
in	Fenton	chemistry	and	can	cause	 formation	of	reactive	oxygen	and	nitrogen	species	
(123).		
H2O2		+		Fe2+		®		Fe3+		+		OH-		+		·OH			(Fenton)	
Iron	is	the	most	abundant	metal	in	the	human	body	and	the	fourth	most	abundant	metal	
in	the	earth’s	crust.	With	the	exception	of	some	lactobacilli	and	spirochetes,	all	organisms	
require	 iron	 for	key	metabolic	pathways,	 including	DNA	replication	and	 transcription	
(122,	124).	In	an	attempt	to	conserve	iron	for	host	functions	and	reduce	the	amount	of	
available	iron	for	invading	microbes,	the	amount	of	free	iron	is	very	limited	within	the	
human	body	and	is	present	at	concentrations	too	low	to	sustain	bacterial	growth,	with	
estimates	ranging	from	10-8	M	to	some	as	low	as	10-24	M	(125).	The	intricate	system	of	
iron	 sequestration	 by	 the	 host	 is	 referred	 to	 as	 nutritional	 immunity	 and	 is	 a	 crucial	
component	 of	 microbial	 control	 and	 clearance	 (123).	 In	 addition	 to	 the	 active	
sequestration	of	iron,	at	physiological	pH	and	in	the	presence	of	oxygen,	iron	is	readily	
oxidized	 from	 ferrous	 (Fe2+)	 to	 biologically	 inactive,	 ferric	 (Fe3+)	 iron.	 Therefore,	 a	
defining	characteristic	of	pathogens	is	the	ability	to	acquire	iron	from	the	host	despite	
the	extreme	efforts	of	the	human	body	to	keep	iron	away	from	invading	microbes.							
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1.4.1 Host sequestration of iron 
Iron	is	an	essential	nutrient	in	the	human	body,	where	20-26	mg	of	iron	is	used	daily;	the	
largest	portion	of	 this	 iron	 (~80%)	 is	 found	 intracellularly	associated	 to	heme	 (126–
128).	 The	 heme	 prosthetic	 group	 is	 a	 planar	 molecule	 coordinated	 by	 Fe2+	 iron.	
Spontaneous	auto-oxidation	of	heme	results	in	formation	of	ROS	that	can	cause	severe	
damage	to	cells	and	tissue;	thus	heme	has	intrinsic	toxic	properties	that	are	ameliorated	
by	 binding	 to	 large	 globular	 proteins,	 such	 as	hemoglobin	 (Hb)	 (129).	Hemoglobin	 is	
typically	 contained	 within	 red	 blood	 cells;	 however,	 during	 destruction	 of	 senescent	
erythrocytes	 or	hemolysis,	Hb	 is	 released	 into	 the	 blood	where	 it	 can	 have	 cytotoxic	
effects.	Although	the	concentration	of	extracellular	Hb	is	usually	low	in	the	body,	during	
conditions	of	 rapid	erythrocyte	destruction,	 free	Hb	 and	 free	heme	 in	 the	plasma	can	
increase	 to	 harmful	 concentrations.	 To	 combat	 this,	 haptoglobin	 (Hp)	 scavenges	
hemoglobin	in	the	blood,	whereas	hemopexin	(Hx)	is	involved	in	sequestration	of	free	
heme.	Through	receptor-mediated	endocytosis,	Hp-Hb	and	Hx-heme	complexes	are	then	
taken	up	by	cells	(129,	130).		
Although	heme	is	a	critical	source	of	intracellular	iron,	the	extracellular	cycling	of	iron	is	
another	important	pathway	of	iron	control	in	the	host.	Most	dietary	iron	is	in	the	Fe3+	
form	and	must	be	reduced	to	Fe2+	iron	through	ferroxidases	on	the	surface	of	enterocytes	
in	 order	 to	 be	 taken	 up	 by	 the	 divalent	metal	 ion	 transporter-1	 (DMT-1)	 (126,	 130).	
Within	enterocytes,	ferrous	iron	typically	follows	one	of	three	possible	pathways:	i)	it	is	
used	to	produce	biliverdin,	ii)	it	is	incorporated	into	the	multimeric,	iron-storage	protein,	
ferritin,	 or	 iii)	 it	 is	 oxidized	 back	 to	 ferric	 iron	 and	 is	 exported	 out	 of	 the	 cell	 by	
ferroportin.	 Ferroportin	 is	 the	 only	 iron	 exporter	 characterized	 in	 humans	 and	 is	
expressed	in	enterocytes,	macrophages,	hepatocytes,	cells	of	the	central	nervous	system,	
and	placenta	syncytiotrophoblasts	(130,	131).		
Once	 released	 into	 the	 blood	 stream	 by	 ferroportin,	 ferrous	 iron	 is	 converted	 by	
ceruloplasmin	 to	 ferric	 iron,	 which	 is	 then	 bound	 by	 transferrin	 (Tf).	 Transferrin	
scavenges	 free	 ferric	 iron	 in	 the	blood	stream,	 reducing	 formation	of	 reactive	oxygen	
species,	and	delivers	 iron	to	various	cells	and	tissues.	Transferrin	 is	also	considered	a	
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member	of	 the	 innate	 immune	system	as	 it	sequesters	 free	 iron	 in	the	serum	limiting	
access	to	invading	organisms	(126,	130).	Diferric-Tf	can	be	taken	up	by	cells	via	binding	
to	 the	 transferrin	 receptor	1	 (TfR1)	 followed	by	 receptor-mediated	endocytosis.	 Free	
iron	 can	 also	 be	 bound	 by	 the	 transferrin-like	 glycoprotein,	 lactoferrin	 (Lf);	 Lf	 is	
commonly	 found	 in	mucosal	 secretions	 but	 is	 also	 found	 intracellularly	 stored	 in	 the	
secondary	granules	of	neutrophils	(132).		
A	homologous	transferrin	receptor	to	TfR1	is	TfR2,	present	on	the	surface	of	hepatocytes,	
where	endocytosis	of	diferric-Tf	via	TfR2	is	thought	to	stimulate	hepcidin	release	(126,	
130,	 133).	 Hepcidin	 is	 a	 hormone	 secreted	 by	 the	 liver	 that	 directly	 regulates	
internalization	and	degradation	of	 ferroportin.	Therefore,	hepcidin	 is	most	 frequently	
released	in	response	to	excess	levels	of	extracellular	iron,	either	to	combat	transferrin	
saturation	or	as	part	of	an	inflammatory	response	(133).	Upon	ferroportin	degradation,	
iron	 is	 stored	 intracellularly,	 dietary	 iron	 uptake	 is	 halted,	 and	 iron	 release	 from	
macrophages,	 specifically	 macrophages	 involved	 in	 phagocytosis	 of	 senescent	 or	
degraded	erythrocytes,	is	stopped.	Binding	of	hepcidin	to	ferroportin	has	been	shown	to	
decrease	serum	iron	levels	by	as	much	as	30%	(133).			
NGAL	is	a	member	of	the	lipocalin	family	of	proteins,	secreted	by	many	cells	in	the	human	
body,	 such	 as	 neutrophils	 (134).	NGAL	serves	 to	 scavenge	 and	 bind	 catecholate-	 and	
phenolate-type	 siderophores.	 Siderophores	 are	 small	 iron	 chelators	 produced	 by	
bacteria	as	a	means	to	obtain	ferric	iron	(to	be	discussed	in	section	1.5.2),	where	NGAL	is	
characteristically	known	to	bind	enterobactin,	a	widely	synthesized	siderophore	among	
Enterobacteriaceae	 (134,	 135).	Mice	 that	 are	NGAL	deficient,	NGAL-/-,	 are	much	more	
susceptible	 to	 infections	by	Gram-negative	bacteria	 than	mice	with	a	 functional	NGAL	
mechanism	 (136,	 137),	 demonstrating	 the	 importance	 of	 siderophore-mediated	 iron	
acquisition	in	establishing	infection	(134).		
Although	NGAL	associates	with	complexed-iron	it	does	not	have	the	intrinsic	ability	to	
bind	iron	directly,	necessitating	the	function	of	the	endogenous	human	siderophore,	2,5-
DHBA.	The	likely	purpose	of	2,5-DHBA	is	to	scavenge	free	iron,	preventing	formation	of	
ROS,	and	make	 iron	readily	available	 to	 tissue	and	cells	of	 the	 innate	 immune	system	
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(138,	139).	Similar	in	structure	to	2,3-DHBA	is	the	iron	carrier	molecule	synthesized	by	
E.	coli,	2,5-DHBA,	that	is	capable	of	promoting	growth	of	E.	coli	in	a	mammalian	model;	
therefore,	 it	 is	 not	 surprising	 that	 synthesis	 of	 2,5-DHBA	 is	 downregulated	 during	
infection,	freeing	NGAL	to	bind	to	bacterial	siderophores	(138,	140).	Figure	1-2	highlights	
the	battle	over	 iron	during	 infection	and	 illustrates	 strategies	used	by	 the	host	 and	S.	
aureus	to	maintain	iron	homeostasis.		
1.5 Bacterial Iron acquisition systems 
Due	to	stringent	 iron	sequestration	exerted	by	the	host,	perhaps	the	most	challenging	
obstacle	for	most	pathogens	to	overcome	during	infection	is	iron	acquisition.	Therefore,	
a	 defining	 characteristic	 of	 pathogens	 is	 their	 ability	 to	 acquire	 iron	 bound	 by	 host	
proteins.	 Below	 I	 discuss	 some	 of	 the	 pathways	 bacteria	 use	 to	 acquire	 this	 essential	
metal.			
1.5.1 Uptake of ferrous iron 
Uptake	 of	 free	 ferrous	 iron	 in	 many	 bacteria	 is	 facilitated	 by	 the	 Feo	 transporter.	
Although	characterized	extensively	in	members	of	Enterobacteriaceae,	homologs	of	Feo	
have	been	observed	in	Gram-positive	pathogens	such	as	S.	aureus,	Bacillus	anthracis,	and	
Listeria	 monocytogenes	 (123).	 The	 iron-regulated	 feoABC	 genes	 encode	 proteins	
necessary	 for	 Fe2+	 iron	 transport.	 FeoA	 is	 a	 small	 cytoplasmic	 protein	 that	 is	 often	
encoded	in	close	proximity	to	feoB.	The	exact	role	of	FeoA	in	Fe2+	uptake	is	unknown;	
however,	deletion	of	feoA	in	E.	coli	resulted	in	a	60%	decrease	in	Fe2+	uptake	(141),	and	
in	Vibrio	 cholerae	and	Salmonella	 enterica,	deletion	of	 feoA	completely	abrogated	Fe2+	
transport	(142,	143).	This	suggested	that	FeoA	plays	a	critical,	and	 in	some	instances	
essential,	role	in	Fe2+	transport.		
FeoB	in	many	Gram-negative	species	interacts	directly	with	FeoA	(144).	FeoB	is	an	iron-
regulated,	 multi-domain,	 transmembrane	 permease.	 It	 is	 comprised	 of	 three	 main	
domains:	the	cytoplasmic	G-protein	domain	that	is	responsible	for	GTP	hydrolysis;	the	
cytoplasmic	GDP	dissociation	inhibitor	(GDI)	domain	that	functions	as	a	linker	region	
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Fig	1-2.	The	host-pathogen	battle	for	iron.	Illustration	of	the	various	strategies	used	by	
the	host	to	sequester	iron	from	invading	pathogens	and	the	counter-strategies	used	by	
pathogens	 to	 obtain	 host	 iron.	 On	 mucosal	 surfaces,	 lactoferrin	 sequesters	 iron,	 yet	
bacteria	 can	 obtain	 iron	 from	 lactoferrin	 by	 secreting	 siderophores	 or	 by	 secreting	
reductases	that	reduce	iron	from	Fe3+	to	Fe2+,	releasing	it	from	lactoferrin.	Bacteria	can	
obtain	 iron	 bound	 to	 heme	 by	 secreting	 hemolysins,	 which	 release	 intracellular	
hemoglobin	 and	 heme	 into	 the	 blood.	 While	 the	 host	 uses	 hemoglobin-	 and	 heme-
scavenging	 proteins	 to	 sequester	 these	 iron	 sources,	 bacteria	 have	 mechanisms	 to	
counter	these	systems.	Macrophages	move	iron	from	the	phagosome	and	the	cell	using	
natural	resistance	macrophage	protein	1	and	ferroportin,	respectively,	to	keep	iron	from	
intracellular	 pathogens.	 In	 response	 to	 binding	 by	 the	 iron	 homeostasis	 hormone	
hepcidin,	 membrane-bound	 ferroportin	 is	 degraded,	 thus	 withholding	 iron	 in	
intracellular	 compartments.	Fe2+	 that	 is	secreted	 is	 rapidly	oxidized	by	 ceruloplasmin	
(Cp),	 and	 the	 Fe3+	 is	 quickly	 picked	 up	 by	 transferrin.	 Transferrin-bound	 iron	 is	
scavenged	 by	 bacteria	 using	 transferrin-binding	 proteins	 or	 through	 secretion	 of	
siderophores.	Bacteria	can	also	obtain	iron	using	the	mammalian	siderophore	2,5-DHBA.	
Neutrophils	secrete	NGAL	which	serves	to	capture	some	bacterial	siderophores.	Some	
bacteria	synthesize	and	secrete	stealth	siderophores,	which	are	not	NGAL	substrates	and	
can	 remove	 transferrin-bound	 iron	 even	 in	 the	 presence	 of	 NGAL.	 Lf,	 lactoferrin;	 Tf,	
transferrin;	 sid,	 siderophore;	 Hp,	 haptoglobin;	 Hx,	 hemopexin;	 Hb,	 hemoglobin;	 Hm,	
heme;	Cp,	 ceruloplasmin.	This	 figure	 is	published	 	 in	Sheldon,	 J.	R.,	 Laakso,	H.	A.,	 and	
Heinrichs,	D.	E.	(2016)	Virulence	Mech.	Bact.	Pathog.	(123)..	
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between	the	G-protein	and	transmembrane	domains	and	enhances	GDP	binding;	and	the	
transmembrane	domain	that	functions	as	the	channel	for	iron	transport	(144).		
feoC	 (yhgG)	 is	 only	 found	 in	 γ-proteobacteria,	 and	 was	 thought	 to	 encode	 a	
transcriptional	 repressor	 of	 the	 feo	operon	 because	 of	 the	winged-helix	DNA-binding	
motif	found	in	the	protein	(144).	In	Klebsiella	pneumoniae,	however,	FeoC	was	shown	to	
not	interact	with	DNA,	but	rather	was	bound	tightly	to	the	G-protein	and	GDI	domains	of	
FeoB	(145).	In	Salmonella	enterica,	FeoC	binds	and	protects	FeoB	from	FtsH-mediated	
proteolytic	degradation	in	iron-deplete,	anoxic	environments.	Reduction	of	Fe-S	clusters	
in	 aerobic	 environments	 targets	 FeoC	 itself	 to	 oxygen-sensitive,	 Lon-mediated	
proteolysis.	Thus,	FeoC	may	function	as	an	oxygen	sensor	to	Fe2+	uptake.	In	iron-limiting,	
anoxic	conditions,	an	environment	that	favors	Fe2+	iron,	FeoC	is	resistant	to	proteolysis	
and	 stabilizes	 the	 FeoB	 transporter.	 In	 aerobic	 environments,	 FeoC	 undergoes	
proteolytic	 degradation	 resulting	 in	 destabilization	 of	 FeoB	 and	 reduced	 ferrous	 iron	
import	(146).					
Fe2+	is	rarely	found	in	the	host	because	of	the	presence	of	oxygen,	and	thus	Fe2+	is	rapidly	
oxidized	 to	 insoluble	 Fe3+.	 Therefore,	 in	 response	 to	 this,	 bacteria	 have	 developed	
multiple	mechanisms	to	take	up	Fe3+.				
1.5.2 Siderophores 
One	of	the	key	pathways	utilized	by	pathogens	to	acquire	ferric	iron	is	through	use	of	low	
molecular	 mass,	 iron-chelators,	 called	 siderophores.	 Siderophores	 are	 endogenously	
synthesized	and	are	secreted	into	the	extracellular	milieu	where	they	can	bind	free	ferric	
iron	 or	 remove	 iron	 from	 proteins	 such	 as	 transferrin	 and	 lactoferrin	 (123).	 The	
siderophore-iron	 complex	 is	 too	 large	 to	 diffuse	 through	membrane	 porins,	 and	 thus	
must	 be	 actively	 transported	 inside	 the	 cell	 by	 specific,	 ATP-dependent	 transporters	
(147).	 Over	 500	 different	 siderophores	 have	 been	 identified	 in	 nature	 observed	 in	
bacteria,	fungi,	yeast,	and	recently	animals,	such	as	2,5-DHBA	previously	described	(139,	
148).			
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Siderophores	are	typically	characterized	by	the	chemical	structure	of	the	iron-binding	
moieties	 they	 contain.	 There	 are	 five	 common	 siderophore	 types:	 (α-hydroxy-)	
carboxylate,	catecholate,	phenolate,	hydroxamate,	and	mixed	siderophores	that	contain	
two	more	moieties	(149).	Due	to	their	high	electronegativity,	most	siderophores	have	
high	 affinity	 for	 ferric	 iron,	 exceeding	 the	 affinity	 of	 transferrin	 or	 lactoferrin.	 The	
hexacoordinated	structure	of	siderophores	encompasses	the	Fe3+	 ion	 in	an	octahedral	
geometry,	 where	 the	 number	 of	 bound	 Fe3+	 ions	 varies	 on	 the	 type	 and	 number	 of	
moieties	 present	 (125).	 Bacterial	 siderophores	 are	 synthesized	 through	 one	 of	 two	
different	 pathways:	 the	 non-ribosomal	 polypeptide	 synthetase	 (NRPS)	 pathway,	 or	
through	NRPS-independent	(NIS)	pathway.	NRPS	involves	large	multi-domain	proteins	
that	use	non-proteinogenic	amino	acids	to	build	polypeptide	siderophores	in	the	absence	
of	a	RNA	template;	whereas	NIS	synthesis	 involves	a	series	of	condensation	reactions	
from	dicarboxylic	acid	and	diamine	or	amino	alcohol	building	blocks	that	are	linked	by	
ester	or	amide	bonds	(150).		
1.5.3 NRPS siderophores 
The	 NRPS	 pathway	 uses	 large	 multidomain	 enzymes,	 that	 assemble	 siderophore	
complexes	 from	 a	 broad	 array	 of	 amino,	 carboxy,	 and	 hydroxy	 acids.	 This	 allows	 for	
molecules	of	generally	higher	molecular	weight	and	also	high	structural	variability	that	
can	 be	 increased	 through	 various	 substrate	 modifications.	 NRPS	 siderophores	 are	
typically	aryl-capped	through	a	domain	of	one	of	the	enzymes	(151).	Well	studied	NRPS	
siderophores	 include	 enterobactin,	 a	 common	 siderophore	 produced	 by	
Enterobacteriaceae,	 yersiniabactin	 from	Yersinia	 spp.,	 pyochelin	 and	 pyoverdine	 from	
Pseudomonas	 aeruginosa,	 and	 vibriobactin	 produced	 by	 Vibrio	 cholerae.	 Other	 NRPS	
compounds	 include	 common	 antibiotics	 such	 as	 penicillins,	 vancomycin,	 and	
cyclosporine	(123,	150).			
Enterobactin	was	first	isolated	in	the	1970’s	from	S.	enterica	sv.	Typhimurium	and	E.	coli,	
and	has	been	extensively	studied	since	(152,	153).	It	is	a	hallmark	NRPS	siderophore	that	
is	found	in	many	Gram-negative	enteric	bacteria,	but	has	also	been	isolated	from	three	
Gram-positive	 species,	 Corynebacterium	 glutamicum,	 Bacillus	 subtilis,	 and	 two	
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Streptomyces	 species	 (154–156).	 The	 synthesis	 of	 enterobactin	 was	 among	 the	 first	
siderophore	 synthesis	pathways	 to	be	elucidated	 in	 vitro	 and	 relies	on	 the	activity	of	
three	enzymes	that	form	seven	domains	(157).	The	synthesis	starts	with	the	aromatic	
amino	acid	precursor,	chorismic	acid,	which	is	converted	into	2,3-DHB	by	enzymes	EntC,	
EntB,	and	EntA,	through	stepwise	reactions	with	intermediates	isochorismate	and	2,3-
dihydro-2,3-dihydroxybenzoate	 (158).	 Following	 the	 formation	 of	 2,3-DHB,	 L-serine	
forms	an	amide	linkage	with	2,3-DHB	through	catalytic	action	of	EntD,	EntE,	EntF,	and	
the	C-terminal	aryl	carrier	of	EntB.	The	final	enterobactin	molecule	is	released	from	the	
terminal	 thioesterase	 domain	 of	 EntF	 following	 the	 hydrolysis	 of	 three	 DHB-serine	
molecules	 by	 intramolecular	 cyclization.	 Enterobactin	 binds	 iron	 through	 three	
catecholate	 moieties	 that	 are	 linked	 in	 a	 triserine	 macrocycle.	 Iron	 release	 from	
enterobactin	 is	 achieved	 through	 the	 action	 of	 a	 cytoplasmic	 esterase	 (158).	
Enterobactin’s	affinity	for	iron	is	one	of	the	highest	characterized	with	a	binding	constant	
of	1052	M,	which	is	considerably	higher	than	that	of	transferrin	at	1023	M.		
Most	 NRPS	 siderophores	 are	 constructed	 as	 described	 above	 and	 are	 key	 virulence	
factors	 in	 many	 pathogens.	 For	 example,	 enterobactin	 in	 Campylobacter	 jejuni	 and	
Salmonella	enterica	(159,	160),	pyoverdine	in	Pseudomonas	aeruginosa	and	Pseudomonas	
syringae	 (161,	 162),	 and	 yersiniabactin	 in	 Yersinia	 pestis,	 Klebsiella	 pneumoniae	 and	
Proteus	mirabilis	(163–165),	are	all	essential	for	virulence	in	animal	models	of	infection.		
1.5.4 NIS siderophores 
The	NIS	siderophore	pathway	has	been	much	less	characterized	and	does	not	require	the	
large	 multi-domain	 enzymes	 of	 NRPS	 but	 instead	 relies	 on	 smaller	 condensation	
reactions	of	alternating	subunits	of	dicarboxylic	acids	with	diamines,	amino	alcohols	and	
alcohols	(125).	The	synthetases	involved	in	NIS	pathways	have	been	characterized	based	
on	 common	 function.	 Aerobactin,	 a	 mixed-type	 siderophore	 that	 contains	 two	
hydroxamate	 moieties	 and	 one	 carboxylate	 moiety,	 found	 in	 many	 Gram-negative	
bacteria	and	often	essential	for	virulence,	is	a	hallmark	of	the	NIS	pathway	(150).	Type	A	
enzymes,	such	as	IucA,	found	within	the	iucABCD	operon	that	encodes	enzymes	involved	
in	aerobactin	synthesis,	catalyze	the	condensation	of	a	prochiral	carboxyl	group	of	citrate	
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to	form	either	an	amide	bond	to	an	amine	group,	or	ester	bond	to	an	alcohol	group	of	the	
second	 substrate.	 Type	 B	 synthetases	 catalyze	 the	 substitution	 reaction	 of	 the	 C5	
carboxyl	of	α-ketoglutarate	for	the	citrate	carboxyl.	Lastly,	type	C	enzymes,	represented	
by	 IucC,	 catalyze	 condensation	 of	 monoamide/monoester	 derivatives	 of	 citrate	 or	
succinate	to	carboxyl	groups	on	molecules	with	an	amine	or	an	alcohol	(150,	166).		
The	 synthesis	of	 aerobactin	was	 the	 classic	 example	of	NIS	 siderophore	 synthesis	 for	
nearly	a	decade;	however,in	recent	years,	seven	other	gene	clusters	have	been	uncovered	
that	encode	NIS	biosynthetic	genes.	All	NIS	biosynthetic	pathways	contain	at	least	one,	
and	 typically	 two	 or	 three,	 IucA	 and	 IucC	 enzymes	 (150).	 Discussed	 below	 are	 the	
siderophores	utilized	by	S.	aureus,	of	which	two,	staphyloferrin	A	and	staphyloferrin	B,	
are	NIS	siderophores.	
1.5.5 Staphylococcal siderophores 
The	 preferred	 iron	 source	 for	 S.	 aureus	 is	 heme;	 however,	 deletion	 of	 heme	 uptake	
pathways	 only	 partially	 abrogates	 virulence	 suggesting	 that	 other	 iron	 acquisition	
mechanisms	are	utilized	(167,	168).	A	key	mechanism	of	S.	aureus	iron	acquisition	is	the	
use	of	siderophores,	of	which	three	siderophores	have	been	characterized	in	S.	aureus:	
staphyloferrin	 A,	 staphyloferrin	 B,	 and	 staphylopine.	 A	 fourth	 siderophore,	 named	
aureochelin,	has	also	been	discovered,	but	its	function	in	metal	homeostasis	is	currently	
unknown	(169,	170).	The	major	siderophore	pathways	utilized	by	S.	aureus	are	outlined	
in	figure	1-3.	
Staphyloferrins 
Staphyloferrin	A	(SA)	and	staphyloferrin	B	(SB)	are	the	two	predominant	siderophores	
used	by	S.	aureus	for	iron	uptake	(169,	171,	172).	Both	SA	and	SB	are	polycarboxylate-
type	siderophores	and	are	synthesized	by	NIS	pathways.	Despite	their	similarities,	both	
siderophores	have	distinct	sets	of	synthetases	and	molecular	precursors	(125,	173–176).	
One	of	the	notable	advantages	of	carboxylate	siderophores	is	that	they	have	lower	pKa	
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Fig	1-3.	Summary	of	siderophore	synthesis	and	transport	pathways	in	S.	aureus.	S.	aureus	
endogenously	 produces	 three	 siderophores:	 polycarboxylate	 siderophores	
staphyloferrin	B	 (biosynthetic	operon	 sbn)	 and	 staphyloferrin	A	 (biosynthetic	operon	
sfa),	 and	 the	 nicotianamine	 siderophore,	 staphylopine	 (biosynthetic	 operon	 cnt)	 that	
each	 have	 their	 own	 efflux	 and	 import	 transporters.	 In	 addition	 to	 its	 endogenous	
siderophores,	S.	aureus	can	also	uptake	hydroxamate	and	catecholate	xenosiderophores	
through	Fhu	and	Sst	transport	systems,	respectively.	
	
	
 
 29 
	
	
	
 
 30 
values	than	the	other	siderophore	moieties,	ranging	from	3.5-5,	compared	to	other	
siderophores	 that	 have	 pKa	 values	 that	 are	 upwards	of	 8.	 This	makes	 carboxylate	
siderophores	ideal	for	acidic	environments	(151).	
Staphyloferrin A 
Staphyloferrin	A,	 first	 identified	 in	S.	hyicus,	 is	 found	 in	all	S.	aureus	strains	and	 is	
widespread	among	coagulase-negative	staphylococci	(177).	SA	is	comprised	of	two	
citrate	molecules	bridged	by	a	D-ornithine	and	has	the	chemical	formula	N2,N5-di-(1-
oxo-3-hydroxy-3,4-dicarboxylbutyl)-D-ornithine	 (48	 kDa)	 (128,	 178).	 The	
biosynthetic		proteins	for	SA	were	identified	through	BLAST	searches	of	iucABC	genes	
in	the	S.	aureus	chromosome,	and	are	encoded	on	the	sfaABC	operon,	and	divergently	
transcribed	 sfaD.	 SfaD	 and	 SfaB	 are	 NIS	 synthetases	 that	 use	 the	 substrates	 D-
ornithine,	 citric	 acid,	 and	 ATP	 to	 generate	 SA;	 SfaC	 is	 a	 racemase,	 and	 SfaA	 is	
transmembrane	efflux	pump	that	secretes	SA.	SA	transport	into	the	cell	is	facilitated	
by	HtsABC	ATP-dependent	transporter	(177).		
Staphyloferrin B 
Staphyloferrin	B	is	comprised	of	one	unit	each	of	citric	acid,	alpha-ketoglutaric	acid,	
1,2-diaminoethane,	 and	 2,3-diaminopropionic	 acid	 (128,	 173–176,	 179).	 The	 sbn	
operon	encodes	the	biosynthetic	proteins	and	efflux	protein	for	SB,	and	the	sir	operon	
encodes	proteins	needed	for	SB	import	into	the	cell	(173–176,	178,	179).	The	operon	
is	 comprised	 of	 nine	 genes,	 sbnA-I.	 The	 gene	 product	 of	 sbnD	 is	 an	 efflux	 pump	
involved	in	secretion	of	SB,	and	the	gene	products	of	sbnABCEFGH	are	all	involved	in	
SB	synthesis:	the	gene	product	of	sbnA	is	a	O-phospho-L-serine	sulfhydrylase,	sbnB	
encodes	 a	 NAD+-dependent	 dehydrogenase,	 sbnC,	 sbnE,	 and	 sbnF	 all	 encode	 NIS	
synthetases,	 sbnG	 encodes	 a	 citrate	 synthase,	 and	 the	 gene	 product	 of	 sbnH	 is	 a	
decarboxylase	(172–174,	180).	The	functions	of	these	genes	are	well	established	as	
SB	 has	 been	 entirely	 synthesized	 in	 vitro	 using	 only	 the	 purified	 enzymes	
SbnABCEFGH	 and	 precursor	 molecules	O-phosphoserine,	 glutamate,	 oxaloacetate,	
and	acetyl-CoA	(171,	173).	Interestingly,	the	terminal	gene	in	the	sbn	operon,	sbnI,	is	
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not	 required	 for	 SB	 synthesis	 in	 vitro,	 and	 prior	 to	 this	 study,	 had	 not	 been	
characterized.		
Mutation	of	the	SA	biosynthetic	genes	in	S.	aureus	does	not	affect	its	growth	in	iron-
restricted	media	due	to	the	functional	redundancy	with	SB.	Furthermore,	SB	is	the	
primary	 siderophore	 utilized	 by	 S.	 aureus	during	 growth	 in	 serum	 due	 to	 limited	
availability	 of	 citrate	 in	 the	 cell.	 SA,	 unlike	 SB,	 relies	 on	 citrate	made	 by	 CitZ,	 an	
essential	protein	in	the	TCA	cycle	that	uses	substrates	oxaloacetate	and	acetyl-CoA	to	
produce	 citrate	 (180,	 181).	 During	 growth	 in	 iron-restricted	 media,	 and	 in	 the	
presence	of	glucose,	the	iron-sparing	response	is	initiated	causing	downregulation	of	
iron-consuming,	 but	 non-essential	 pathways,	 such	 as	 the	 TCA	 cycle.	 In	 the	 iron-
sparing	response,	 glycolysis	 is	utilized	as	 the	central	 carbon	metabolism	pathway,	
which	 does	 not	 produce	 citrate	 as	 a	 by-product,	 resulting	 in	 no	 available	 citrate	
substrate	for	SA.	SB	overcomes	the	necessity	for	CitZ,	and	the	TCA	cycle,	by	having	its	
own	dedicated	citrate	synthase	on	the	sbn	operon,	SbnG	(172,	180).	The	activity	of	
SbnG	 is	 thought	 to	 be	 specific	 to	 SB,	 and	 cannot	 be	 used	 in	 both	 siderophore	
pathways.	Therefore,	growth	in	serum	is	not	permissive	for	SA	production,	as	serum	
is	 iron-restrictive	 and	 glucose-rich.	 This	 has	 been	 corroborated	 in	 vivo,	 where	
mutation	 of	 sbnE	 alone	 significantly	 abrogates	 the	 ability	 of	 S.	 aureus	 to	 cause	
abscesses	 in	 murine	 infection	 model	 (169).	 Despite	 this,	 however,	 SA	 is	 not	
indispensable	and	seems	to	be	important	for	formation	of	abscesses	in	a	murine	skin	
colonization	model	(182).		
Staphylopine 
Staphylopine	(Stp)	is	a	newly	identified	nicotianamine-like	siderophore	that	not	only	
binds	 iron,	 but	 also	nickel,	 cobalt,	 zinc,	 and	 copper	 (183).	 This	 non-proteinogenic	
amino	acid	chelator,	nicotianamine,	is	one	of	the	most	common	metal	chelators	found	
in	 plants	 (184).	 Homologues	 of	 Stp	 have	 been	 identified	 in	 human	 pathogens,	
nonetheless,	such	as	Y.	pestis	and	P.	aeruginosa	(185).	Nicotianamine	is	synthesized	
through	nicotianamine	 synthase	 (NAS):	 a	pathway	of	 three	S-adenosyl	methionine	
molecules	 (SAM)	 that	 form	 an	 azetidine	 ring	 from	 condensation	 of	 three	 α-
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aminobutyric	 acid	moieties	 (184).	The	enzymes	 responsible	 for	Stp	 synthesis	 in	S.	
aureus	are	encoded	on	the	cobalt	and	nickel	transporter	(cnt)	genes	cntK,	cntL,	and	
cntM.	CntL	is	a	NAS-like	enzyme;	CntM	is	related	to	octopine	dehydrogenase,	and	is	a	
NAD(P)H-dependent	 enzyme;	 and	 CntK	 is	 a	 diaminopimelate	 epimerase.	 Thus	 the	
formation	of	Stp	starts	with	the	CntK	epimerase	converting	L-His	into	D-His;	D-His	is	
then	modified	by	CntL	through	the	nucleophilic	attachment	of	one	α-aminobutyric	
acid	moiety	onto	D-His	to	produce	the	intermediate	xNA;	lastly	CntM	condenses	the	
intermediate,	xNA,	with	a	molecule	of	pyruvate,	resulting	in	the	final	metallophore	
structure	(183).		
cntKLM	 genes	are	on	 the	 same	 loci	 as	 the	nickel	 and	cobalt	 importer,	 encoded	on	
genes	 cntA-F.	 CntABCDEF	 importer	 was	 previously	 shown	 to	 be	 important	 for	 S.	
aureus	virulence	(186,	187).	The	cnt	genes	are	upregulated	in	metal-deplete	media,	
where	 mutations	 to	 either	 cntL	 and	 cntA-F	 caused	 decreased	 intracellular	
accumulation	 of	 iron,	 nickel,	 zinc,	 copper,	 and	 cobalt,	 as	 shown	 by	 ICP-MS,	
demonstrating	 importance	 of	 Stp	 for	 import	 of	 these	 essential	 metals	 (183).	
Chemically	 synthesized	 Stp	 had	 affinity	 for	 all	 five	 heavy	 metals	 with	 Kd	 affinity	
greatest	for	Cu2+,	followed	by	Ni2+,	Co2+,	Zn2+,	and	lastly	Fe2+.	Although	Stp	is	capable	
of	binding	to	 iron,	 its	affinity	 for	 iron	 is	 far	 lower	than	SB	or	SA.	Recent	work	has	
demonstrated	that	Stp	is	largely	responsible	for	zinc	import,	and	is	thought	to	remove	
zinc	from	host-derived	protein,	calprotectin;	thus	in	the	context	of	infection,	Stp	may	
primarily	function	as	a	zincophore	(188).	
Xenosiderophores and stress hormones 
In	addition	to	taking	up	its	own	siderophores,	S.	aureus	is	also	able	to	take	up	other	
iron-containing	 compounds,	 including	 hormones	 (also	 referred	 to	 as	
pseudosiderophores)	and	xenosiderophores;	the	latter	are	siderophores	produced	by	
other	organisms.	This	ability	is	not	limited	to	S.	aureus	but	has	been	observed	in	other	
bacteria,	 attesting	 to	 the	 resourcefulness	of	microbes	 to	obtain	essential	nutrients	
(123).	 S.	 aureus	utilizes	 the	 ferric	 hydroxamate	 uptake	 (Fhu)	 pathway	 to	 take	 up	
xenogenous	ferric-hydroxamate	complexes	(189).	Fhu	is	widely	conserved,	found	in	
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many	Gram-positive	and	-negative	bacteria.	The	three	genes	 in	 the	 fhuCBG	operon	
encode	proteins	of	an	ABC	transporter,	where	FhuC	is	a	promiscuous	ATPase,	FhuB	
and	 FhuG	 form	 a	 bipartate	 transmembrane	 permease,	 where	 mutation	 of	 FhuG	
abrogates	 substrate	 uptake,	 and	 FhuD1	 and	 FhuD2	 are	 membrane-anchored	
receptors	 that	 bind	 and	 transfer	 ferric-hydroxamate	 complexes	 to	 FhuCBG	 for	
transport	(189–191).	FhuD1	and	FhuD2	have	unique	binding	affinities,	where	FhuD1	
appears	 to	 bind	 a	 limited	 subset	 of	 siderophores,	 namely	 ferrichrome	 and	
desferrioxamine,	whereas	FhuD2	 is	 involved	 in	 the	 acquisition	of	 a	wide	 range	of	
hydroxamate	 substrates,	 including	 ferichrome,	 desferioxamine	 B,	 aerobactin	 and	
coprogen	(190,	192).					
S.	 aureus	 also	 is	 able	 to	 take	 up	 xenogenous	 catecholate-type	 siderophores	 and	
catecholamine	stress	hormones,	such	as	epinephrine	and	norepinephrine.	S.	aureus	is	
not	the	only	pathogen	capable	of	this;	Listeria	spp.	and	Bacillus	spp.	are	also	capable	
of	catecholate	substrate	transport	(193–198).	Catecholamine	stress	hormones,	such	
as	epinephrine	and	norepinephrine,	are	able	to	remove	ferric	iron	from	transferrin	
and	 lactoferrin,	 not	 due	 to	 a	 higher	 affinity	 for	 ferric	 iron,	 such	 as	 bacterial	
siderophores,	but	through	reduction	of	ferric	iron	to	ferrous	iron	(199).	Catecholate	
substrates	 are	 taken	 up	 by	 S.	 aureus	 by	 a	 highly	 conserved	 staphylococcal	
siderophore	transporter,	SstABCD	(199).	In	vivo	studies	done	in	mice	demonstrated	
that	 an	 sstABCD	mutant	 had	 significantly	 lower	 colony	 forming	 units	 in	 the	 heart	
compared	 to	WT;	 however,	 no	 significant	 differences	 were	 seen	 in	 other	 organs,	
namely	the	liver	and	kidneys	(199).	
1.5.6 Removal of transferrin/lactoferrin-bound iron by Tbp and Lbp 
Part	 of	 the	 success	 of	 mucosal	 pathogens	 like	 Neisseria	 spp.,	 Moraxella	 spp.,	
Haemophilus	 spp.,	and	Pasteurella	 spp.	 is	 their	 ability	 to	 obtain	 iron	directly	 from	
transferrin	or	lactoferrin.	This	feat	is	achieved	through	transferrin	binding	proteins	
(Tbp)	or	lactoferrin	binding	proteins	(Lbp).	Tbp	and	Lpb	are	surface-expressed,	iron-
regulated	 proteins	 that	 directly	 interact	 with	 extracellular	 host	 glycoproteins.	
Transferrin	binding	is	mediated	by	the	outer	membrane	receptor	protein,	TbpA,	and	
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surface-associated	 lipoprotein	 TbpB	 (200,	 201).	 In	 this	 pathway,	 TbpB	 binds	
holotransferrin	and	transfers	it	to	lipoprotein	TbpA,	which	can	bind	either	holo-	or	
apo-transferrin	 (202).	 TbpB	 is	 not	 required	 in	 this	 pathway,	 but	 greatly	 aids	 in	
transferrin	capture.		
Unlike	siderophore-iron	complexes,	transferrin	is	not	brought	into	the	cell	cytoplasm,	
thus	the	iron	is	liberated	prior	to	transport	across	the	outer	membrane.	Initial	binding	
of	TbpB	to	human	transferrin	at	the	C-lobe	prevents	protonation	of	H349,	a	critical	
residue	in	iron	liberation,	and	thus	serves	to	stabilize	holo-transferrin	for	transfer	to	
TbpA	(123).	TbpA	also	binds	transferrin	at	the	C-lobe	at	a	non-overlapping	site	for	
TbpB	binding,	causing	a	substantial	conformational	change	in	transferrin.	α-helical	
extensions	of	TbpA	extend	into	the	iron-binding	cleft	of	transferrin,	widening	the	cleft	
and	facilitating	iron	release.	The	free	iron	is	then	transferred	to	the	periplasm	through	
TonB-dependent	transporter	(TBDT),	and	then	 in	the	periplasm	taken	up	by	 ferric	
binding	protein	A	(FbpA).	FbpA	escorts	iron	to	the	inner	membrane	ABC	transporter,	
FbpB/C,	 that	 ultimately	 brings	 the	 ferric	 iron	 into	 the	 cytoplasm	 (202).	 The	
lactoferrin-iron	uptake	pathway	is	very	similar	to	transferrin,	although	requires	its	
own	designated	receptors,	namely	lactoferrin	binding	protein	A	(LbpA)	and	LbpB.	
As	mentioned	 in	 section	 1.4.1,	 the	 largest	 pool	 of	 iron	 in	 the	 human	body	 is	 iron	
complexed	to	protoporphyin	IV,	or	heme	(130).	Thus	most	bacterial	pathogens	have	
developed	mechanisms	to	acquire	iron	from	this	tightly	controlled,	but	abundant	iron	
source	(130).	Acquisition	of	heme	generally	follows	a	three-step	process:	i)	bacteria	
secrete	 hemolysins	 or	 cytolysins	 to	 lyse	 heme-containing	 host	 cells,	 such	 as	
erythrocytes,	 causing	 release	of	 free	hemoglobin,	 and	 traces	of	 free	heme	 into	 the	
environment;	ii)	through	either	proteases	that	disrupt	hemoglobin-heme	interaction,	
hemophores	 that	 bind	 free	 heme	 or	 take	 it	 from	hemoproteins,	 or	 through	 direct	
binding	of	heme/hemoglobin	to	receptors	on	the	cell	surface,	heme	is	brought	to	the	
cell	membrane;	 iii)	 heme	 at	 the	 cell	membrane	 is	 transported	 into	 the	 cytoplasm	
where	the	iron	is	then	liberated	from	the	protoporphyrin	ring	through	degradation	
or	oxidation	(203,	204).		
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1.5.8 Gram-negative bacteria heme uptake 
Gram-negative	bacteria	commonly	acquire	heme	through	direct	uptake	of	heme,	or	
removal	 of	 heme	 at	 the	 cell	 surface,	 by	 the	 outer	 membrane,	 TonB-dependent	
transporters	(TBDTs)	that	may	work	in	collaboration	with	hemophores.	Hemophores	
have	 been	 characterized	 in	 many	 Gram-negative	 bacteria	 and	 work	 similarly	 to	
siderophores,	in	that	they	are	freely	diffusible	and	scavenge	for	free	heme	or	remove	
it	from	host	proteins.	The	most	well	characterized	hemophore	is	HasA,	first	identified	
in	Serratia	marcescens	 (205),	 and	has	 since	 been	 identified	 in	 a	 number	of	 Gram-
negative	species	including	P.	aeruginosa,	P.	fluorescens,	Y.	enterocolitica,	and	Y.	pestis	
(203).		
HasA	 is	secreted	by	 inner	membrane	ABC	transporters,	HasD	and	HasE,	and	outer	
membrane	 complex	HasF,	 into	 the	 extracellular	milieu	 (203).	 In	 the	 environment,	
HasA	 sequesters	 free	 heme	 or	 strips	 heme	 bound	 to	 host	 hemoproteins.	 Crystal	
structures	 of	 HasA	 demonstrate	 that	 the	 heme	 molecule	 is	 almost	 completely	
surrounded	by	unstructured	 loops,	 in	contrast	 to	most	heme-binding	proteins	that	
use	 helices	 in	 the	 binding	 pocket.	 The	 structure	 of	 the	 HasA	 protein	 has	 been	
described	as	a	fish,	where	the	“mouth”	of	the	fish	is	the	heme-binding	site,	and	the	
“body”	of	the	fish	is	comprised	of	two	domains,	i)	7	twisted	β-sheets,	and	ii)	four	α	–
helices	(206).						
Heme-complexed	to	HasA	interacts	with	membrane	receptor,	HasR,	that	facilitates	its	
import	 into	 the	 cell	 (207,	 208).	 HasR	 is	 capable	 of	 interacting	 with	 a	 variety	 of	
hemoproteins,	including	albumin,	hemoglobin-haptoglobin,	and	free	heme;	however,	
the	heme-transport	process	 is	made	100-fold	more	efficient	with	HasA	(209,	210).	
HasR	 is	 a	member	 of	 a	 large	 and	 crucial	 family	 of	 transporters	 in	 Gram-negative	
species,	 the	 TonB-dependent	 transporter	 (TBDT)	 family,	 to	 be	 discussed	 in	 detail	
later	in	section	1.5.11.		
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1.5.9 Heme uptake strategies of Gram-positive bacteria  
Few	heme	uptake	systems	have	been	identified	in	Gram-positive	bacteria;	however,	
one	 that	 has	 been	 extensively	 characterized	 is	 the	 iron-surface	 determinant	 (Isd)	
system.	The	best	characterizations	of	this	pathway	are	from	studies	in	S.	aureus	and	
B.	anthracis.	The	Isd	proteins	form	a	protein	shuttle	cascade	that	imports	heme	from	
the	 environment,	 across	 the	 peptidoglycan	 layer,	 and	 uses	ABC	 transport	 into	 the	
cytoplasm.	Highly	conserved	in	this	pathway	are	the	near-iron	transporter	(NEAT)	
domains	that	allow	for	heme	ligation.	NEAT	domains	are	120-125	amino	acids	that	
assemble	 into	 an	 eight-stranded	 β-sandwich	 fold.	 Heme	 is	 ligated	 by	 tyrosine	
residues	in	a	YXXXY	motif	within	a	hydrophobic	pocket	(211,	212).		
B.	anthracis	contains	six	Isd	proteins:	IsdC,	a	peptidoglycan-anchored	heme	receptor,	
ABC	transporter	IsdDEF,	and	two	secreted	hemophors,	IsdX1	and	IsdX2	(213).	The	
two	hemophores	 transfer	heme	 to	 IsdC	at	 the	membrane;	 although	heme	 transfer	
between	IsdX1	to	IsdX2	has	also	been	characterized,	suggesting	a	redundant	role	for	
IsdX2	as	a	heme	receptor	(214).	Interestingly,	mutation	of	IsdX1	and	IsdX2	impaired	
cells	for	growth	in	vitro	where	hemoglobin	was	the	sole	iron	source;	however,	this	
mutant	was	not	attenuated	in	vivo	in	animal	models	of	infection	(213,	215).	Following	
this	work,	 two	other	NEAT-domain	proteins	were	discovered:	B.	anthracis	S-layer	
protein	K	(BslK)	and	BAS0520.	BslK	contains	three	S-layer	homology	domains	(SLH),	
which	mediates	the	non-covalent	association	of	proteins	to	the	cell	wall,	thus	BslK	in	
the	peptidoglycan	layer	binds	to	heme/hemoglobin	and	passes	it	to	IsdC	receptor	for	
import	(216,	217).	The	role	of	BAS0520	NEAT-domain	has	yet	to	be	determined.						
The	 first	 identified	 heme-acquisition	 system	 in	 Gram-positive	 bacteria,	 due	 to	 its	
sequence	 similarity	 to	 Gram-negative	 pathways,	 was	 in	 C.	 diphtheriae	 (204).	
Mutations	 in	one	 of	 the	 three	 heme-uptake	 (hmu)	 genes,	hmuT,	hmuU,	and	hmuV,	
resulted	in	an	inability	of	the	strains	to	grow	with	heme	as	the	sole	iron	source.	These	
three	 genes	 were	 identified	 as	 parts	 of	 an	 ABC	 transporter,	 where	 HmuT	 was	 a	
lipoprotein	 capable	 of	 binding	 heme	 and	 hemoglobin,	 and	 HmuUV	 formed	 the	
transmembrane	 permease	 and	 ATPase	 (218,	 219).	 Three	 other	 genes	 were	
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discovered	in	this	region,	htaA,	htaB,	and	htaC	(220).	HtaA	was	found	to	be	another	
membrane-anchored	heme	receptor,	HtaB	also	had	heme-binding	capabilities	and	is	
suggested	to	be	a	heme	receptor,	although,	its	overall	importance	appears	marginal,	
and	the	function	of	HtaC	has	yet	to	be	elucidated	(221).					
1.5.10 S. aureus heme uptake 
Because	 of	 the	 thick	 peptidoglycan	 wall	 in	 Gram-positive	 bacteria,	 movement	 of	
molecules	from	the	environment	to	the	cell	membrane	is	restricted,	and	thus	requires	
peptidoglycan	 anchored	 receptors	 to	 facilitate	 transport.	 A	 screen	 to	 identify	 the	
enzyme(s)	responsible	for	the	covalent	attachment	of	proteins	to	the	peptidoglycan	
wall	 uncovered	 sortase	 A	 (SrtA)	 (222).	 SrtA	 specifically	 cleaves	 a	 conserved,	 C-
terminal,	five-amino	acid	recognition	motif,	LPXTG,	forming	a	sortase-substrate	acyl-
enzyme	 intermediate.	This	 intermediate	undergoes	nucleophilic	 attack	by	 the	 free	
amino	group	of	lipid	II-linked	to	pentapeptide,	a	key	building	block	of	the	cell	wall.	
The	lipid	II-linked	protein	is	then	incorporated	into	the	peptidoglycan	via	the	normal	
transpeptidation	reaction	of	cell	wall	biosynthesis	(223–226).		
This	important	discovery	of	SrtA	led	to	database	searches	of	the	S.	aureus	genome	to	
identify	 other	 sortases.	 These	 searches	 uncovered	 sortase	 B	 (SrtB),	 which	 was	
encoded	 in	 what	 seemed	 to	 be	 an	 eight-gene	 operon	 (226).	 Three	 genes	 in	 this	
operon,	named	isdA,	isdB,	and	isdC,	had	gene	products	that	were	anchored	to	the	cell	
wall	and	were	also	capable	of	binding	heme	(224).	IsdA	and	IsdB	are	anchored	via	
SrtA,	whereas	IsdC	is	anchored	by	SrtB.	IsdB	is	the	most	surface-exposed,	followed	by	
IsdA	and	IsdC,	forming	a	heme	shuttle	pathway:	IsdB	binds	heme	and	transfers	it	to	
IsdA,	 that	 then	 transfers	 heme	 to	 IsdC	 at	 the	 cell	 membrane	 (224,	 227–231).	
Discovered	 later	 was	 another	 peptidoglycan	 anchored	 protein,	 IsdH,	 which	 also	
participated	 in	 the	 heme	 transport	 assembly	 line	 (232).	 IsdB	 contains	 two	 NEAT	
domains,	 N1	 binds	 hemoglobin	 and	 hemoglobin-haptoglobin	 complexes,	 and	 N2	
binds	only	to	heme.	IsdH	contains	three	NEAT	domains,	where	N1	and	N2	both	bind	
hemoglobin	and	haptoglobin,	where	N3	 interacts	only	with	heme	 (233).	Thus,	 the	
proposed	model	 is	 that	N1	(and	N2	 in	the	case	of	 IsdH)	bind	to	hemoproteins	and	
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transfer	the	extracted	heme	molecule	to	the	downstream	NEAT	domains	(N2	for	IsdB,	
and	 N3	 for	 IsdH).	 IsdA	 is	 partially	 surface-exposed	 and	 contains	 only	 one	 NEAT	
domain	that	binds	only	to	heme.	Thus,	IsdH	and	IsdB	bind	to	host	hemoproteins	at	
the	surface	of	the	peptidoglycan	layer,	remove	the	heme	and	transfer	it	to	IsdA,	which	
then	shuttles	heme	to	IsdC	(234).		Transport	into	the	cell	is	achieved	through	a	three-
protein	 complex	with	homology	 to	ABC	 transporters,	designated	 IsdDEF.	 IsdE	 is	 a	
membrane	anchored	heme	receptor,	 IsdD	is	a	transmembrane	permease,	and	IsdF	
the	associated	ATPase	(222).		
The	last	piece	of	the	puzzle	was	the	discovery	of	isdG	and	isdI	genes.	IsdG	and	IsdI	are	
heme	oxygenases	that	degrade	heme	to	release	iron,	resulting	in	staphylobilin.	IsdG	
and	IsdI	are	expressed	during	infection	and	are	required	for	growth	where	heme	is	
the	sole	iron	source	(235,	236).	The	S.	aureus	Isd	pathway	is	illustrated	in	figure	1-4.	
Like	siderophores,	heme	can	be	transported	as	an	intact	molecule	into	the	cell	where	
the	iron	is	subsequently	removed.		
1.5.11 Transport of iron complexes 
Iron	 complexed	 to	 siderophores	 or	 heme	 is	 too	 large	 to	 passively	 diffuse	 through	
porins	in	the	membrane,	and	thus	needs	to	be	transported	into	the	cell	by	designated	
transporters.	 The	 main	 transporters	 characterized	 in	 this	 process	 are	 the	 ATP-
binding	 cassettes	 (ABC)	 and	 the	 Gram-negative	 TonB-dependent	 transporters,	
depicted	in	figure	1-4.		
In	Gram-negative	bacteria,	 iron-complexes	are	brought	 into	 the	 cell	 through	TonB	
dependent	 transporters	 (TBDT).	 Approximately	 50	 different	 TBDTs	 have	 been	
characterized,	 all	 with	 different	 ligands,	 although	 the	 majority	 of	 TBDTs	 are	
responsible	 for	 siderophore	 uptake	 (237).	 Other	 identified	 ligands	 for	 TBDTs	 are	
heme,	vitamin	B12,	 carbohydrates,	 and	nickel	chelates.	Due	 to	porin	 channels,	 the	
outer	membrane	 lacks	 a	 proton	motive	 force	 and	 thus	 does	 not	 have	 the	 energy	
source	needed	for	active	transport.	Therefore,	TBDTs	rely	on	ATP	generated	from	the	
inner	membrane	to	supply	the	energy	required	to	transport	iron-complexes	into	the		
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Fig	1-4.	A,B.	Model	of	iron	uptake	mechanisms	in	Gram-negative	and	Gram-positive	
bacteria.	Diagrams	depicting	the	envelope	proteins	required	for	the	uptake	of	iron,	or	
iron	 scavenged	 from	 siderophores	 or	 heme.	 This	 is	 a	 composite	 diagram	 and	
represents	 mechanisms	 used	 by	 many	 pathogenic	 bacteria.	 A.	 Model	 of	 TonB-
dependent	 transport	 in	 Gram-negative	 bacteria.	 An	 iron	 siderophore	 complex	
entering	 through	 a	 TonB-dependent	 transporter	 (TBDT)	 in	 the	 outer	 membrane	
(OM).	Movement	through	the	TBDT	requires	an	interaction	of	the	TonB	box	with	the	
TonB	protein,	with	the	energy	 for	conformational	changes	provided	by	the	proton	
motive	 force	 captured	 by	 the	 ExbB	 and	ExbD	 proteins.	 Intracellular	 iron,	 via	 Fur,	
negatively	 regulates	 transcription	 of	 genes	 encoding	 iron	 acquisition	 systems.	 In	
some	TBDTs,	an	N-terminal	extension	is	present	to	provide	an	extra	layer	of	control	
of	 gene	 expression,	 in	 addition	 to	 Fur.	 This	 involves	 an	 anti-σ-	 factor	 and	
extracytoplasmic	function	σ-factor,	allowing	for	gene	expression	in	response	to	the	
uptake	of	particular	iron	chelates.	B.	Gram-positive	bacteria	rely	on	ABC	transporters	
for	 iron-complex	 import.	 In	 the	 case	of	heme	 transport	 in	Staphylococcus	spp.	and	
Bacillus	spp.,	heme	 is	 shuttled	across	 the	peptidoglycan	 (PG)	 layer	by	 isd	encoded	
hemoproteins.	 Depicted	 is	 the	 Isd	 pathway	 characterized	 in	 S.	 aureus.	 OM,	 outer	
membrane;	 PG,	 peptidoglycan;	 CM,	 cytoplasmic	membrane;	 sid,	 FeIII-siderophore;	
Hm,	heme;	Hb,	hemoglobin;	Hp,	haptoglobin.	This	figure	is	published		in	Sheldon,	J.	R.,	
Laakso,	H.	A.,	and	Heinrichs,	D.	E.	(2016)	Virulence	Mech.	Bact.	Pathog.	(123).	
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periplasm	(238).	Energy	generated	 from	the	 inner	membrane	 is	 transduced	to	the	
outer	membrane	by	TonB,	ExbB	and	ExbD.		
The	first	characterized	TBDTs	were	FhuA	and	FepA,	which	are	responsible	for	import	
of	ferrichrome	and	ferric-enterobactin,	respectively	(239–241).	FhuA	and	FepA	are	
comprised	 of	 twenty-two	 stranded,	 β-barrel	 structures	 that	 span	 the	 outer	
membrane,	and	consist	of	a	N-terminal	periplasmic	“plug”	domain,	referred	to	as	the	
TonB-box.	In	the	resting	state,	the	plug	domain	fully	obstructs	the	β-barrel	interior	
and	prevents	transport	(242,	243).	When	the	ligand,	a	ferric-siderophore,	binds	to	the	
extracellular	 substrate-binding	 residues	 of	 the	 transporter,	 it	 transduces	 a	 signal	
across	the	membrane	that	causes	defolding,	or	“unplugging”,	of	the	TonB	box	from	
inside	 the	 barrel,	 allowing	 for	 transport	 of	 the	 substrate	 into	 the	 periplasm.	 This	
process	 is	 reliant	 on	 the	 TonB-ExbB-ExbD	 proteins	 of	 the	 inner	 membrane	 that	
supply	 the	 necessary	 energy	 (244).	 TonB	 contains	 three	 functional	 domains:	 N-
terminal	 signal	 sequence	 that	 directs	TonB	 to	 the	 inner	membrane,	 a	 proline-rich	
periplasmic	spacer	region	that	is	thought	to	confer	flexibility	to	TonB	and	allows	it	to	
span	the	periplasm,	and	lastly	a	C-terminal	domain	that	interacts	with	TonB-boxes	of	
TBDTs.	The	unfolding	of	TonB-box	upon	substrate	binding	causes	it	to	interact	with	
TonB-ExbB-ExbD	complex	and	signals	that	the	substrate	is	ready	for	transport.	This	
energizes	 the	 transporter	 to	bring	 the	 iron-complex	 into	 the	periplasm.	The	exact	
mechanism	behind	 the	 domain	 rearrangement	 of	 TonB-box	 is	 currently	 unknown	
(240,	242,	243).			
Some	TBDTs	also	possess	an	N-terminal	extension	domain,	or	signaling	domain,	that	
signal	 to	 cytoplasmic	 transcription	 factors	 binding	 of	 the	 substrate,	 causing	
downstream	 activation	 of	 appropriate	 genes.	 This	 N-terminal	 extension	 has	 been	
found	in	the	E.	coli	ferric-citrate	receptor,	FecA	(245),	the	ferric-pyoverdine	receptor,	
FpvA,	 of	P.	 aeruginosa	 (246),	 and	 in	heme-iron	 transporter	HasR	of	S.	marcescens	
(247).	 The	 α-/anti-α-factor	 is	 localized	 to	 the	 cytoplasmic	 membrane	 where	 it	
sequesters	an	associated	and	often	co-transcribed	extracytoplasmic	 function	(ECF)	
sigma	factor.	Upon	binding	of	 the	 ferric-substrate	to	 the	TBDT,	 the	TBDT	interacts	
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with	the	anti-α-factor	causing	liberation	of	the	ECF	sigma	factor	that	is	then	free	to	
direct	RNA	polymerase	 to	genes	 involved	 in	 the	 substrate-specific	uptake,	 such	as	
genes	encoding	 inner	membrane	ATPase	 transporters	or	siderophore	biosynthetic	
enzymes	(237).	This	additional	domain	allows	regulation	of	 iron-responsive	genes	
beyond	the	classical	ferric	uptake	regulator	(Fur)	regulation	and	is	a	way	for	the	cell	
to	fine-tune	the	iron-acquisition	mechanism	in	response	to	the	iron	source	available.		
1.5.12 Iron-substrate import with ABC transporters 
TBDT-dependent	uptake	of	iron-substrates	is	specific	to	Gram-negative	bacteria		and	
is	a	specific	way	to	import	iron-complexes	into	the	periplasm.	Once	in	the	periplasmic	
space,	 the	 substrate	 is	 directed	 by	 periplasmic-binding	 proteins	 to	 a	 specific	 ATP	
binding	cassette	(ABC)	transporter	in	the	cytoplasmic	membrane	for	import	into	the	
cytoplasm	 (123).	 In	 an	 analogous	 process,	 Gram-positive	 bacteria	 rely	 on	 ABC	
transporters	and	substrate-specific	membrane-anchored	lipoproteins	to	bring	iron-
substrates	 inside	 the	 cell.	 ABC	 transporters	 consist	 of	 a	 cytosolic	 ATP-binding	
lipoprotein,	a	transmembrane	permease,	and,	for	Gram-negative	bacteria,	a	soluble	
periplasmic	 protein,	 or	 an	 analogous	 membrane	 anchored	 lipoprotein	 in	 Gram-
positive	bacteria	(248).	ABC	transporters	are	ubiquitous	and	are	responsible	for	the	
import	of	many	essential	nutrients	such	as	amino	acids,	peptides,	sugars,	organic	and	
inorganic	ions,	polyamine	cations,	opines,	vitamins,	and	metals	(248).			
The	transmembrane	permeases	share	high	structural	similarity	and	typically	consist	
of	two	hydrophobic	membrane-spanning,	or	integral	membrane	(IM),	domains	that	
constitute	 roughly	 65%	 of	 the	 permease,	 and	 two	 hydrophilic	 domains	 in	 the	
cytoplasm.		These	four	domains	are	typically	independent	polypeptide	chains	that	are	
assembled	to	 form	a	multimeric	complex	 in	 transporters	responsible	 for	substrate	
influx.	For	exporters,	however,	these	four	domains	are	usually	derived	from	a	single	
polypeptide	 chain	 (249).	 Slight	 differences	 in	 the	 amino	 acid	 sequence	 of	 the	 IM	
domain	 provide	 the	 specificity	 needed	 to	 transport	 the	 appropriate	 substrate.	
Typically,	there	is	only	one	ABC	transporter	per	substrate,	which	confers	the	cell	with	
greater	 precision	 for	 iron-substrate	 uptake.	 Along	 with	 transport	 across	 the	
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membrane,	 the	 permease	 must	 recognize	 the	 specific	 periplasmic	 protein,	 or	
lipoprotein,	extract	the	substrate	for	transport,	and	utilize	the	corresponding	ATPase	
to	achieve	active	transport	of	the	substrate	(248).		
ATP-binding	proteins	are	readily	identified	by	a	conserved,	homologous	200-amino	
acid	sequences	 flanked	by	“Walker	A”	and	“Walker	B”	consensus	sequences.	These	
sequences	are	characterized	by	the	presence	of	nucleotide-binding	sites,	and	located	
internal	to	the	“Walker”	sequences	is	a	signature	motif,	unique	to	ABC	proteins	(250).	
The	precise	molecular	mechanism	for	ATP	hydrolysis	 is	controversial,	although	all	
ABC	 structures	 contain	 a	 highly	 conserved	 structural	 fold,	 suggesting	 that	 they	
hydrolyze	ATP	by	a	common	mechanism.		
The	periplasmic	binding	proteins	(PBPs)	of	Gram-negative	bacteria	are	diverse,	often	
sharing	only	a	10%	sequence	similarity	(203).	Despite	this,	the	structure	of	PBPs	is	
conserved:	PBPs	are	bi-lobed	proteins	comprised	of	β-sheets	flanked	by	α-helices	that	
are	connected	by	a	short	polypeptide	chain	that	functions	as	a	flexible	linker	domain.	
This	linker	domain	gives	movement	to	the	lobes	via	a	hinge	mechanism	that	encloses	
around	the	substrate	in	a	“Pac-Man”	type	motion	(251).	Specificity	and	recognition	of	
the	substrate	is	achieved	through	slight	rearrangements	of	the	β-sheets	and	α-helices	
of	 the	 two	 globular	 domains.	 Periplasmic	 proteins	 interact	 directly	 with	 the	
transmembrane	permease,	where	they	deliver	and	release	the	bound	substrate	for	
transport	into	the	cytoplasm.			
Lastly,	 essential	 to	 the	 transport	 of	 iron-complexes	 in	 Gram-positive	 bacteria	 are	
membrane	anchored	 lipoproteins.	Lipoproteins	 serve	 in	a	wide	 range	of	 functions	
from	uptake	of	other	essential	nutrients,	sensing	and	signaling	of	the	environment,	
protein	 secretion,	 and	 antibiotic	 resistance	 (252).	 Much	 like	 the	 analogous	
periplasmic-binding	 proteins	 of	 Gram-negative	 bacteria,	 the	 protein	 portions	
recognize	 with	 high	 specificity	 their	 iron-substrates,	 whereas	 the	 N-terminal,	
covalently-linked	 lipid	 portion	 is	 anchored	 to	 the	membrane	 preventing	diffusion.	
The	 hydrophilic	 protein	 is	 acylated	 to	 promote	 the	 coalescence	 of	 lipid	 to	 the	
phospholipid	bilayer	in	the	membrane,	positioning	the	lipoprotein	in	close	proximity	
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to	the	designated	ABC	transporter.	Once	bound	to	the	substrate,	lipoproteins	transfer	
the	substrate	to	the	ABC	transporter	for	import	(252,	253).		
1.5.13 S. aureus iron acquisition mechanisms and virulence 
The	preferred	iron	source	for	S.	aureus	is	heme	(254).	Heme	is	acquired	through	use	
of	 the	 Iron-surface	 determinant	 (Isd)	 system	 as	 previously	 described	 in	 section	
1.5.10.	The	utilization	of	heme	is	an	important	virulence	factor	for	S.	aureus,	and	thus	
its	 internalization	 is	mediated	 through	redundant	pathways;	 even	 isd	mutants	 can	
still	uptake	heme	for	use	as	an	iron	source,	although	the	mechanism	behind	this	is	
currently	unknown	(255).	An	isdB	mutant,	however,	still	had	significantly	lower	CFU	
counts	in	kidneys	and	spleens	in	a	systemic	mouse	model	of	infection,	compared	to	
the	isogenic	WT	(256).	This	finding	highlights	the	importance	of	the	Isd	system,	and	
specifically	heme	acquisition,	in	S.	aureus	survival	in	vivo.		
S.	 aureus	 utilizes	 polycarboxylate	 siderophores,	 staphyloferrin	 A	 (SA)	 and	
staphyloferrin	B	(SB),	for	uptake	of	free	ferric	iron	or	to	remove	ferric	iron	from	host	
glycoproteins,	transferrin	and	lactoferrin.	Both	SA	and	SB	are	stealth	siderophores,	
and	thus	are	not	recognized	by	the	host	protein	NGAL	(125).	S.	aureus	siderophores	
are	described	in	section	1.5.5.	Both	SA	and	SB	are	important	virulence	factors	in	vivo.	
Following	intravenous	injection,	a	SB-deficient	strain	(sbnE	mutant)	had	significantly	
fewer	CFUs	than	WT	in	a	murine	kidney	abscess	model	(199),	suggesting	that	SB	is	
critical	 for	systemic	 infection.	SA	 is	 important	for	skin	 infections,	as	a	SA-deficient	
strain	had	significantly	fewer	recoverable	CFUs	than	isogenic	WT,	and	a	SB-deficient	
strain,	 in	 a	 murine	 skin	 abscess	 model	 (182).	 Thus,	 differential	 siderophore	
production	by	S.	aureus	may	represent	another	means	by	which	this	pathogen	adapts	
to	different	host	environments.	Table	1-1	 lists	the	key	 iron	acquisition	mechanism	
utilized	by	S.	aureus.		
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Table	1-1	Predominant	iron	uptake	pathways	in	S.	aureus.		
S.	aureus	gene	(s)	 Role	in	iron	acquisition	 Reference	
sbnA-I	 Staphyloferrin	B	(SB)	 (171–173,	180,	
257,	258)	sbnA-C,	sbnE-H	 Biosynthesis	proteins	
sbnD	 SB	Efflux	 	
sirABC	 ABC	transporter	for	SB	import	 (257,	259,	260)	
	 	 	
sfa	 Staphyloferrin	A	(SA)	 (177,	179,	229,	
261)	sfaBCD	 Biosynthetic	proteins	
sfaA	 SA	Efflux	 	
htsABC	 ABC	transporter	for	SA	import	 (262)	
	 	 	
cnt	 Staphylopine	(Stp)	 (63,	183,	187,	263)	
cntE	 Stp	Efflux		 	
cntKLM	 Biosynthetic	proteins	 	
cntABCDF	 ABC	transporter	for	Stp	import	 	
	 	 	
isdA-I	 Heme	uptake	pathway	 (128,	168,	235,	
264–266)	
isdA-C,	isdH	 Surface	associated	heme-binding	proteins	
isdDEF	 ABC	transporter	for	heme	import	
isdG,I	 Heme	oxygenases	
	 	 	
fhuABC	 Uptake	of	ferric-hydroxamate	complexes	 (189–191)	
sstABCD	 Uptake	of	ferric-catecholate	complexes	 (199)	
feoABC	 Ferrous	iron	uptake	 (267)	
 
1.5.14 Regulation of iron uptake systems  
Iron-uptake	 systems	are	 tightly	 regulated	 in	 response	to	 the	 intracellular	 levels	of	
iron.	A	very	well	characterized	gene	regulator	in	Gram-negative	and	-positive	bacteria	
is	 Fur.	 Fur	was	 first	 identified	 in	E.	 coli,	where	 a	 single	mutation	 in	 the	 fur	 gene	
resulted	 in	 constitutive	 expression	 of	 iron	 acquisition	 genes	 (268–270).	 Since	 the	
initial	discovery,	Fur	has	been	extensively	characterized	 in	many	bacterial	species.	
Based	 on	 a	 Pfam	 sequence	 search,	 there	 are	 currently	 9,049	 sequences	 of	 Fur	
belonging	to	3,802	different	species	from	all	domains	of	life.		
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Fur	typically	functions	as	a	homodimer	and	regulates	gene	expression	in	response	to	
intracellular	iron	levels	by	binding	to	the	promoter	region	of	target	genes	(252,	271).	
Each	Fur	monomer	is	comprised	of	two	domains:	a	canonical	helix-turn-helix	motif	
necessary	for	DNA	binding	and	a	carboxy-terminal	domain	that	contains	the	metal-
binding	residues	and	is	essential	for	dimerization.	Zinc	is	the	coordinating	metal	for	
Fur	dimerization	and	is	bound	in	a	tetrahedral	fashion	to	two	cysteine	residues	(272,	
273).	
When	 iron	 is	 replete	 in	 the	 cell,	 Fur	 binds	 to	 ferrous	 iron,	 altering	 its	 dimer	
conformation	 to	 promote	 DNA	 binding	 to	 a	 19-bp	 Fur-binding	 consensus	 site,	
referred	to	as	 the	Fur	box.	Fur	boxes	are	typically	A/T-rich,	19-bp	 inverted	repeat	
sequences	usually	overlapping	the	-10	and	-35	promoter	elements	(274).	Fur	bound	
to	 the	 Fur	 box	 effectively	 blocks	 RNA	 polymerase	 from	 accessing	 the	 promoter,	
leading	to	repressed	transcription	of	target	genes.	In	iron	deplete	conditions,	levels	
of	intracellular	free	iron	are	low	and	thus	Fur	does	not	interact	with	ferrous	iron.	This	
prevents	Fur	from	forming	the	conformation	conducive	to	DNA	binding,	resulting	in	
disassociation	from	the	Fur	box,	thereby	allowing	expression	of	target	genes	(275).	
Nearly	all	genes	that	encode	products	that	participate	in	iron-uptake,	such	as	heme-
binding	 proteins	 and	 heme	 transporters,	 and	 biosynthesis,	 export	 and	 import	 of	
siderophores,	 are	 regulated	 via	 Fur.	 In	 S.	 aureus,	 nearly	 all	 genes	 involved	 in	
siderophore-mediated	 iron	uptake,	heme	uptake,	 and	ferrous	 iron	uptake	are	Fur-
regulated;	such	operons	include	fhu,	sir,	sbn,	sfa,	hts,	isd,	and	feo	(169,	179,	199,	257).		
Fur	has	been	shown	to	regulate	genes	not	only	directly	implicated	in	iron-acquisition,	
but	also	genes	 involved	 in	the	TCA	cycle,	glycolysis,	respiration,	chemotaxis,	redox	
stress	and	DNA	synthesis	(276,	277).	In	E.	coli,	Fur	represses	53	genes	and	activates	
48;	 these	 genes	 generally	 fall	 into	 two	 categories:	 those	 that	 contribute	 to	 iron	
metabolism	 and	 those	 implicated	 in	 energy	 metabolism.	 As	 a	 profound,	 global	
transcription	factor,	Fur	is	very	abundant	with	approximately	5,000	copies	per	E.	coli	
cell	(278).		
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A	key	aspect	to	Fur’s	global	regulation,	specifically	its	activation	of	certain	genes,	is	
the	expression	of	a	highly-conserved,	small	untranslated	RNA	(sRNA),	named	ryhB	
(279).	This	sRNA	is	repressed	by	Fur;	however,	in	iron	deplete	conditions	when	Fur	
is	inactive,	RyhB	binds	to	target	mRNA.	Notable	genes	regulated	by	RyhB	are	sodB,	
which	encodes	superoxide	dismutase,	genes	acnA	and	fumA,	which	encodes	enzymes	
of	the	TCA	cycle,	ftnA	and	bfr,	which	encode	proteins	involved	in	iron	storage,	and	the	
succinate	dehydrogenase	operon,	sdhCDAB	(280).	Binding	of	RhyB	to	mRNA	targets	
them	 for	 degradation.	 This	 process	 is	 a	 part	 of	 what	 is	 called	 the	 “iron-sparing	
response”,	 in	 which	 iron-containing	 enzymes	 and	 iron-storage	 proteins	 are	
negatively	 regulated	 during	 metal-starvation	 to	 prioritize	 cytoplasmic	 iron	 for	
essential	pathways	(281).	RhyB	regulation	is	found	in	many	Gram-negative	bacteria;	
however,	very	little	has	been	done	to	characterize	the	iron-sparing	response	of	Gram-
positive	bacteria.							
There	 is	 a	 large	 number	 of	 Fur	 homologs	 that	 have	 been	 identified.	 Some	 of	 the	
widespread	 Fur-homologs	 are	 Zur,	 regulator	 of	 zinc-homoestasis	 (282),	 PerR	 that	
regulates	 genes	 in	 response	 to	 oxidative	 stress	 (283),	 Mur,	 gene	 regulation	 in	
response	 to	manganese	 (284),	Nur,	 a	nickel-responsive	 regulator	 (285),	 and	 Irr	of	
Bradyrhizobium	 spp.	 (286).	 Irr	 is	 upregulated	 in	 response	 to	 iron-starvation	 and	
functions	as	a	negative	 regulator	of	hemB,	 a	 gene	encoding	 the	heme	biosynthetic	
enzyme	δ-aminolevulinic	acid	dehydratase,	and	genes	in	bacterioferritin	production	
(286–289).	In	the	presence	of	heme,	Irr	disassociates	from	DNA	causing	derepression	
of	 regulated	 genes.	 In	 some	 species,	 Irr	 can	 also	 activate	 genes	 involved	 in	 iron	
uptake.	Unlike	other	metalloregulators	that	function	as	repressors	in	the	presence	of	
their	metal	 ion,	 instead,	 when	 Irr	 is	 complexed	 to	 its	 response	 substrate,	 namely	
heme,	it	undergoes	degradation	causing	derepression	of	target	genes	(290).			
In	 some	 GC-rich,	 Gram-positive	 bacteria,	 such	 as	 Streptomycetes,	Corynebacterium	
spp.,	 and	Mycobacterium	spp.,	 another	 iron-responsive	 regulator	 is	utilized	named	
DtxR	 (diphtheria	 toxin	 regulator).	DtxR	 transcription	 factors	 regulate	 similar	gene	
clusters	 to	 Fur,	 often	 repressing	 genes	 that	 encode	 siderophore	 biosynthesis	 and	
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transport,	heme	transport,	and	ferric	iron	transport	in	response	to	intracellular	iron	
(291,	 292).	 DtxR	 is	 not	 a	 member	 of	 the	 Fur	 family,	 and	 contains	 no	 sequence	
similarity	 to	Fur,	although	the	structures	of	 these	two	regulators	are	similar.	Both	
regulators	 contain	 two	metal	 binding	 sites	 per	monomer;	 are	 assumed	 to	 bind	 to	
ferrous	iron,	have	the	canonical	helix-turn-helix	motif	that	is	critical	for	DNA-binding,	
and	function	as	dimers	(202,	293).	There	are	a	number	of	DtxR	homologs,	such	as	SirR	
in	S.	epidermidis	(294),	and	IdeR	of	Mycobacterium	tuberculosis	(295).		
1.6 Copper  
Like	 iron,	 copper	 is	 an	 essential	 micronutrient	 for	 living	 systems	 and	 plays	 an	
important	role	 in	central	metabolism,	oxidative	phosphorylation,	 iron	metabolism,	
hydrolytic	pathways,	and	 is	a	key	metal	cofactor	 for	many	enzymes	(122).	Despite	
being	 required	 by	 biological	 systems,	 copper	 is	 also	 incredibly	 toxic	 at	 high	
concentrations	due	to	its	readiness	to	accept	electrons.	In	aerobic	conditions,	copper	
produces	hydroxyl	radicals	via	Fenton	and	Haber-Weiss	chemistry	(296).	
Cu1+	+	H2O2	⟶	Cu2+	+	OH-	+	·OH	(Fenton)	
Cu2+	+	·O2	⟶	Cu1+	+	O2		(Haber-Weiss)	
Production	of	reactive	oxygen	species	causes	destruction	of	most	macromolecules,	
leading	to	damage	of	proteins,	nucleic	acid,	and	lipids.	In	the	cytoplasm,	copper	can	
react	with	thiol	groups	to	drive	the	oxidation	of	disulfide	bond	formation	and	can	also	
interact	 with	 S-nitrosothiols	 groups	 to	 generate	 nitric	 oxide;	 as	 copper	 is	 more	
reactive	than	most	transition	metals,	including	iron,	its	presence	in	biological	systems	
can	have	considerable	deleterious	effects	(297).		
1.6.1 Copper treatment in a health care setting  
In	 2008	 the	 US	 Environmental	 Protection	 Agency	 (EPA)	 granted	 recognition	 to	
copper	as	having	antimicrobial	efficacy,	approving	over	300	different	copper	surfaces	
(298).	Test	results	showed	that	most	microbes	examined	were	killed	within	hours	on	
copper	 surfaces,	 and	 this	 was	 exacerbated	 with	 decreased	 humidity,	 increased	
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temperature,	 and	 increased	 copper	 alloy	 content.	 Specifically,	 MRSA	 killing	 time	
varied	from	45	min	to	180	min	on	“wet”	surface	testing	(298,	299).	The	deletion	of	
copper	resistance	mechanisms,	as	expected,	decreased	killing	time,	suggesting	that	
free	copper	ions	are	present	in	the	cytosol	of	microbes	(299).	The	presence	of	oxygen	
also	 increased	 lethality,	 suggesting	 that	 the	 formation	 of	 ROS	 is	 an	 important	
consideration	 in	 microbial	 killing.	 Although	 the	 process	 of	 contact	 killing	 is	 not	
completely	resolved,	it	is	thought	to	begin	with	membrane	damage,	followed	by	the	
influx	of	copper	ions,	formation	of	ROS,	cell	death	and	DNA	fragmentation,	although	
this	specific	sequence	is	tentative	(299).		
Based	on	these	results	and	others,	studies	examined	the	potential	efficacy	of	copper	
surfaces	in	health	care	settings	to	reduce	hospital	acquired	infections.	Stainless	steel	
is	the	predominant	metal	coating	used	in	hospital	settings,	despite	having	no	clear	
antimicrobial	 properties.	 A	 study	 in	 Birmingham,	 UK,	 showed	 that	 compared	 to	
stainless	 steel,	 and	 other	 surfaces	 commonly	 used,	 copper-coated	 surfaces	
dramatically	decreased	 the	bacterial	 burden,	having	a	90-100%	reduction	up	 to	6	
months	after	installation	(300).	A	study	in	Hamburg,	Germany,	measured	the	survival	
of	microbes	and,	in	particular,	the	survival	of	ciprofloxacin-resistant	Staphylococcus	
(CRS)	as	a	 reporter	 for	multi-drug	 resistant	pathogens	 common	 to	hospitals.	They	
found	dramatic	differences	in	the	bacterial	burden	of	the	overall	microbe	population	
(63%	reduction);	however,	there	were	no	significant	differences	observed	with	CRS,	
although	 it	 trended	 to	 lower	 counts	 on	 copper	 surfaces	 compared	 to	 the	 control	
(301).		
Beyond	surfaces,	copper	is	also	being	examined	as	a	water	treatment	option.	One	of	
the	first	studies	to	exam	this	looked	at	the	copper	and	silver	ionization	of	drinking	
water	 in	 16	 hospitals	 to	 prevent	 hospital-acquired	 Legionnaires	 disease.	 Prior	 to	
installation	 in	 1995,	 all	 16	 hospitals	 had	 reported	 hospital-acquired	 legionnaires	
disease,	and	47%	of	hospitals	reported	having	more	than	30%	of	distal	water	sites	
test	 positive	 for	 Legionella	 contamination.	 During	 the	 study,	 50%	 of	 hospitals	
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reported	 no	 Legionella	 contamination	 in	 the	 water	 supply,	 and	 all	 16	 hospitals	
reported	0%	hospital-acquired	legionnaires	disease	(302).			
1.6.2 Copper and the environment 
There	is	an	increasing	amount	of	copper	and	zinc	usage	in	agriculture,	particularly	in	
animal	feed,	where	excess	amounts	of	these	heavy	metals	end	up	in	manure	and	seep	
into	water	and	soil	(303).	Due	to	this,	there	is	a	rising	number	of	heavy	metal-resistant	
bacteria	 emerging	 within	 livestock	 and	 crops	 (304).	 Unlike	 metals,	 antibiotics	
transiently	 persist	 in	 soil	 and	 water	 as	 they	 are	 prone	 to	 degradation	 and	
sequestration.	Recent	work	has	suggested	that	the	presence	of	copper,	mercury,	zinc,	
and	arsenic	may	in	fact	aid	in	persistence	of	antibiotic-resistant	genes	(ARG),	as	both	
metal-resistance	 proteins	 and	 antibiotic-resistance	 proteins	 share	 high	 functional	
and	 structural	 similarities	 and	 are	 frequently	 found	 on	 the	 same	 mobile	 genetic	
elements	(303,	305,	306).	Moreover,	among	the	heavy	metals	tested,	copper	had	the	
greatest	impact	on	antibiotic	resistance	compared	to	other	heavy	metals,	including	
nickel,	zinc,	lead,	and	iron	(305).			
Although	 still	 in	 the	 early	 stages,	 examination	 of	 copper	 surfaces	 and	 copper	
treatment	as	a	possible	means	to	reduce	microbial	growth	in	the	health	care	setting	
and	 livestock	 feed	appears	to	be	effective	against	most	microbes.	However,	as	was	
seen	in	the	German	hospital	study	(301),	copper’s	ability	to	kill	antibiotic-resistant	
pathogens	may	be	limited	and	may	in	fact	aid	in	persistence	of	antibiotic-resistance	
genes	(301,	303).	Therefore,	long-term	copper	exposure	could	increase	the	number	
of	highly	resistant	strains	over	time,	although	further	work	is	required	to	examine	the	
long-term	effects	of	copper	treatment.						
1.6.3 Copper homeostasis in humans  
Like	 iron,	 copper	 is	 essential	 to	 the	human	body,	 as	 it	 is	not	only	 involved	 in	key	
metabolic	 functions,	but	also	plays	a	role	 in	blood	clotting,	 iron	transport,	peptide	
hormone	 production,	 pigmentation,	 and	 brain	development	 (307).	 Similar	 to	 iron,	
most	 of	 the	 copper	 in	 the	 human	body	 is	 acquired	 through	 diet,	where	 copper	 is	
absorbed	through	enterocytes	that	line	the	intestine	and	is	transported,	typically	via	
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albumin	and	histidine,	through	the	portal	blood	to	the	liver	(297).	The	total	copper	
content	in	the	body	is	around	100	mg,	with	the	daily	uptake	being	around	1-2	mg.	It	
is	not	entirely	clear	if	copper	absorption	in	the	intestine	is	in	response	to	hormones	
secreted	by	the	 liver	when	there	are	 low	copper	 levels,	 like	hepcidin-regulation	of	
iron,	and	a	copper-responsive	hormone	has	been	suggested	in	mice	(308).	In	the	liver,	
much	of	 the	newly	acquired	copper	 is	loaded	onto	ceruloplasmin,	a	serum	protein	
that	 binds	 6-7	 copper	 ions	 and	 holds	 90-95%	 of	 copper	 in	 the	 human	 body.	 The	
remainder	of	the	hepatic	copper	is	transported	to	key	enzymes	in	the	cell	by	copper-
binding	chaperones.	Unlike	iron,	copper	is	not	stored	in	the	human	body,	and	thus	
intake	of	dietary	copper	is	essential,	and	excess	copper	is	removed	through	biliary	
excretion	(309).		
Ceruloplasmin	is	an	acute-phase	protein	that,	along	with	binding	hepatic	copper,	also	
binds	to	free	copper	in	the	serum	and	delivers	it	to	cells	and	tissues	in	the	body.	It	has	
been	well	documented	that	during	infection	hepatic	secretion	of	ceruloplasmin	into	
the	serum	increases	(310–312);	furthermore,	high	levels	of	ceruloplasmin	observed	
in	 the	 urinary	 tract	 are	 thought	 to	 prevent	 urinary	 tract	 infections	 (313).	
Ceruloplasmin	is	not	required	for	copper	absorption	or	copper	uptake	in	the	liver,	as	
aceruloplasminemic	mice	did	not	display	decreased	ability	in	these	pathways.	These	
mice,	however,	did	display	a	defect	 in	 iron	mobilization,	 a	 result	of	 ceruloplasmin	
functioning	 as	 an	 essential	 ferroxidase	 (314–316).	 Additionally,	 unlike	 ferric-
transferrin,	 ceruloplasmin	 is	 not	 endocytosed	 into	 cells,	 with	 the	 exception	 of	
hepatocytes,	but	is	membrane-bound	and	deposits	the	copper	at	the	cell	surface	for	
import	into	the	cell	via	surface	receptor	copper	transport	receptor	1	(CTR1)	(315).	
CTR1	is	an	essential	gene	for	embryonic	development,	as	homozygous	deletion	of	the	
ctr1	 gene	 in	 mice	 resulted	 in	 mortality	 half	 way	 through	 gestation.	 CTR1	 is	 the	
primary	human	transporter	of	copper;	however,	even	in	CTR1-deficient	cells,	copper	
uptake	 remains	 about	 ~20%,	 suggesting	 that	 there	 are	 alternative,	minor	 copper	
transport	systems	(317,	318).			
 
 52 
Free	copper	is	rarely	found	inside	cells	because	of	its	high	redox	potential,	where	the	
amount	of	free	copper	in	the	cell	is	estimated	to	be	less	than	10-18	M,	as	it	is	actively	
sequestered	by	copper	binding	chaperones	(319).	There	are	a	number	of	cytoplasmic	
chaperones	 that	 sequester	 and	 deliver	 copper	 to	 target	 proteins,	 for	 instance	
ATOX1/HAH1	delivers	copper	within	the	trans-golgi	network	to	ATP7A,	Sco1/COX17,	
delivers	copper	to	enzymes	involved	in	the	synthesis	of	cytochrome	C	oxidase,	and	
copper	chaperone	for	SOD	(CCS)	transports	copper	to	superoxide	dismutase	(SOD)	
(319,	 320).	 Transport	 of	 copper	within	 cells	 is	 largely	 facilitated	 through	 the	 Cu-
activated,	 P-type	 ATPase	 transporters,	 ATP7A	 and	 ATP7B,	 which	 are	 critical	 for	
proper	copper	homeostasis	(320).	
1.6.4 Copper usage by macrophages 
Although	 essential	 for	 central	 metabolism,	 copper	 is	 also	 critical	 for	 bacterial	
clearance.	Unlike	iron,	which	is	actively	sequestered	away	from	invading	pathogens	
as	a	part	of	nutritional	immunity,	copper	is	used	as	a	defense	mechanism	due	to	its	
potent	antimicrobial	properties.	Early	work	demonstrated	that	rodents	fed	copper-
deficient	diets	had	decreased	oxidative	burst	and	impaired	macrophage	function	and	
thus	 were	 much	 more	 susceptible	 to	 bacterial	 infection	 and	 infection-related	
mortality	(321,	322).		
Copper	plays	many	roles	in	immune	function	(323);	recently	characterized	was	the	
transport		of	copper	within	macrophages	from	the	cytosol	into	phagosomes,	where	
the	combination	of	free	copper	ions	and	acidifying	environment	results	in	decreased	
survival	 of	 engulfed	 microbes	 (296).	 This	 mechanism	 is	 performed	 through	 the	
concerted	effort	of	outer	membrane	copper-transporter	CTR1,	which	imports	copper	
from	 the	extracellular	milieu	 to	 cytoplasmic	 chaperone	ATOX1,	which	shuttles	 the	
copper	either	to	the	golgi,	or,	in	the	case	of	infection,	to	the	phagosome	for	efflux	by	
ATP7A	into	the	phagosome	(324).	Due	to	the	high	 levels	of	copper	experienced	by	
microbes	 inside	 the	phagosome,	 and	 in	 the	environment,	bacteria	have	developed	
sophisticated	copper	detoxification	systems.	
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1.7 Copper detoxification systems in bacteria 
The	major	players	in	bacterial	copper	detoxification	systems	are	P1B	-type	ATPases	
that	 are	 involved	 in	 extrusion	 of	 copper	 from	 the	 cytoplasm;	 copper-binding	
chaperones	 that	 sequester	and	deliver	 copper	 to	efflux	pumps	 for	 secretion,	or	 to	
cuproenzymes	 for	enzymatic	 function;	and	multicopper	oxidases	(MCOs)	that	bind	
free	copper	ions	and	convert	reactive	cuprous	(Cu+)	copper	to	less	active,	oxidized	
cupric	(Cu2+)	copper	(325).	
1.7.1 Enterococcus hirae copper detoxification pathway 
The	majority	of	 heavy	metal	 efflux	 pumps	 are	 a	 sub-class	 of	 P-type	ATPases,	 that	
receive	 their	 name	 due	 to	 a	 universally	 conserved	 aspartic	 acid	 residue	 in	 the	
phosphorylation	domain,	DKTGT	sequence,	that	is	phosphorylated	in	the	course	of	
the	reaction	cycle	(326).	These	transporters	also	have	a	distinguishing	CPC/CPH/SPC	
motif	located	in	the	middle	of	a	membrane	helix	(327).	Other	conserved	domains	are	
the	TGE	sequence	making	up	the	actuator	domain,	and	the	GCGINDAP	sequence	that	
comprises	the	nucleotide	binding	domain	(328).		
The	 copper	 efflux	 system	 of	 Enterococcus	 hirae	 is	 the	 most	 well	 studied	 copper	
detoxification	system	in	prokaryotes,	in	which	E.	hirae	CopA	and	CopB	were	the	first	
copper	ATPases	described	(329).	Copper	detoxification	mechanisms	in	E.	hirae	are	
representative	of	many	copper	systems	in	Gram-positive	bacteria,	including	S.	aureus.	
The	E.	hirae	copper	efflux	mechanisms	are	encoded	on	the	copABZY	operon,	where	
copA	and	copB	encode	ATPase	efflux	pumps,	copY	is	a	copper	responsive	repressor,	
and	copZ	is	a	copper	binding	chaperone	(330).		
It	is	generally	considered	that	CopA	in	E.	hirae	functions	in	both	the	uptake	and	efflux	
copper.	 This	 observation	 was	 based	 on	 two	 experiments:	 i)	 a	 copA	 mutant	 had	
reduced	growth	in	copper	limiting	media,	and	ii)	copA	mutants	were	less	sensitive	to	
growth	in	silver,	suggesting	that	both	copper	and	silver	may	be	imported	through	this	
transporter	(331).	CopA	possesses	a	CXXC	motif	at	the	N-terminus	that	is	responsible	
for	heavy	metal	binding.	The	 cysteines	 in	 this	motif	were	also	necessary	 for	CopA	
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interaction	 with	 copper	 chaperone,	 CopZ	 (332).	 The	 other	 ATPase	 copper	 efflux	
pump,	CopB,	does	not	contain	a	CXXC	motif	but	has	a	histidine-rich	N	terminus	that	
aids	in	metal	binding.	This	same	histidine-rich	N-terminal	motif	was	also	observed	in	
CopA	and	CopB	from	P.	syringae	(333).		The	CopB	in	E.	hirae	effluxes	copper	and	silver,	
where	maximal	transport	for	both	metals	was	observed	at	a	pH	6.0	(334,	335).		
The	founding	member	of	prokaryotic	copper	chaperones	was	CopZ	from	E.	hirae	and	
has	since	been	found	in	many	Gram-positive	and	-negative	bacteria	(336).	The	CopZ	
structure	 is	 a	 βαββαβ	 ferredoxin-like	 structure,	 that	 also	 contains	 the	 CxxC	motif.	
CopZ	functions	as	a	dimer,	where	copper	is	complexed	between	four	cysteines,	with	
two	cysteines	donated	from	each	CopZ	monomer	(337).	In	conditions	of	high	copper,	
CopZ	delivers	copper	to	both	CopY,	a	copper-responsive	regulator	that	de-represses	
the	copABZY	operon	when	complexed	to	copper,	and	to	CopA	for	efflux	of	copper	out	
of	the	cell	(332,	338).			
1.6.2 Copper detoxification in E. coli  
Like	E.	hirae,	the	copper	detoxification	system	of	E.	coli	is	well	studied	(339).	Figure	
1-5	 is	 a	 schematic	 of	 the	 major	 copper	 detoxification	 systems	 in	 E.	 coli	 and	 is	
representative	of	many	Gram-negative	bacteria.	Although	E.	coli	is	not	characterized	
as	 a	 macrophage-specific	 intracellular	 pathogen,	 it	 commonly	 infects	 the	
gastrointestinal	tract	of	mammals,	which	contains	relatively	high	amounts	of	copper	
that	may	have	enhanced	potency	due	to	the	acidic	environment	of	the	intestine	(340).	
Therefore,	many	enteric	pathogens	have	developed	enhanced	copper	detoxification	
systems.		
Copper	ions	enter	E.	coli	through	the	porin	in	the	outer	membrane,	OmpC	(341).	It	is	
also	thought	that	copper	and	zinc	may	enter	the	cell	through	siderophores	via	a	TonB-
dependent	transport.	Once	inside	the	cell,	homeostasis	is	maintained	to	avoid	copper	
toxicity.	E.	coli	requires	copper	for	key	metabolic	proteins,	such	as	the	cytochrome	bo	
terminal	oxidase	(342)	and	NADH:oxidoreductase	II	Ndh-2	(343).	The	vast	majority	
of	copper-binding	domains	of	metabolic	enzymes,	and	other	copper	binding	proteins,		
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Fig	1-5.	Copper	homeostasis	mechanisms	in	E.	coli.	Copper	enters	the	bacterial	cell	
through	an	outer	membrane	importer.	CueO,	a	multicopper	oxidase,	and	CopA,	a	P-
type	 ATPase	 transports	 copper	 from	 the	 cytoplasm	 into	 the	 periplasm,	 are	
upregulated	 in	 response	 to	 copper	 via	 the	 copper-binding	 regulator,	 CueR.	 In	 the	
periplasm,	CueO	oxidizes	Cu+	 to	Cu2+.	Alternatively,	 the	two-component	regulatory	
system	 CusRS,	 where	 CusS	 is	 a	 histidine	 kinase,	 that	 senses	 periplasmic	 Cu+	 and	
subsequently	phosphorylates	(P)	CusR,	a	response	regulator,	to	activate	transcription	
of	cusCFBA	genes.	CusF,	a	Cu+-binding	metallochaperone,	shuttles	periplasmic	copper	
to	CusCBA,	a	RND-family	exporter.		
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are	largely	restricted	to	the	periplasm.	This	suggests	that	E.	coli	requires	copper	in	
the	periplasm,	but	copper	concentrations	in	the	cytoplasm	are	limited;	a	convenient	
compartmentalization	that	may	serve	to	protect	nucleic	acid	in	the	cytoplasm	from	
the	damaging	effects	of	copper-mediated	oxidation	(340).			
Copper	 in	 the	 periplasm	 is	 readily	 oxidized	 from	 Cu+	 to	 Cu2+	 by	 proteins	 of	 the	
electron	 transport	 chain	 (344).	 Cuprous	 copper	 is	 also	 oxidized	 by	 CueO,	 a	
multicopper	 oxidase	 (MCO)	 that	 uses	 molecular	 oxygen	 to	 oxidize	 copper	 (345).	
Additionally,	 metal	 chaperones	 in	 the	 periplasm	 sequester	 copper	 and	 prevent	
uncontrolled	oxidation.	Examples	 of	 copper	 chaperones	 found	 in	E.	 coli	and	other	
bacterial	species	include	the	PcoC/CopC-like	and	PcoE/CopE-like	chaperones,	as	well	
as	the	CusF	chaperone	(340).		
The	 final	 fate	of	periplasmic	 copper	 is	 efflux	 from	 the	periplasm	by	metal-specific	
transporters.	As	the	oxidation	of	Cu+	 to	Cu2+	by	oxidases	requires	oxygen,	efflux	of	
copper	 from	 the	 cell	 is	 particularly	 important	 under	 anaerobic	 conditions.	 Two	
different	efflux	systems	have	been	characterized	in	E.	coli	that	work	to	rid	the	cell	of	
copper.	 The	 first	 system	 is	 the	 Cu-sensing,	 or	 cusRS	 locus	 that	 encodes	 a	 two-
component	 regulatory	 system,	where	 CusS	 is	 a	membrane-bound	histidine	 kinase	
and	 CusR	 the	 cytoplasmic	 response	 regulator	 (346).	 This	 two-component	 system	
regulates	 the	cusCFBA	operon,	 and	 the	plasmid	encoded	pco	operon.	The	cusCFBA	
operon	encodes	a	RND-family	of	proton-cation	antiporters	that	are	involved	in	the	
excretion	of	metal	ions	in	anaerobic	conditions.	CusC	is	a	trimeric	outer	membrane	
component,	CusA,	a	trimeric	inner	membrane	component,	and	CusB	is	a	hexameric	
membrane	 fusion	 and	 adaptor	 protein.	 CusF,	 a	 periplasmic	 copper-binding	
chaperone,	delivers	 copper	 to	CusB	where	 the	metal	 ion	 is	 transported	out	of	 the	
periplasm	by	the	CusCBA	complex	(347).	E.	coli	also	utilizes	ATPase	CopA	for	efflux	
of	copper	out	of	the	cytoplasm	into	the	periplasm.		
Multicopper	oxidase	 (MCO)	CueO	 (YacK)	was	 initially	 identified	 in	a	genome-wide	
search	to	uncover	MCOs	(348).	CueO	binds	six	copper	ions	per	polypeptide	chain	and	
works	to	sequester	free	copper	in	the	periplasm	(349).	Due	to	the	limited	number	of	
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copper	 ions	 bound	 by	 CueO,	 however,	 it	 was	 hypothesized	 that	 it	 may	 serve	 an	
additional	 function	 in	 the	 cell	 other	 than	 to	 sequester	 and	 oxidize	 copper	 (350).	
Experiments	 revealed	 that	 the	 copper	 bound	 by	 CueO	 had	 enzymatic	 function,	 as	
CueO	 had	 both	 ferroxidase	 and	 phenoloxidase	 activity.	 Thus,	 in	 addition	 to	
functioning	as	a	MCO,	CueO	also	functions	as	a	ferroxidase	and	oxidizes	chelated	iron	
from	 phenolate	 siderophores,	 namely	 2,3-dihydroxybenzoate	 and	 enterobactin	
(349).	The	proposed	mechanism	 is	 that	 copper	may	enter	 the	 cell	non-specifically	
through	 divalent	 metal	 ion	 transporters,	 such	 as	 Feo.	 In	 high	 concentrations	 of	
copper,	Cu+	 ions	may	compete	with	Fe2+	 for	 transport,	resulting	 in	decreased	 iron	
inside	the	cell.	Therefore,	CueO	may	function	as	a	way	to	compensate	for	a	decrease	
in	iron,	as	it	liberates	chelated	iron	from	phenolate	siderophores	whilst	sequestering	
free	copper,	helping	to	maintain	the	balance	of	copper	and	iron	concentrations	in	the	
periplasm	(349).			
1.7.3 Copper-responsive regulation in bacterial systems 
Copper	regulation	can	be	broadly	divided	into	two	groups:	copper	monitoring	that	
occurs	in	the	periplasm,	which	is	largely	achieved	through	two-component	regulatory	
systems,	 or	 regulation	 that	 occurs	 in	 the	 cytoplasm,	 comprised	 of	 mostly	 single-
component	regulators	or	activators.		
CopY transcription factors 
CopY	 is	 the	 founding	member	of	 copper-responsive	 transcription	 factors,	 and	was	
originally	 identified	 in	 E.	 hirae,	 and	 has	 since	 been	 characterized	 in	 other	 Gram-
positive	 organisms,	 namely	Enterococcus	 faecalis,	 Lactococcus	 lactis,	 Streptococcus	
mutans,	 and	 Streptococcus	 pneumoniae	 (351).	 As	 previously	 discussed	 in	 section	
1.7.1,	in	E.	hirae	CopY	regulates	the	copABZY	operon,	that	encodes	two	ATPases,	CopA	
and	CopB,	CopZ,	a	copper	chaperone	that	transfers	copper	to	CopY,	and	lastly,	its	own	
expression	(331).		
CopY	 typically	 functions	 as	 a	 dimer	 of	 two	 bipartite	monomers;	 each	monomer	 is	
comprised	of	a	N-terminal	DNA-binding	motif,	similar	to	β-lactamase	repressors,	and	
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also	a	putative	QQ	motif	that	interacts	with	ACA	triplets	in	the	DNA	binding	site.	In	
vitro	DNA	binding	assays	with	CopY	showed	that	mutation	of	ACA	to	TCA	abrogated	
DNA	binding,	 supporting	 the	notion	 that	 the	putative	QQ	motif	 is	needed	 for	DNA	
interaction	 (331).	 The	 C-terminal	 portion	 of	 CopY	 contains	multiple	 Cys	 residues	
arranged	as	CxCx4CxC,	which	is	necessary	for	metal	binding.	In	vitro	the	“resting	state”	
CopY	binds	to	one	molecule	of	Zn2+,	allowing	DNA	binding	and	repression	of	the	cop	
operon.	When	copper	becomes	available	in	the	cytoplasm,	CopZ	transfers	two	copper	
ions	to	Zn2+-CopY,	most	likely	through	direct	CopZ-CopY	interaction,	displacing	Zn2+	
and	releasing	CopY	from	DNA,	resulting	in	expression	of	cop	genes	(338).					
Two component CusRS copper regulators 
Two-component	regulatory	systems	(TCS)	are	found	in	all	prokaryotic	organisms	and	
are	key	factors	to	environmental	adaptation.	As	previously	described,	TCS	typically	
consist	 of	 a	 membrane-spanning	 sensor	 kinase,	 that	 “senses”	 an	 outside	 signal,	
causing	phosphorylation	of	a	conserved	aspartate	residue	on	the	associated	response	
regulator.	This	phosphorylation	event	causes	release	of	the	response	regulator	that	
then	activates	transcription	of	genes	necessary	for	the	cellular	response	(351).	CusRS	
is	a	copper-sensing	TCS	that	has	been	identified	in	many	prokaryotes.	These	include	
proteobacteria	P.	 flourescens,	 P.	 putida,	 P.	 syringae	 (352–355),	 H.	 pylori	 (356),	 the	
cyanobacterium	Synechocystis	sp.	PCC	6803	(357),	and	the	Gram-positive	bacterium	
C.	 glutamicum	 (358).	 It	 is	 best	 characterized	 in	E.	 coli	where	 the	 cusRS	genes	 are	
divergently	transcribed	from	the	cusCFBA	operon,	which	encodes	components	of	the	
RND-family	copper	exporter	(CusCBA)	and	copper	chaperone	(CusF)	(359).		
E.	coli	encodes	at	least	two	copper	regulators,	CusRS	and	cytoplasmic	CueR.	Although	
both	 are	 responsive	 to	 copper,	 the	 CusRS	 TCS	 is	 responsive	 during	 growth	 in	
anaerobic	environments,	whereas	CueR	 is	 active	during	aerobic	growth.	Thus,	 the	
main	function	of	CusRS	is	to	provide	copper	tolerance	under	anoxic	environments,	a	
condition	where	copper	toxicity	is	heightened,	by	upregulating	the	cus	system.	CusRS	
is	also	active	when	copper	concentrations	are	incredibly	high	and	overwhelm	CopA	
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and	 CueO,	 and	 thus,	 in	 these	 instances,	 CusCBA	 is	 needed	 to	 maintain	 copper	
homeostasis	(360).			
Cornybacterium	glutamicum	 is	another	organism	that	has	a	dual	copper	regulatory	
system.	 In	 addition	 to	 the	 single-component,	 cytoplasmic	 regulator	 CsoR,	 C.	
glutamicum	 also	 expresses	 the	 TCS,	 CopRS.	 CopS	 of	 C.	 glutamicum	 shares	 a	 21%	
sequence	identity	to	CusS	of	E.	coli,	and	CopR	contains	a	34%	sequence	identity	to	
CusR	 (358).	CopRS	 regulates	 two	gene	clusters,	 cg3281-3285	and	cg3286-cg3289.	
The	 cg3281-3285	 operon	 encodes	 CopR,	 CopS,	 putative	 copper	 chaperone	 CopZ,	
putative	 lipoprotein,	 and	 copper	 efflux	 ATPase	 CopB.	 The	 cg3286-cg3289	 gene	
cluster	encodes	multicopper	oxidase	CopO,	whereas	 the	 function	of	 the	 remaining	
gene	products	are	currently	unknown.	CsoR	regulation,	to	be	discussed	later	in	this	
section,	regulates	expression	of	copZ,	the	lipoprotein,	and	copB;	however,	does	not	
affect	expression	of	CopRS	(362).						
CueR-like transcriptional regulators 
CueR	copper	regulators	are	MerR-type	transcription	factors	that	are	found	in	many	
proteobacteria.	MerR	is	a	large	family	of	transcription	factors	that	respond	to	a	wide	
array	 of	 environmental	 stimuli.	 These	 regulators	 consist	of	 three	 domains:	 the	N-
terminal	 domain	 that	 contains	 the	 classical	 helix-turn-helix	 DNA-binding	 motif,	 a	
central	dimerization	domain,	 and	 the	C-terminal	metal	binding	domain	 (363).	The	
CueR	regulator	was	first	described	in	E.	coli	and	was	the	sole	activator	of	the	copA	
gene.	The	CueR	DNA	binding	site	in	E.	coli	contained	a	19	bp	extended	spacer	region	
located	between	 the	 -10	and	 -35	promoter	elements,	 that	 contains	a	7	bp	dyad	of	
perfect	 symmetry	 and	 7	 bp	 dyad	 of	 non-symmetrical	 sequence.	 It	 is	 at	 the	 dyad	
sequences	where	protein	binding	is	observed.	CueR	coordinates	one	copper	ion	per	
monomer,	where	both	the	holo-	and	apo-forms	of	the	CueR	can	complex	with	DNA;	
however,	only	the	holo-form	of	the	protein	can	recruit	RNA	polymerase	and	activate	
transcription	(364).	Along	with	activating	expression	of	copA	and	cueO	in	response	to	
copper,	 genome-wide	 transcriptomics	 in	 E.	 coli	 demonstrated	 that	 CueR	 could	
potentially	 regulate	 hundreds	 of	 genes	 involved	 in	 iron	 metabolism,	 energy	
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metabolism,	 general	 stress	 response,	 and	 flagellar	 biosynthesis;	 in	 addition,	 197	
putative	 CueR	 promoter	 sites	 have	 been	 found	 in	 the	 chromosome,	 suggesting	 a	
global	regulatory	role	for	CueR	(364,	365).		
CsoR transcription factors 
Regulation	of	many	copper	detoxification	systems	is	facilitated	through	the	copper-
sensitive	operon	repressor	(CsoR)	(366).	In	bacteria	lacking	the	CueR	transcription	
factor,	CsoR	 is	 the	primary	 single-component,	copper-sensing	 transcription	 factor.	
CsoR	 regulators	 were	 first	 identified	 in	Mycobacterium	 tuberculosis,	 and	 are	 now	
widespread	in	Gram-positive	bacteria,	namely	B.	subtilis,	L.	monocytogenes,	S.	aureus,	
and	Streptococcus	lividans	(351).	Although	CsoR	structures	lack	any	canonical	DNA-
binding	motifs,	they	all	form	antiparallel	four-helix	bundles	that	are	thought	to	act	as	
a	 DNA-binding	 domain.	 CsoR	 family	 members	 adopt	 a	 flat	 disc-shape	 dimer,	 and	
typically	function	as	homodimers,	or	tetramers,	where	each	dimer	binds	two	copper	
ions;	 copper	 binding	 occurs	 through	 binding	of	 two	 conserved	 cys	 residues	 (367,	
368).	CsoR,	unlike	CueR	which	 functions	as	an	activator	of	 gene	expression	 in	 the	
presence	of	copper,	is	mechanistically	similar	to	Fur:	CsoR	represses	gene	expression	
in	 the	 absence	 of	 copper,	 but	 when	 intracellular	 copper	 is	 present,	 undergoes	 a	
conformational	change	that	decreases	 its	affinity	 for	DNA,	causing	derepression	of	
genes	(369).			
1.7.4 Copper detoxification pathways and intracellular survival  
The	 first	 connection	 of	 copper	 to	 the	 innate	 immune	 system	 was	 neutropenia	
observed	in	humans	and	animals	that	were	copper	deficient	(370,	371).	Interestingly,	
neutrophils	 of	 copper-deficient	 patients	 had	 impaired	 function	 presenting	 as	
decreased	 phagocytosis	 and	 bacterial	 clearance;	 these	 defects	 could	 be	 restored,	
however,	with	increase	in	dietary	Cu	(372,	373).	Copper	deficiency	had	similar	effects	
on	macrophage	function,	resulting	in	decreased	phagocytosis	and	respiratory	burst	
(321).	Furthermore,	Pasteurella	haemolytica	infection	in	mice	with	copper-deficiency	
showed	 depressed	 LD50,	 significantly	 higher	 bacterial	 counts	 in	 the	 spleen,	 and	
 
 61 
reduced	 fever	 (374).	 Further	 studies	 showed	 similar	 results	 demonstrating	 that	
hypercupremia	leads	to	greater	susceptibility	to	infection	(375–377).		
Since	 these	 early	 discoveries,	 mutation	 of	 key	 copper	 efflux	 systems	 have	
demonstrated	 that	 these	 are	 important	 virulence	 factors	 in	 E.	 coli	 (324),	
Mycobacterium	 tuberculosis	 (378,	 379),	 Pseudomonas	 aeruginosa	 (380),	S.	 enterica	
(381,	382),	and	Streptococcus	pneumoniae	(383).	Examination	of	the	metal	content	of	
the	phagosome	following	phagocytosis	of	M.	smegmatis	showed	a	notable	increase	in	
copper	concentration	that	was	further	enhanced	through	activation	by	IFN-!	(384).	
The	mechanism	behind	copper,	macrophage	function,	and	infection	was	uncovered	
by	work	done	 in	murine	macrophages	 infected	with	E.	 coli.	White	et	al.	made	 two	
important	 discoveries:	 (i)	 that	 IFN-!	 activation	 of	 macrophages,	 resulted	 in	
upregulation	 of	 ATP7A,	 that	 directly	 affected	 the	 intracellular	 survival	 of	 E.	 coli,	
whereas	silencing	ATP7A	increased	bacterial	counts;	and	(ii)	E.	coli	strains	lacking	
the	P-type	ATPase	CopA	had	attenuated	survival	(324).	After	decades	of	observations	
that	linked	copper	to	macrophage	and	neutrophil	efficacy,	this	was	the	first	study	to	
propose	a	mechanism	behind	copper-mediated	bacterial	killing	by	phagocytes.	In	this	
mechanism,	 ATP7A	 effluxes	 excess	 copper	 into	 the	 phagosome	 that	 results	 in	
deleterious	 effects	 on	 microbial	 growth.	 Although	 the	 exact	 mechanism	 behind	
copper-mediated	killing	is	still	unresolved,	it	is	hypothesized	that	the	generation	of	
OH·	 from	hydrogen	 peroxide	 and	 copper	 in	 the	 phagosome	 aids	 in	 clearance.	 The	
physiological	concentrations	of	hydrogen	peroxide	in	the	phagosome	are	typically	too	
low	to	cause	cell	death.	Therefore,	inside	the	phagosome,	copper	may	be	needed	to	
increase	the	concentration	of	hydrogen	peroxide	and	potentiate	hydrogen	peroxide-
mediated	killing	(385).				
1.7.5 Copper homeostasis in Mycobacterium tuberculosis  
One	 of	 the	 most	 studied	 bacterial	 copper	 homeostasis	 systems	 is	 that	 of	 M.	
tuberculosis	(Mtb).	Mtb	survives	in	macrophages,	as	it	is	able	to	arrest	phagosomal	
maturation	and	hijack	 intracellular	systems	essential	 to	pathogen	clearance	(386).	
Like	all	other	organisms	discussed,	Mtb	requires	copper	for	proteins	in	respiration,	
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specifically	the	cytochrome	C	oxidase;	however,	at	high	concentrations	copper	is	toxic	
to	 the	 cell,	 and	 Mtb	 is	 acutely	 sensitive	 to	 copper	 compared	 to	 many	 other	
microorganisms	 (387).	 Interestingly,	 Mtb	 has	 a	 cytochrome	 bd	 oxidase,	 which	 is	
upregulated	 in	oxygen	 limited	environments.	This	cytochrome	bd	oxidase	can	also	
function	as	the	terminal	electron	acceptor	in	the	ETC.	However,	it	does	not	require	a	
copper	 cofactor,	 suggesting	 that	 Mtb	 is	 capable	 of	 changing	 to	 a	 copper	 free	
metabolism	when	 oxygen	 is	 limited	 as	 a	 possible	 means	 to	 protect	 the	 cell	 from	
copper	in	conditions	that	exacerbate	copper	toxicity	(388).	The	outer	membrane	of	
Mtb	functions	to	protect	the	cell	from	copper,	by	preventing	diffusion	of	copper	into	
the	 cell;	 instead,	 copper	 is	 transported	 through	 a	 designated	 porin,	 MspA	 (389).	
Despite	 these	additional	 levels	of	protection,	Mtb	 still	 requires	 copper	detoxifying	
mechanisms	 to	 survive	 the	 copper	 concentrations	 inside	 the	 phagosome.	 Mtb	
overcomes	 copper	 toxicity	 through	 two	 main	 mechanisms:	 i)	 through	 reducing	
copper	influx,	and	ii)	through	efflux	of	excess	copper	from	the	cytoplasm.		
Although	 considered	 a	 Gram-positive	 bacterium,	 Mtb	 has	 a	 protective	 outer	
membrane	 that	 is	 comprised	 of	 lipids	 and	 mycolic	 acids,	 and	 thus	 structurally	
resembles	 Gram-negative	 bacteria.	 MctB	 is	 an	 outer	 membrane	 transporter	 with	
specificity	to	copper	and	silver	that	is	thought	to	work	similarly	to	the	CusABC	system	
of	E.	coli,	in	which	copper	in	the	cytoplasm	is	effluxed	into	the	periplasmic	space	and	
then	excreted	by	MctB	(378,	390).	Also	 in	 the	periplasm	is	MmcO,	a	homologue	of	
CueO,	that	oxidizes	highly	reactive	Cu+	to	less	reactive	Cu2+	(391)		
Mtb	 encodes	 eleven	 P-type	 ATPases,	 three	 of	 which	 can	 secrete	 copper	 from	 the	
cytoplasm,	CtpA,	CtpB,	and	CtpV	(392);	however,	only	CtpV	and	putative	zinc	efflux	
pump,	CtpG,	 are	upregulated	 in	 response	 to	 copper	 (390).	 In	 the	 cytoplasm	 is	 the	
metallothionein	 MymT,	 the	 first	 characterized	 metallothionein	 in	 Gram-positive	
bacteria.	Mammalian	metallothioneins	 are	 cysteine-rich	 proteins,	 typically	30%	of	
their	amino	acid	residues,	that	allows	them	to	bind	to	roughly	7	divalent	ions	or	12	
monovalent	 ions,	making	 them	 efficient	 metal	 chelators.	 MymT	 is	 upregulated	 in	
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response	 to	 copper,	 cadmium,	 cobalt,	 lead,	 and	 zinc,	with	 the	 strongest	 induction	
being	from	copper	(393).			
Like	many	Gram-positive	bacteria,	Mtb	copper	detoxification	 is	controlled	by	CsoR	
that	regulates	ctpV,	two	genes	of	unknown	function,	and	its	own	expression	(368).	
RicR	 is	 an	 additional	 copper-sensing	 regulator	 that	 regulates	 the	 ric	 regulon,	 that	
encodes	RicR	and	metallothionein	MymT	(393,	394).	
For	survival	in	vivo,	an	obvious	candidate	to	examine	was	inner	membrane	ATPase	
CtpV.	 Infecting	 mice	 with	 a	 ctpV	 mutant	 significantly	 decreased	 the	 severity	 of	
infection,	although	this	was	not	complementable	by	restoring	the	ctpV	gene	 in	the	
chromosome,	 leaving	 the	 exact	 contribution	 of	 CtpV	 to	Mtb	 virulence	 unresolved.	
Furthermore,	infection	of	the	ctpV	mutant	and	isogenic	WT	into	a	guinea	pig	model	of	
infection	showed	decreased	bacterial	counts	at	21	days	post	infection,	yet	no	other	
differences	were	 observed	 at	 later	 time-points	 (395).	 Overall,	 CtpV	 appears	 to	 be	
important	for	the	full	virulence	of	Mtb	in	the	early	stages	of	infection;	however,its	full	
contribution	to	virulence	is	not	delineated.		
Deletion	 of	 the	 metallothionein-encoding	 gene,	 mymT,	 showed	 increased	 copper	
sensitivity	of	Mtb	 in	 vitro,	 although	 failed	 to	 affect	 virulence	 in	 a	mouse	model	of	
infection	(393).	It	was	not	until	the	deletion	of	the	outer	membrane	efflux	protein,	
mctB,	that	a	significant	decrease	in	survival	was	observed	in	both	mice	and	guinea	pig	
models	of	 infection	compared	to	what	was	observed	with	WT	(378).	These	results	
demonstrated	that	copper	efflux	through	outer	membrane	protein	MctB	is	essential	
for	Mtb	virulence	in	vivo.	No	other	single	mutation	of	copper	detoxification	genes	had	
a	role	on	virulence	other	than	mutation	of	the	regulator	ricR,	so	as	to	prevent	RicR	
from	binding	to	copper	resulting	in	constitutive	repression	of	copper	detoxification	
genes.	The	constitutive	repression	of	RicR-regulated	operons	resulted	in	significant	
attenuation	in	a	mouse-lung	model	of	infection	(379).			
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1.7.6 Copper detoxification in Salmonella  
Like	many	other	Gram-negative	bacteria,	Salmonella	spp.	encodes	the	copper	efflux	
ATPase	CopA	that	secretes	copper	 ions.	CopA	expression	 is	 induced	by	copper	via	
CueR,	and	mutation	of	copA	in	S.	enterica	sv.	Typhimurium	showed	reduced	survival	
in	macrophages	 (396).	CueR/SctR	 is	 a	 transcriptional	regulator	 that	 controls	copA	
and	cueO	genes	in	response	to	copper	(397).	A	cueR	mutant	had	decreased	resistance	
to	 copper,	 suggesting	 that	 CueR	 activates	 the	 expression	 of	 copper	 resistant	
mechanisms,	namely	CueO.	An	S.	enterica	sv.	Typhimurium	mutant	lacking	CueO	had	
increased	copper	and	hydrogen	peroxide	sensitivity	and	demonstrated	a	significant	
decrease	in	growth	compared	to	WT	in	a	murine	infection	model	(398).	Interestingly,	
the	cueO	mutation	only	appeared	 to	affect	 systemic	growth	and	did	not	affect	 the	
ability	 of	 the	 strain	 to	 invade	 intestinal	 epithelial	 cells	 or	 translocate	 across	 the	
reticuloendothelial	system,	as	the	mutant	had	no	growth	defect	in	Peyer’s	patches	or	
mesenteric	lymph	nodes.	In	addition,	the	cueO	mutant	did	not	have	a	defect	in	growth	
in	murine	macrophages,	suggesting	that	the	defect	seen	in	vivo	is	not	due	to	survival	
in	 the	 phagosome	 but	 is	 most	 likely	 due	 to	 host	 factors	 that	 S.	 enterica	 sv.	
Typhimurium	encounters	during	systemic	growth	in	the	host	(398).					
In	 vitro,	 a	 copA	 mutant	 had	 increased	 sensitivity	 to	 copper;	 however,	 ATPase-
transporter,	GolT,	which	primarily	 functions	as	a	gold	efflux	pump,	 is	 also	able	 to	
efflux	 copper	 in	 the	 absence	 of	 CopA,	 and	 thus	 compensates	 for	 copA-mutant	
phenotype	 in	 vivo	 (399).	 Therefore,	 it	 required	 deletion	 of	 both	 copA	 and	golT	 to	
observe	a	significant	attenuation	of	growth	in	a	murine	infection	model,	compared	to	
WT.	This	attenuation	was	due	to	copper,	as	the	growth	phenotype	of	the	copA,golT	
mutant	was	 restored	 to	WT	 levels	 in	Atp7aLysMcre	mice	 (382).	 This	 suggested	 that,	
unlike	 the	 cueO	 mutant,	 mutation	 of	 copA	 and	 golT	 hindered	 S.	 enterica	 sv.	
Typhimurium	growth	inside	the	macrophage.				
1.8 Copper homeostasis in S. aureus  
All	 sequenced	 S.	 aureus	 genomes	 contain	 the	 copAZ	 locus	which	 encodes	 CopA,	 a	
copper-translocating	 P-type	 ATPase,	 and	 CopZ,	 a	 cytoplasmic,	 copper-binding	
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chaperone	(400).	Previous	work	has	shown	that	deletion	of	copA	in	S.	aureus	renders	
the	cell	sensitive	to	high	concentrations	of	copper,	and,	to	a	lesser	extent,	lead,	iron,	
and	hydrogen	peroxide	 in	 vitro	 (401).	S.	aureus	CopA	contains	 the	 conserved	CPC	
sequence	(residues	C451-C453),	and	other	conserved	motifs	such	as	the	N-terminal,	
metal	binding	motif	CXXC	(sequence	CAAC;	residues	C16-C19	and	C83-C86),	where	
mutation	of	the	cysteines	abrogates	copper	binding	abilities	(400).	Also	conserved	in	
CopA	is	the	nucleotide	binding	sequence	GDGVNDAP	(residues	G689-P696).			
The	copAZ	locus	is	regulated	by	CsoR,	which	represses	the	copAZ	operon	in	copper-
deplete	 conditions,	but	de-represses	copAZ	after	binding	 to	 cytoplasmic	 copper	 in	
copper	replete	conditions	(351,	366).	Like	all	characterized	CsoR	regulators,	 the	S.	
aureus	 CsoR	 lacks	 any	 canonical	 DNA	 regulatory	 motifs,	 but	 forms	 planar	 helical	
structures	comprised	of	dimers	or	tetramers.	Encoded	immediately	downstream	of	
csoR	is	a	210	bp	gene	of	unknown	function,	but	thought	to	be	a	copper	chaperone	due	
to	 the	 presence	 of	 an	 ~30	 amino	 acid	 heavy-metal-associated	 (HMA)	 domain,	
designated	 as	 csoZ	 (402).	 The	 role	 of	 csoZ	 in	 copper	 detoxification	 is	 currently	
unknown,	but	it	may	function	to	bring	copper	to	CsoR,	similar	to	what	is	observed	
with	copper	chaperone	CopZ	and	transcription	factor	CopY	in	E.	hirae	(338).	Figure	
1-6	highlights	 the	major	copper	detoxification	mechanisms	found	 in	all	sequenced	
strains	of	S.	aureus.		
Previously	shown	was	that	copBmco	on	the	pSAP019A	plasmid,	a	member	of	the	S.	
aureus	accessory	genome	 found	only	 in	 some	clinical	 isolates,	 is	 also	 regulated	by	
CsoR	 (402).	 The	 copBmco	 encodes	 another	 P1B-type	 ATPase,	 CopB,	 and	 other	
resistance	mechanisms	to	heavy	metals	arsenic	and	cadmium.	Disruption	of	CsoR	in	
S.	aureus	results	in	constitutive	expression	of	copA	and	copBmco,	even	in	low	copper	
concentrations.	 Interestingly,	 in	 a	 csoR	mutant	 strain,	 copAZ	 and	 copBmco	 gene	
expression	was	notably	lower	than	that	of	WT,	when	strains	were	grown	in	excess	
copper	(402).	This	suggested	that	with	excess	copper,	CsoR	is	somehow	needed	for	
full	induction	of	the	cop	genes	or,	perhaps,	regulates	additional	genes	involved	in	the		
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Fig	1-6.	 Schematic	of	S.	aureus	 copper	detoxification	 system.	Copper	 is	potentially	
brought	into	the	cell	through	a	non-specific	cation	transporter.	Inside	the	cell,	copper	
may	be	sensed	by	putative	copper	chaperone,	CsoZ,	that	may	deliver	copper	to	the	
transcriptional	repressor	CsoR.	Binding	of	CsoR	to	copper	causes	a	conformational	
change	resulting	in	disassociation	from	the	copAZ	promoter	region	and	derepression	
of	copA	and	copZ.	The	copper-chaperone	CopZ	sequesters	free	iron	in	the	cytoplasm	
and	delivers	it	to	CopA,	a	P1B-ATPase	efflux	pump	that	then	excretes	excess	copper	
out	of	the	cell.		
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copper-induced	 stress	 response.	 Thus,	 further	 work	 is	 needed	 to	 understand	 the	
regulation	of	copper	detoxification	systems	in	S.	aureus.	
In	addition	to	CsoR,	there	is	another	regulator	that	indirectly	regulates	copAZ	called	
CymR.	 CymR	 functions	 as	 a	 repressor,	 and	 is	 the	 master	 regulator	 of	 cysteine	
metabolism.	 cymR	mutants	 have	 increased	 copAZ	 expression	 as	well	 as	 increased	
expression	of	superoxide	dismutases,	sodA	and	sodM.	CymR	does	not	bind	to	the	copA	
promoter	 directly,	 and	 thus	 the	 mechanism	 behind	 CymR	 regulation	 of	 copAZ	 is	
unclear;	however,	it	has	been	shown	to	function	independently	of	metal	responsive	
regulators,	Fur	and	PerR	(403).	
A	transposon	library	of	S.	aureus	ATCC	12600	that	examined	genes	essential	to	metal	
resistance	revealed	a	multi-copper	oxidase	(MCO)	located	downstream	of	copAZ.	This	
MCO	had	35%	amino	acid	sequence	identity	to	CueO	of	E.	coli;	however,	this	MCO	was	
identified	in	only	3	laboratory	strains	of	S.	aureus,	suggesting	that	its	role	in	copper	
resistance	 is	 dispensable	 (404).	 A	 conserved	 multi-copper	 oxidase	 has	 yet	 to	 be	
characterized	in	S.	aureus.				
In	vivo	expression	technology	(IVET)	in	a	renal	abscess	model	that	identified	S.	aureus	
virulence	genes	upregulated	during	mammalian	infection,	uncovered	copA	as	having	
heightened	expression	in	vivo.	This	suggested	that	CopA	may	play	an	important	role	
in	 virulence	 (405).	 Gene	 expression	 profiles	 of	 S.	 aureus	 grown	 in	 excess	 copper	
showed	that	copper	induced	the	expression	of	stress	response	genes,	such	as	catalase,	
and	 that	proteins	 in	 the	oxidative	 stress	 response	are	necessary	 for	growth	under	
copper-rich	environments.	Moreover,	copper	repressed	the	global	regulators	agr	and	
sae,	key	virulence	factors	in	S.	aureus,	suggesting	that	copper	toxicity	has	a	profound	
effect	 on	 the	 cell	 and	 that	 further	 investigation	 is	 necessary	 to	 understand	 the	
implications	of	copper	toxicity	during	infection	(406).				
1.9 Iron and copper in biology 
Iron	 and	 copper	 have	 similar	 biological	 functions	 and	 thus	 have	 considerable	
pathways	 of	 convergence	 in	 mammalian	 and	 bacterial	 systems.	 Along	 with	 the	
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formation	of	intracellular	ROS,	leading	to	destruction	of	nucleic	acids,	proteins,	and	
lipids,	 one	 of	 the	 most	 deleterious	 results	 of	 copper	 toxicity	 is	 the	 irreversible	
displacement	 of	 Fe	 in	 Fe-S	 clusters	 (407).	 Indeed,	 previous	work	 in	E.	 coli	 and	B.	
subtilis	demonstrated	that	the	primary	targets	 for	copper	toxicity	are	Fe-S	clusters	
(407–410).	 Fe-S	 clusters	 are	 essential	 cofactors	 for	many	 enzymes;	 these	 include	
enzymes	 involved	 in	amino	acid	biosynthesis,	where	 it	was	shown	in	E.	coli	that	a	
mutant	 defective	 in	 the	 major	 copper	 detoxification	 systems	 (copA,cueO,cusCFBA	
strain)	was	unable	to	grow	in	minimal	medium	in	the	presence	of	copper.	However,	
supplementation	of	the	minimal	medium	with	branched	chain	amino	acids	partially	
restored	 growth	 (407).	 Moreover,	 enzymes	 responsible	 for	 Fe-S	 biogenesis,	 IscA,	
IscU,	 and	 SufA,	 also	 rely	 on	 Fe-S	 clusters.	 Displacement	 of	 Fe	 by	 Cu	 not	 only	
dramatically	 alters	 the	 biochemistry	 of	 the	 Fe-S	 cofactor,	 abrogating	 enzymatic	
activity,	 but	 also	 liberates	 free	 iron,	 perhaps	 accelerating	 ROS	 formation	 and	
subsequent	oxidative	damage	(409).		
In	contrast,	copper-containing	enzymes	have	also	been	shown	to	be	beneficial	to	iron	
metabolism.	Previously	described	 in	section	1.6.2,	 the	E.	coli	multi-copper	oxidase,	
CueO	(YacK)	is	partly	responsible	for	the	oxidation	of	iron	bound	to	phenolate-type	
siderophores,	such	as	enterobactin.	This	is	thought	to	offset	the	ratio	of	copper	to	iron	
in	the	cell,	where	CueO	serves	a	dual	role	in	balancing	copper	and	iron	homeostasis:	
first,	it	sequesters	free	copper	in	the	periplasm	by	binding	up	to	six	copper	ions,	and	
secondly,	releases	iron	from	phenolate	siderophores	to	increase	iron	concentrations	
(349).	In	addition	to	CueO,	the	siderophore	yersiniabactin	(Ybt)	is	another	example	
of	copper	and	siderophore	interaction.		
Ybt	is	a	catecholate	siderophore	that	has	been	shown	to	bind	ferric	iron	in	a	1:1	molar	
ratio	(411),	and	is	an	essential	virulence	factor	for	some	Gram-negative	species	(163–
165).	In	addition	to	binding	ferric	iron,	recent	work	has	demonstrated	a	role	for	Ybt	
in	extracellular	copper	chelation	in	uropathogenic	E.	coli	(412).	In	this	study,	Cu2+-Ybt	
complexes	were	 detected	 by	mass	 spectrometry	 in	 urine	 samples	 from	mice	 and	
humans	 with	 urinary	 tract	 infections,	 infected	 with	 uropathogenic	 E.	 coli.	
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Furthermore,	 in	 copper-supplemented	 media,	 the	 Ybt-deficient	 strain	 had	
significantly	 greater	 sensitivity	 to	 copper	 compared	 to	 isogenic	 WT	 (412).	
Gentamicin-protection	assays	with	RAW264.7	murine	macrophages	showed	 that	a	
Ybt-deficient	 strain	 of	 E.	 coli	 was	 significantly	 attenuated	 compared	 to	 WT	 and,	
furthermore,	Cu2+-Ybt	exhibited	superoxide	dismutase	activity	suggesting	a	role	 in	
defense	against	oxidative	burst.	These	findings	demonstrate	that	Ybt	not	only	aids	in	
copper	resistance	in	the	urinary	tract	but	also	in	intracellular	survival	(413).	Mass	
spectrometry	 on	 TBDT	 FyuA	 (ferric-Ybt	 uptake	 protein	 A),	 the	 outer	 membrane	
transporter	for	Ybt,	showed	that	FyuA	not	only	imports	Fe2+-Ybt,	but	also	recognizes	
Cu2+-Ybt	and	Ga3+-Ybt	(414).	Lastly,	 inside	the	periplasm,	copper	 is	 liberated	 from	
Cu2+-Ybt	most	 likely	 by	 reducing	 Cu2+	 to	 Cu+,	 allowing	 Ybt	 to	 be	 recycled	 and	 the	
liberated	copper	 to	be	used	elsewhere	 in	 the	cell,	 such	as	 for	TynA,	 a	periplasmic	
copper	amine	oxidase,	that	showed	enhanced	activity	with	the	presence	of	Cu2+-Ybt	
(415).	 These	 findings	 have	 profound	 implications	 in	 understanding	 siderophore-
mediated	metal	homeostasis	outside	of	the	canonical,	iron-centered	pathways.		
Work	 done	 in	 E.	 coli,	 Shewanella	 oneidensis,	 and	 Rhodopseudomonas	 palustris	
demonstrated	that	copper	and	iron	work	synergistically	to	kill	bacteria	during	anoxic	
growth.	S.	oneidensis	and	R.	palustris	were	chosen	for	this	study	as	they	can	tolerate	
millimolar	 concentrations	 of	 iron	with	 no	 obvious	 growth	 defect.	 However,	 when	
grown	 in	 environmentally	 relevant	 concentrations,	 the	 combination	 of	 iron	 and	
copper	caused	growth	inhibition,	greater	than	either	metal	alone.	The	reason	for	this	
synergistic	 effect	 was	 attributed	 to	 iron-interference	 in	 copper	 regulatory	
mechanisms	or	copper	efflux	(416).			
This	cross-talk	between	copper	and	iron	is	not	limited	to	microbial	systems	but	is	also	
important	in	mammalian	metal	homeostasis.	In	humans,	it	was	observed	that	copper	
and	iron	deficiency,	resulting	in	anemia,	had	similar	manifestations,	suggesting	that	a	
common	pathway	or	factor	was	affected	in	the	disease	progressions	(417,	418).	It	was	
later	 discovered	 that	 the	 uptake	 of	 iron	 requires	 copper	 (418).	 Studies	 in	 animal	
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models	 have	 demonstrated	 that	 copper	 deficiency	 leads	 to	 anemia,	 largely	 due	 to	
inactivation	of	copper-binding	ferrioxidase	ceruloplasmin	(419).		
Once	 iron	 passes	 the	 basolateral	 membrane	 and	 enters	 the	 circulating	 iron	 pool,	
ceruloplasmin	is	involved	in	reducing	ferrous	iron	to	ferric	iron	which	aids	in	iron	
loading	to	transferrin	and	ultimately	delivery	of	iron	to	cells	(297).	Furthermore,	in	
macrophages,	 ceruloplasmin	 induces	 the	 expression	 of	 ferroportin	 (Fpn),	 a	 cell	
membrane	 transporter	 that	 excretes	 ferrous	 iron	 from	 the	macrophage	 cytoplasm	
(420).	 Conversely,	 in	 persons	 with	 aceruloplasminemia	 (an	 autosomal	 recessive	
disorder	that	results	in	an	inability	to	produce	ceruloplasmin),	there	is	an	unusually	
high	concentration	of	 iron	stored	 in	the	tissues,	 leading	to	high	serum	ferritin	and	
mild	anemia	(421).	
1.10 Objective of this study 
During	infection,	the	host	controls	the	access	of	essential	metals	to	invading	microbes	
in	a	process	 termed	nutritional	 immunity.	The	 two	different	 transition	metals	 are	
examined	 in	 this	 study,	 iron	 and	 copper,	 that	 represent	 two	 unique	 facets	 of	
nutritional	immunity.	Iron	is	actively	sequestered	by	the	host,	such	that	the	available	
concentrations	of	free	iron	are	extremely	low.	In	contrast,	in	macrophages	a	surplus	
of	copper	is	transported	into	the	phagosome	to	cause	microbial	killing.	Both	facets	of	
metal	 control	 represent	unique	challenges	 to	 invading	microbes,	where	a	defining	
characteristic	of	successful	pathogens	is	their	ability	to	obtain	essential	metals,	such	
as	iron,	and	remove	toxic	molecules,	such	as	copper.		
S.	aureus	is	a	serious	human	pathogen	that	is	able	to	cause	infection	in	every	bodily	
niche,	and	thus	is	able	to	overcome	aspects	of	nutritional	immunity.	The	preferred	
iron	source	for	S.	aureus	is	heme	(422),	although	prior	to	this	work	the	mechanism	
behind	 this	 preference	 was	 unknown.	 A	 major	 contributor	 to	 S.	 aureus	 iron	
acquisition	is	the	use	of	high	affinity	iron	chelators,	termed	siderophores.	S.	aureus	
produces	 two	main	 siderophores,	 staphyloferrin	A	 (SA)	and	staphyloferrin	B	 (SB),	
both	of	which	have	been	 implicated	 in	virulence	 in	murine	 infection	models	 (169,	
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182).	 In	 chapter	 2,	 I	 examine	 the	 regulation	 of	 synthesis	 of	 SB.	 The	 biosynthetic	
operon	for	SB	synthesis,	the	sbn	operon,	encodes	nine	genes,	of	which	the	first	eight	
genes	 have	 been	 extensively	 characterized	 and	 encode	 biosynthetic	 enzymes	
(SbnA,B,C,E,F,G,	 and	 H)	 and	 the	 SB-specific	 efflux	 pump	 (SbnD).	 The	 role	 of	 the	
terminal	gene	product,	SbnI,	however,	was	unknown	and,	although	having	no	clear	
enzymatic	role	in	SB	production,	is	highly	conserved	among	sbn-encoding	S.	aureus	
strains.	Thus	the	central	question	in	the	first	portion	of	this	work	was	to	characterize	
the	function	of	SbnI	in	SB	utilization.	
In	chapter	3,	I	examine	the	role	of	copper	detoxification	systems	in	S.	aureus.	Already	
known	was	 the	 function	of	 CopA	 and	CopZ	 in	 copper	 resistance,	where	 CopA	 is	 a	
copper-translocating	efflux	pump	and	CopZ	a	copper-binding	chaperone	(400).	The	
role	of	these	pathways	in	survival	in	the	host	have	previously	not	been	characterized.	
Furthermore,	 pandemic	 CA-MRSA	 strain	 USA300	 contains	 another	 putative	metal	
transporter	 encoded	 on	 the	ACME	 cassette.	 Thus,	 the	 central	 hypothesis	was	 that	
USA300	contained	another	copper	efflux	pump,	endowing	this	strain	with	heightened	
copper	resistance,	and	furthermore,	both	CopAZ	and	the	ACME-encoded	efflux	pump	
would	aid	in	S.	aureus	survival	in	the	phagosome.			
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Chapter 2 
2 A heme-responsive regulator controls synthesis of 
Staphyloferrin B in Staphylococcus aureus 
2.1 Introduction 
Staphylococcus	 aureus	 is	 a	 formidable	 human	pathogen	 capable	 of	 causing	 a	wide	
range	 of	 opportunistic	 infections	 including	 endocarditis,	 meningitis,	 and	
osteomyelitis,	and	is	currently	the	most	frequent	cause	of	bloodstream	infections	in	
Canada	 and	 the	 United	 States	 (1–5).	 Like	 the	 vast	 majority	 of	 all	 characterized	
organisms,	with	the	exception	of	some	lactobacilli	and	spirochaetes	(6,	7),	S.	aureus	
requires	the	use	of	iron	to	survive.	Iron	in	a	human	host,	however,	is	typically	not	free	
as	it	is	bound	within	host	proteins	that	serve	essential	host	functions	and,	at	the	same	
time,	 limits	 the	 amount	of	 readily	 available	 iron	 to	 invading	microbes	 (8,	9).	 This	
process	of	iron	limitation	is	referred	to	as	host	nutritional	immunity	and	is	an	obstacle	
to	the	survival	of	microbes,	including	S.	aureus.		
To	overcome	this	obstacle,	S.	aureus	has	evolved	multiple,	sophisticated	iron	uptake	
mechanisms	(10,	11).	Since	the	predominant	source	of	iron	in	the	human	body	is	iron	
bound	to	heme,	representing	greater	than	70%	of	all	intracellular	iron,	heme	is	an	
important	source	of	iron	during	S.	aureus	infection	(12).	S.	aureus	acquires	heme	from	
hemoglobin	using	proteins	of	the	iron-regulated	surface	determinant	(Isd)	pathway	
(13).	 This	 well-characterized	 pathway	 involves	 a	 series	 of	 cell-wall	 anchored	
proteins,	 lipoproteins,	 membrane	 permeases,	 and	 cytosolic	 proteins	 that	 work	 in	
concert	to	bind	and	extract	heme	from	hemoglobin	at	the	cell	surface,	and	mobilize	
heme	through	the	thick	peptidoglycan	layer	and	through	the	membrane	and	into	the	
cytoplasm	 where	 iron	 may	 be	 removed	 through	 the	 activity	 of	 heme	 degrading	
enzymes	(10,	11,	14–16).	
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Although	representing	less	than	0.1%	of	iron	in	the	body,	an	important	extracellular	
source	of	iron	is	that	which	is	bound	by	host	glycoproteins	transferrin	and	lactoferrin	
(9).	Through	use	of	 small	 iron-chelating	molecules,	 referred	 to	as	 siderophores,	S.	
aureus	is	capable	of	removing	iron	from	these	glycoproteins	and	delivering	it	to	the	
bacterial	cell	(10,	11).	There	are	two	predominant	classes	of	siderophore	synthesis	
pathways:	 non-ribosomal	 peptide	 synthetase	 (NRPS)-dependent	 and	 NRPS-
independent	siderophore	(NIS)	synthesis	(17).	NRPS	siderophore	synthesis	has	been	
well	 characterized	 for	 many	 siderophores,	 such	 as	 enterobactin	 (18).	 S.	 aureus	
produces	 two	 NIS,	 citrate-based	 siderophores,	 staphyloferrin	 A	 (SA)	 and	
staphyloferrin	 B	 (SB).	 As	 NIS	 siderophores,	 SA	 and	 SB	 are	 synthesized	 not	 in	 a	
stepwise	 fashion	 using	 large,	 multi-domain/modular	 proteins,	 but	 instead	
constructed	through	use	of	synthetase	enzymes	that	form	siderophores	by	sequential	
condensation	 reactions	 of	 alternating	 subunits	 of	 dicarboxylic	 acid	 with	 amino-
alcohols,	alcohols,	and	diamines	(19–22).	
The	biosynthetic	enzymes	and	efflux	protein	for	SA	are	encoded	within	the	sfa	(a.k.a.	
sfna)	 locus	 (22,	23),	where	 genes	 sfaA,	 sfaB,	 and	 sfaC	 form	 an	operon	 and	 sfaD	 is	
divergently	 transcribed	to	sfaA.	SfaB	and	SfaD	are	NIS	type	A-like	synthetases	that	
facilitate	the	condensation	of	D-ornithine	with	two	molecules	of	citrate	(22).	SfaC	is	a	
PLP-dependent	amino	acid	racemase,	and	SfaA	is	an	efflux	pump	that	secretes	SA	into	
the	extracellular	milieu	(22,	24).					
The	 9-gene	 sbn	 gene	 cluster	 encodes	 SB	 biosynthesis	 and	 efflux	 genes,	 and	 these	
genes	have	been	 implicated	 in	virulence	 in	both	the	mouse	bacteremic	and	the	rat	
infective	endocarditis	models	of	S.	aureus	infection	(25,	26).	SbnA	and	SbnB	perform	
the	 first	step	 in	SB	synthesis	with	the	 formation	of	 the	precursor	molecules	L-2,3-
diamino-propionic	 acid	 (L-Dap)	 and	 α-ketoglutarate	 (α-KG)	 from	 O-phospho-L-
serine	and	L-glutamate	(21),	while	SbnG	acts	as	a	citrate	synthase	to	convert	acetyl-
CoA	 and	 oxaloacetate	 into	 citrate	 (27,	 28);	 L-Dap,	 citrate	 and	 α-KG	 are	 the	
constituents	of	SB.	The	siderophore	synthase	enzymes	SbnC,	SbnE	and	SbnF	facilitate	
condensation	reactions	with	these	precursors	to	build	the	SB	molecule,	while	SbnH	is	
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a	 decarboxylase	 that	 converts	 one	 of	 the	 two	 L-Dap	 molecules	 within	 SB	 into	
ethylenediamine	(19).	The	function	of	the	terminal	gene	product	in	the	sbn	operon,	
SbnI,	is	previously	uncharacterized	and	thus	the	focus	of	this	study	was	to	determine	
the	function	of	SbnI	in	the	cell.			
The	 regulation	 of	 genes	 that	 encode	 proteins	 implicated	 in	 iron	metabolism	 in	 S.	
aureus	is	controlled	by	the	Ferric	Uptake	Regulator	(Fur),	a	transcriptional	regulator	
found	in	many	gram-positive	and	-negative	bacteria	(29).	Functioning	as	a	dimer	and	
with	the	use	of	metal	cofactors,	Fur	binds	to	an	AT-rich,	19-bp	palindromic	consensus	
sequence	 referred	 to	 as	 the	 Fur	 box,	 located	 in	 the	 promoter	 region	 of	 regulated	
genes.	Fur	bound	to	the	Fur	box	results	in	limited	transcription	of	downstream	genes	
(29,	30).		
In	 the	 absence	 of	 Fur	 repression	 during	 growth	 in	 iron-starved	 conditions,	 some	
bacteria	adopt	additional	regulatory	mechanisms	for	fine-tuning	gene	expression	of	
iron-regulated	 genes.	 In	 Ralstonia	 solanacearum,	 a	 soil-borne	 pathogen	 that	 also	
utilizes	 staphyloferrin	 B	 for	 iron	 acquisition,	 the	 synthesis	 of	 SB	 is	 negatively	
regulated	by	Fur	in	high	iron	concentrations	and	is	also	negatively	regulated	in	low	
iron	 concentrations	 by	 PhcA	 (31).	 PhcA	 is	 an	 environmentally	 responsive	
transcription	 factor	 that	 responds	 to	 the	 presence	 of	 the	 autoinducer	 3-
hydroxypalmitic	acid	methyl	ester,	a	molecule	produced	as	a	result	of	quorum	sensing	
(31,	32).	Thus	PhcA	is	able	to	afford	R.	solanacearum	an	additional	level	of	control	for	
siderophore	 synthesis	 that	works	 in	 response	to	environmental	 cues.	 In	S.	aureus,	
however,	it	is	unclear	as	to	what	regulates	expression	of	many	genes	implicated	in	
iron	metabolism	when	cells	are	growing	in	limited	iron	supply.			
In	this	study	I	report	a	novel,	heme-responsive	regulatory	protein,	SbnI,	that	controls	
expression	of	the	genes	in	the	sbn	operon,	and	thus	controls	siderophore-mediated	
iron	uptake.	The	sbnI	mutant	demonstrated	a	SB-dependent	growth	defect	in	iron-
limited	media,	owing	to	delayed	and	reduced	production	of	SB,	due	to	significantly	
decreased	 transcript	 levels	 for	 genes	 sbnDEFGH	 in	 the	 mutant.	 Electrophoretic	
mobility	 shift	 assays	 demonstrated	 that	 SbnI	 binds	 DNA	 upstream	 of	 a	 newly	
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identified	 promoter	within	 the	 sbnC	 coding	 region.	Moreover,	 I	 show	 that	 SbnI	 is	
capable	of	binding	to	heme	and	heme	binding	inhibits	DNA	binding.	I	propose	a	model	
whereby	SbnI	is	required	for	transcription	throughout	the	SB	biosynthetic	operon,	
and	senses	intracellular	heme	as	a	means	to	reduce	SB	synthesis	in	favour	of	heme	
acquisition.		This	model	provides	additional	support	to	the	observations	of	Skaar	and	
colleagues	who	reported	that	heme	is	the	preferred	iron	source	for	S.	aureus	(12).	
2.2 Experimental procedures 
2.2.1 Bacterial strains, plasmids, and growth media 
All	bacterial	strains	and	plasmids	used	in	this	study	are	listed	and	described	in	Table	
2-1.	 Strains	 were	 stored	 in	 15%	 glycerol	 stocks	 at	 -80℃	 and,	 prior	 to	 use,	 were	
streaked	onto	tryptic	soy	broth	(TSB)	(Difco)	agar	plates	containing	the	appropriate	
antibiotic.	Solid	media	were	prepared	with	addition	of	1.5%	w/v	Bacto	agar	(Difco).	
Concentrations	 of	 antibiotics	 used	 were	 as	 follows:	 50	 μg/mL	 kanamycin	 and	
100	μg/mL	ampicillin	 for	Escherichia	coli	 selection,	4	μg/mL	tetracycline,	5	μg/mL	
chloramphenicol,	 and	 3	 μg/mL	 erythromycin	 for	 S.	 aureus	 selection.	 E.	 coli	were	
grown	 in	 Luria	 Broth	 (Difco)	 and	 S.	 aureus	 strains	 were	 grown	 in	 TSB,	 or	 either	
chelex-100-treated	 Tris	 minimal	 succinate	 (cTMS)	 or	 Roswell	 Park	 Memorial	
Institute	(RPMI)	(Gibco)	medium	for	growth	under	iron	restriction.	All	solutions	and	
media	 where	 made	 using	 water	 purified	 with	 Milli-Q	 water	 purification	 system	
(Millipore).	
Table	2-1.	Bacterial	strains,	plasmids,	and	primers	used	in	this	study.		
Bacterial	strains,	
plasmids,	
oligonucleotides	
Description	 Source	or	
Reference	
	
E.	coli	
	
	
	
	
DH5α	 F-Ф80	dLacZΔM15	recA1	endA1	nupG	gyrA96	glnV44	
thi-1	hsdR17(rk-	mk+)	λ-supE44	relA1	deoR	Δ(lacZYA-
argF)U169	
Promega	
BL21(DE3)	 F-	ompT	gal	dcm	lon	hsdSB	(rB-	mB+)	λ	(DE3	[lacI	
lacUV5-T7	gene	1	ind1	sam7	nin5])	
	
Novagen	
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S.	aureus	strains	 	 	
RN4220	 rk-mk+	accepts	foreign	DNA	 (33)	
RN6390	 Prophage-cured	wild-type	strain	 (34)	
H306	 RN6390	sirA::Km;	KmR	 (25)	
H984	 RN6390	sbnI::Tet;	TetR	 This	study	
H1312	 H984/pSbnI;	sbnI	mutant	complemented	with	sbnI	 This	study	
H1313	 H187	containing	pCN51	 This	study	
H1317	 H984	containing	pCN51	 This	study	
H1324	 RN6390	sbn;	TetR	 (23)	
H1448	 RN6390	hts::Tet;	TetR	 (23)	
H3387	 RN6390	arcA::ΦΝΕ;	EryR	 This	study	
	 	 	
Plasmids	 	 	
pET28a(+)	 Overexpression	vector	for	6´His-tagged	proteins;	
KmR	
Novagen	
pCN51	 Cadmium-inducible	expression	vector;	EryR	 (35)	
psbnI	(pAB1)	 pCN51-sbnI;	pCN51	vector	for	expression	of	sbnI;	
EryR	
This	study	
pGylux	 Promoterless	E.	coli/	S.	aureus	shuttle	vector	for	
luminescence,	ApR	,	CmR	
(36)	
pCM326	 1479	bp	sbnA/B	cloned	into	pGylux;	ApR	,	CmR	–
(Fragment	A)	
This	study	
pCM328	 2322	bp	sbnA/B/C	cloned	into	pGylux;	ApR	,	CmR	–
(Fragment	B)	
This	study	
pCM330	 2389	bp	sbnC/D	cloned	into	pGylux;	ApR	,	CmR	–
(Fragment	C)	
This	study	
pCM332	 2395	bp	sbnD/E	cloned	into	pGylux;	ApR	,	CmR	–
(Fragment	D)	
	
This	study	
Oligonucleotides	 	 	
Cloning	of	sbnI	from	
S.	aureus	for	
pET28a(+)	
GC	AGC	CAT	ATG	AAT	CAT	ATT	GCT	GAA	CAT	TTA	A	
(forward)	
TTG	TGT	CTC	GAG	TCA	TCA	TAT	TTC	CCT	CAA	CAT	
(reverse)	
	
Cloning	of	sbnI	from	
S.	aureus	for	
complementing	
vector	(psbnI)	
TTG	AGC	GGA	TCC	CTT	AAG	CCA	TCC	ACA	TCC	TG	
(forward)	
TTG	CGC	GAA	TTC	TCG	CTA	TCA	ATA	CCG	TAA	ATC	
(reverse)	
	
	
Cloning	of	Fragment	
A	
GCC	TCC	CGGGTCAATAAAATATTTATGATTTACATGC	
(forward)	
GACTCCCGGGAACTTGCTTCCATAACTGCAATT	
(reverse)	
	
	
Cloning	of	fragment	B	 GACTCCCGGGTAATTTAGGCATTGCGTTG	(forward)	
GACTCCCGGGCTGCAACCATTAAAGG	(reverse)	
	
	
Cloning	of	fragment	C	 GACTCCCGGGTGTCTGAACATTGCAG	(forward)	
GACTCCCGGGAAATGAACGGCGAATAC	(reverse)	
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Cloning	of	fragment	D	 GACTCCCGGGACTGACAGTACTTGT	(forward)	
GACTCCCGGGCCTGTGTTACTAAAC	(reverse)	
	
	
RT-PCR:	sbnA	 ACTTCTGGTAATTTAGGCATTGCG	(forward)	
TGCATCAGGTTCTTCAACCATTTC	(reverse)	
	
	
RT-PCR:	sbnB	 CCTGAAAATGGACACATCGC	(forward)	
CAAAATAATGACGCCACTTGC	(reverse)	
	
	
RT-PCR:	sbnC	 ATGAATGGGAAGTGGCTCG	(forward)	
GCTAATGGATGAAATGGACGAT	(reverse)	
	
	
RT-PCR:	sbnD	 CGTAGAAATACAGTTGTGGAGTGG	(forward)	
AAATAAGCATACCGCCAAACC	(reverse)	
	
	
RT-PCR:	sbnE	 CGAATCCATTAGGGCAAACAG	(forward)	
CTTAACATCGGTGAATCAGGC	(reverse)	
	
	
RT-PCR:	sbnF	 TTTTATGCGATGGAAGGG	(forward)	
CGTCGTTTCTACTTTATCTTTGTCG	(reverse)	
	
	
RT-PCR:	sbnG	 TCATTAAAGTGTTGGATATGGGTGC	(forward)	
TTAGCCATCTCCATTGCATCAAG	(reverse)	
	
	
RT-PCR:	sbnH	 CGCTCGCAATGCCAAAGATTC	(forward)	
TAACGCCTATGCCACCACCAAG	(reverse)	
	
	
RT-PCR:	rpoB	 AGAGAAAGACGGCACTGAAAACAC	(forward)	
ATAACGACCCACGCTTGCTAAG	(reverse)	
	
	
GSP1	 GAAAGCTGATGTGCTGTTAG	 	
GSP2	 GAGCCCGGGTCTAGACGCATACTTGAAGACGACAG	 	
AUAP	 GATACCCGGGCCACGCGTCGACTAGTAC	 	
UAP	 GGCCACGCGTCGACTAGTACGGGIIGGGIIGGGIIG	 	
Abbreviations:	 ApR	 –	 ampicillin	 resistance;	 CmR	 –	 chloramphenicol	 resistance;	 EryR	 –	
erythromycin	resistance;	KmR	–	kanamycin	resistance;	TetR	–	tetracycline	resistance	
 
2.2.2 Bacterial growth curves 
Bacteria	were	cultured	on	TSB	agar,	then	several	single	isolated	colonies	were	picked	
and	 inoculated	 into	 2	 mL	 cTMS	 (flask:volume	 ratio	 of	 10:1)	 and	 grown	 for	
approximately	8	h	at	37℃	with	shaking	at	220	rpm.	The	bacteria	were	then	harvested,	
resuspended	 in	 fresh	 cTMS	 medium,	 and	 inoculated	 into	 5	 mL	 cTMS	 medium	
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(flask:volume	ratio	10:1)	to	a	starting	OD600	0.005.	For	growth	curves	in	microaerobic	
conditions,	cultures	were	inoculated	into	media	with	a	flask:volume	ratio	1.2:1	with	
lids	tightly	sealed.			
2.2.3 Western Blotting 
Bacteria	were	cultured	on	TSB	agar,	then	several	single	isolated	colonies	were	picked	
and	 inoculated	 into	 2	 mL	 cTMS	 (flask:volume	 ratio	 of	 10:1)	 and	 grown	 for	
approximately	8	h	at	37℃	with	shaking	at	220	rpm.	The	bacteria	were	then	harvested,	
resuspended	 in fresh	 cTMS	 medium,	 and	 inoculated	 into	 5	 mL	 cTMS	 medium	
(flask:volume	ratio	10:1)	to	a	starting	OD600	0.005.	
Cells	were	grown	to	an	OD600	1.0,	and	3	x	109	colony	forming	units	were	harvested	
and	resuspended	 in	0.1	mL	 lysis	buffer	(25	mM	Tris-HCl,	50	mM	glucose,	150	mM	
NaCl,	10	mM	EDTA,	pH	8.0,	5	μg	 lysostaphin,	1´	 Laemmli	buffer	 (60	mM	Tris-HCl,	
pH	6.8,	2%	SDS,	10%	glycerol,	5%	betamercaptoethanol,	0.01%	bromophenol	blue))	
and	incubated	at	37℃	for	1	h	then	boiled	for	10	min	before	being	run	through	a	12%	
polyacrylamide	 gel.	 Following	 electrophoresis,	 proteins	 were	 transferred	 to	 a	
nitrocellulose	membrane	following	standard	protocols.	Primary	anti-SbnI	polyclonal	
antiserum	was	used	at	a	dilution	of	1:1000,	and	secondary	(anti-rabbit	IgG	conjugated	
to	IRDye	800;	Li-Cor	Biosciences,	Lincoln,	NE)	was	used	at	a	1:20,000	dilution.	Rabbit	
polyclonal	antisera	recognizing	SbnI	were	generated	by	ProSci	(Poway,	CA)	using	the	
custom	antibody	production	package	number	1.	Membranes	were	scanned	on	a	Li-
Cor	Odyssey	Infrared	Imager	(Li-Cor	Biosciences)	and	visualized	using	Odyssey	V3.0	
software.		
2.2.4 RNA isolation and qPCR 
S.	aureus	RN6390	and	H984	(RN6390	sbnI)	were	grown	in	quadruplicate	cultures	in	
2	mL	chelexed	Tris	minimal	succinate	(cTMS)	medium	for	8	h.	Cultures	were	then	
harvested	 and	 subcultured	 at	 OD600	 0.005	 in	 10	 mL	 cTMS	 and	 grown	 to	 mid-
exponential	phase	(OD600	~1.0).	Cells	equating	to	an	OD600	3.0	were	harvested	 for	
each	culture	and	RNA	extraction	was	performed	by	E.Z.N.A®	Total	RNA	kit	according	
to	the	manufacturer’s	instructions	with	the	addition	of	0.25	μg/mL	of	lysostaphin	to	
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the	lysis	solution.	RNA	purity	was	determined	by	agarose	gel	and	RNA	concentration	
was	 determined	 by	 NanoDrop®	 ND-1000	 UV-Vis	 Spectrophotometer.	 cDNA	
preparation	was	performed	using	500	ng	of	 total	cellular	RNA	reverse-transcribed	
using	SuperscriptTM	II	reverse	transcriptase	(Invitrogen)	according	to	manufacturer’s	
instructions.	 For	 each	 qPCR	 reaction,	 one	microgram	of	 cDNA	was	 amplified	 in	 a	
Rotor-Gene	6000	(Corbett	Life	Science)	using	the	iScript	One-Step	RT-PCR	Kit	with	
SYBR	Green	(BioRad).	Gene	expression	for	each	sample	was	quantified	in	relation	to	
rpoB	expression.	A	standard	curve	was	generated	for	each	gene	examined.		
2.2.5 Disc diffusion assays 
Concentrated	spent	culture	supernatants	wereprepared	from	10	mL	cultures	of	S.	
aureus	RN6390.	Culture	supernatants	were	taken	at	10,	12,	16,	20,	24,	and	36	h	after	
inoculation.	Growth	was	assessed	via	OD600	and	culturedensities	between	replicates	
and	 strains	 were	 normalized	 for	 each	 time	 point.	 Cells	 were	 harvested	 by	
centrifugation,	and	the	supernatant	was	lyophilized	for	12	h.	Lyophilized	supernatant	
was	resuspended	in	0.5	mL	sterile	ddH2O.	S.	aureus	cells,	the	htsA	mutant	strain	or	the	
sirA	mutant	strain,	were	seeded	into	TMS	agar	containing	10	μM	EDDHA	to	achieve	
1	×	 104	 cells	 per	mL.	 For	 each	 replicate,	 10	 μL	 of	 concentrated	 supernatant	were	
applied	to	sterile	paper	disks	which	were	then	placed	onto	the	plates	containing	the	
seeded	reporter	strains,	and	growth	about	thedisk	was	measured	after	24	and	48	h	
incubation	at	37°C.		
2.2.6 Identification of promoters 
Four	DNA	fragments,	spanning	the	sbn	operon	from	sbnA	to	sbnE,	were	cloned	into	
the	 promoterless	 shuttle	 vector	 pGylux	 (36):	 fragment	 A	 of	 1479	 bp	 (pCM326),	
fragment	B	of	2322	bp	(pCM328),	fragment	C	of	2389	bp	(pCM330)	and	fragment	D	
(pCM332)	 of	 2395	 bp.	 To	 measure	 luciferase	 activity,	 individual	 colonies	 from	 S.	
aureus	 carrying	 these	 plasmids	were	 inoculated	 into	 TMS	medium	 and	 incubated	
overnight	 at	 37°C.	 Cells	were	 subsequently	 inoculated	 into	 cTMS	with	 or	without	
1	μM	 FeCl3	 at	 an	 OD600	 0.1	 and	 incubated	 for	 8	 h.	 At	 that	 time,	 the	 OD600	 and	
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luminescence	were	measured	on	a	SynergyH4	Hybrid	Reader	(Biotek).	Luminescence	
values	were	expressed	as	cps/	OD600.		
2.2.7 Identification of a transcription start site 
To	 identify	 an	 initiation	 of	 transcription	 I	 used	 rapid	 amplification	 of	 cDNA	 ends	
(RACE).		The	original	mRNA	was	prepared	from	S.	aureus	RN6360	grown	in	cTMS,	as	
per	the	protocol	described	for	qPCR.	First	strand	cDNA	was	synthesized	by	incubating	
for	50	min	at	42℃:	1	μg	RNA,	1	μM	gene	specific	primer	1	(GSP1),	50	μM	dNTP,	and	
20	U	Superscript	II	Reverse	Transcriptase	(Invitrogen).		The	mRNA	was	removed	by	
treating	the	synthesized	cDNA	with	RNase	mix	(0.5	U	of	RNaseH	and	50	U	of	RNaseT1)	
for	30	min	at	37℃.	After	purification	of	the	cDNA	with	the	Bio	Array	cDNApurification	
kit	 (ENZO	Life	Sciences)	 it	was	C-tailed	with	20	U	of	Terminal	Transferase	(Roche	
Diagnostics)	 and	 0.5	 mM	 dCTP	 as	 recommended	 by	 the	 supplier.	 The	 first	 PCR	
reaction	was	performed	using	the	universal	anchor	primer	(UAP,	Invitrogen)	that	will	
anneal	 to	 the	 C-tailed	 cDNA	 and	 an	 sbnC	 specific	 primer	 GSP2.	 The	 second	 PCR	
(177bp)	was	performed	using	the	first	PCR	as	a	template,	a	primer	that	will	anneal	to	
the	 abridged	 universal	 anchor	 primer	 (AUAP,	 Invitrogen)	 and	 the	 same	 specific	
primer	GSP2.	GSP2	and	AUAP	contain	SmaI	restriction	endonuclease	sites	that	were	
later	used	for	cloning	the	second	PCR	product	into	pGEM7.	The	pGEM7	clones	were	
later	sequenced	to	determine	the	initiation	of	transcription.	
2.2.8 Protein expression and purification  
Recombinant	SbnI	protein	was	overexpressed	and	purified	essentially	as	previously	
described	 (37).	 In	 brief,	 cells	were	 grown	 to	mid-log	 phase	 at	 37℃	with	 aeration	
before	 the	 addition	 0.4	mM	 isopropyl-b-D-thiogalactopyranoside	 (IPTG);	 the	 cells	
were	then	grown	for	an	additional	16	h	at	room	temperature	with	shaking	before	
harvesting.	 Cells	 were	 resuspended	 in	 50	 mM	 HEPES,	 1	 mM	 ditiothreitol	 (DTT),	
pH	7.4	prior	to	lysis	at	25	kpsi	in	Cell-Disruptor	(Constants	Systems	Ltd.).	Cell	debris	
was	pelleted	by	15-min	centrifugation	at	3000	rpm	in	a	Beckman	Coulter	Allegra®	
6R	Benchtop	Centrifuge	that	was	followed	by	ultracentrifugation	at	50,000	rpm	in	a	
Beckman	Coulter	Optima®	L-900K	ultracentrifuge	for	45	min.	The	lysate	was	filtered	
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with	0.45	μM	nylon	 filter	 (VWR)	and	 then	applied	 to	a	1	mL	HisTrap	column	 (GE	
Healthcare)	 equilibrated	 with	 buffer	 A	 (50	 mM	 HEPES,	 1	 mM	 DTT,	 and	 50	 mM	
imidazole,	pH	7.4).	The	His6-SbnI	was	eluted	with 0-80%	concentration	of	buffer	B	
(50	mM	HEPES,	1	mM	DTT,	and	50	mM	imidazole,	pH	7.4).	Protein	was	dialyzed	in	
50	mM	HEPES,	1	mM	DTT,	pH	7.4,	at	4℃.	Protein	purification	was	determined	by	SDS-
PAGE.	 Protein	 concentrations	were	 determined	 through	Bradford	 assay	 using	 the	
Bio-Rad	Protein	Assay	Dye	(Bradford)	Reagent	Concentrate	(5´),	samples	were	read	
at	 absorbance	 OD595;	 a	 standard	 curve	 was	 made	 for	 each	 concentration	
determination	with	1	mg/mL	BSA.		
Site-directed	mutagenesis	of	SbnI	was	performed	using	Pfu	Turbo®	polymerase	and	
the	 pET28a::SbnI	 vector	 as	 a	 template.	 The	 PCR	products	were	 immediately	DpnI	
(Roche)	 treated	 for	 45	min	 to	 degrade	 template	 DNA,	 and	 introduced	 into	E.	 coli	
DH5α.	Mutations	were	 confirmed	by	 sequencing	at	 the	Robarts	Research	 Institute	
DNA	Sequencing	Facility	(London,	Ontario).	Protein	purification	of	the	mutated-SbnI	
was	performed	as	described	above.		
2.2.9 Oligomerization analysis 
Size	 exclusion	 chromatography	 was	 performed	 using	 a	 Superdex	 200	 10/30	 GL	
column	 (Amersham)	 coupled	 to	 a	 FPLC	 system	 (Pharmacia).	 The	 column	 was	
equilibrated	 with	 300	 mM	 ammonium	 formate	 buffer,	 pH	 7.4.	 SbnI	 samples,	 in	
300	mM	ammonium	formate,	were	run	in	500	μL	injected	into	the	column	and	eluted	
at	a	flow	rate	of	200	μL/min.	Protein	elution	was	measured	at	280	nm.	The	column	
was	 calibrated	 with	 blue	 dextran	 (void	 volume),	 b-amylase	 from	 sweet	 potato	
(200	kDa),	 alcohol	 dehydrogenase	 from	 yeast	 (150	 kDa),	 bovine	 serum	 albumin	
(66	kDa),	carbonic	anhydrase	from	bovine	erythrocytes	(29	kDa),	and	cytochrome	c	
from	horse	heart	(12.4	kDa).		
Recombinant	SbnI	was	dialyzed	in	300	mM	ammonium	formate,	pH	7.4,	and	100	mM	
NaCl	prior	to	sedimentation	velocity	ultracentrifugation	analysis.	For	analysis	of	SbnI	
in	 the	 reducing	 agent,	 buffer	 also	 contained	 10	mM	DTT	 added	 post-dialysis.	 The	
dialysis	buffer	was	 retained	 for	use	 in	 the	 reference	 sector	 for	all	 runs.	Analytical	
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ultracentrifugation	 was	 carried	 out	 in	 a	 Beckman	 XL-A	 Analytical	 Ultracentrifuge	
with	 a	 four-hole	 An-60Ti	 rotor and	 double-sector	 cells	 with	 Epon	 charcoal	
centerpieces.	 Centrifugation	 was	 carried	 out	 at	 5℃.	 A	 total	 of	 60	 absorbance	
measurements	were	taken	at	280	nm	at	5	min	intervals	at	0.002	cm	radial	steps,	and	
averaged	over	3	readings.	The	rotor	speeds	were	35,000	rpm	for	SbnI	in	100	mM	NaCl	
and	 45,000	 rpm	 for	 SbnI	 in	 20	 mM	 DTT.	 Data	 were	 analyzed	 using	 non-linear	
regression	in	Sedfit	software	and	fit	to	a	c(s)	distribution,	to	determine	sedimentation	
coefficients	 corrected	 to	20°C	and	 in	H2O.	All	data	were	 fit	 to	a	 root-mean-square	
deviation	(r.m.s.d.)	equal	or	less	than	0.007.		
2.2.10 DNA-binding assays 
Electrophoretic	mobility	shift	assays	(EMSA)	were	performed	with	purified	SbnI	and	
double	stranded,	fluorescently-labeled,	DNA.	The	DNA	probe	was	amplified	through	
PCR	 with	 IRDye®	 700-labeled	 custom	 primers	 purchased	 from	 Integrated	 DNA	
Technologies	 (IDT®).	 Protein	 and	 DNA	 were	 incubated	 in	 a	 25	 μL	 volume	 that	
contained	120	ng	of	 fluorescently-labeled	DNA,	50	mM	HEPES,	240	μg/mL	bovine	
serum	albumin	(BSA),	15.2	μg/mL	Poly[d(I-C)],	and	SbnI,	at	room	temperature	 for	
45	min.	Samples	were	separated	on	6%	non-denaturing	polyacrylamide	gels	in	TBE	
buffer	(10	mM	Tris,	89	mM	TrisBorate,	2	mM	EDTA,	pH	8.3)	at	120	volts	for	1.5	h.	
Competition	EMSAs	used	120	ng	labeled	sbnC	probe	and	1,200	ng	of	either	unlabeled	
sbnC	or	rpoB	probe.	For	EMSAs	containing	heme,	a	4	mM	heme	stock	was	diluted	to	
250	μM	in	50	mM	HEPES,	pH	7.4,	just	prior	to	use.	For	preparation	of	heme	stock,	see	
section	2.2.11.	
2.2.11 Heme titrations  
Heme	stocks	were	prepared	as	 follows.	Bovine	heme	 (Sigma)	was	resuspended	 to	
5	mM	in	0.1	N	NaOH	(i.e.	0.00326	g/mL)	and	vortexed	vigorously	until	in	solution.	
The	solution	was	sterilized	by	filtration	through	a	0.2	μM	filter.	A	series	of	dilutions	
were	prepared	in	0.1	N	NaOH	and	scanning	UV-Vis	spectra	were	taken	on	the	solution.	
The	post-filtration	 concentration	was	determined	on	 this	 solution	using	 the	molar	
extinction	coefficient	for	hemin	in	0.1	N	NaOH	of	58400	cm-1	M-1	at	385	nm	(38).	Heme	
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solution	was	aliquoted	and	stored	at	-20°C.	Heme	stocks	were	diluted	just	prior	to	
use,	in	the	buffer	or	media	appropriate	to	the	experiment.		
Heme	 titrations,	using	UV-Vis	spectroscopy,	were	performed	using	1	μM	SbnI	and	
increasing	concentrations	of	heme.	SbnI	was	in	300	mM	ammonium	formate,	pH	7.4,	
and	incubated	for	5	min	at	room	temperature	with	heme	concentrations	ranging	from	
0.2	μM	to	2	μM,	with	0.2	μM	increase	after	each	reading.	Heme	stocks	(2.5	mM)	were	
prepared	from	hemin	chloride	(Sigma)	by	adding	NaOH,	which	were	further	diluted	
with	300	mM	ammonium	formate,	pH	7.4,	to	working	concentration	200	μM.	UV-Vis	
spectra	 were	 recorded	 using	 Cary	 50	 Bio	 UV-visible	 spectrophotometer	 with	
background	 correction	 for	 buffer	 and	 for	 each	 heme	 concentration.	 Triplicate	
samples	were	recorded.				
Magnetic	circular	dichroism	measurements	were	taken	with	10	μM	SbnI	prepared	in	
300	 mM	 ammonium	 formate,	 10	 mM	 DTT,	 pH	 7.4.	 Measurements	 at	 room	
temperature	were	made	 in	 1-cm	 cuvettes	 at	 5.5	 T	 in	 an	Oxford	 Instruments	 SM2	
superconducting	 magnet,	 aligned	 in	 a	 Jasco	 J810	 CD	 instrument.	 The	 MCD	 were	
calculated	as	2	´	MCD(+)	minus	the	apo	signal	(CD	correction).	Peak	absorbance	was	
always	near	400	nm.		
ESI-MS	 was	 performed	 by	 using	 50	 μM	 of	 recombinant	 SbnI,	 stored	 in	 300	mM	
ammonium	formate	and	10	mM	DTT,	pH	7.4,	titrated	with	molar	equivalents	of	heme.	
Heme,	for	both	the	MCD	and	ESI-MS	measurements,	was	prepared	in	a	1	mM	stock	by	
dissolving	 10	 mg	 of	 hemin	 in	 concentrated	 NH4OH	 neutralized	 with	 10	 mM	
ammonium	formate,	pH	6.	The	average	incubation	time	for	SbnI	and	heme	was	3	min.	
Spectral	data	were	recorded	with	Bruker	Micro-TOF	II	 (Bruker	Daltonics,	Toronto,	
ON)	operated	in	the	positive	ion	mode	set	for	soft	ionization.	Scan	parameters	where	
set	 for	 500-4000	 m/z,	 and	 the	 spectra	 were	 collected	 for	 minimally	 1	 min	 and	
deconvoluted	 using	 the	 Maximum	 Entropy	 licence	 for	 the	 Bruker	 Compass	
DataAnalysis	software.	
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2.2.12 Generation of an arcA mutant 
The	arcA	mutants	were	generated	by	transducing	the	arcA::ΦΝΕ	insertion	mutation	
from	 the	Nebraska	 transposon	 library,	 into	Heinrichs	 laboratory	RN6390	WT	 and	
sbnI	strains	using	bacteriophage	Φ80α		(Table	2-1)	(36,	37).	Colonies	were	selected	
by	 plating	on	TSA	 containing	 erythromycin.	 The	mutation	was	 confirmed	 through	
PCR	with	primers	specific	to	regions	outside	the	transposon	site.			
2.2.13 Oxygen radical resistance assays 
S.	aureus	strains	were	grown	in	cTMS	overnight,	washed	and	resuspended	in	fresh	
cTMS	with	10	mM	methyl	viologen	(Sigma)	to	an	OD	0.2	into	1	mL	culture	media	(flask	
to	volume	ratio	12:1).	Samples	were	shaken	at	37°C	at	220	RPM	for	a	maximum	of	
60	h.	Viability	was	determined	by	plating	for	CFU	on	TSA	plates	at	designated	time-
points.		
2.3 Results 
2.3.1 Requirement of iron-regulated SbnI for SB production in S. aureus 
SB	can	be	synthesized	entirely	in	vitro	using	purified	sbn-derived	enzymes	(19–21,	
27).	Indeed,	SB	can	be	synthesized	from	the	activities	of	SbnA,	SbnB,	SbnC,	SbnE,	SbnF,	
SbnG,	 and	SbnH	when	provided	with	O-phospho-L-serine,	 glutamate,	oxaloacetate,	
and	acetyl-CoA	as	substrates	(19–21,	27).	Despite	 its	product	seemingly	having	no	
essential	enzymatic	role	in	SB	synthesis,	sbnI,	the	ninth	gene	in	the	sbn	operon	(Fig.	2-
1),	 is	 conserved	 in	 S.	 aureus	 strains,	 along	 with	 the	 rest	 of	 the	 sbn	 operon.	 This	
suggests	 it	may	play	an	 important	 role	 in	SB	biosynthesis.	 Searches	of	 the	protein	
databases	revealed	that	the	protein	shared	limited	sequence	similarity	with	the	DNA	
partitioning	proteins	ParB	and	Spo0J.		
To	assess	 the	 functional	role,	 if	any,	of	SbnI	 in	SB	synthesis,	 I	knocked	out	sbnI	by	
insertion	of	a	tetracycline-resistance	cassette	into	the	middle	of	the	gene.	As	part	of	
the	 initial	 studies	 into	 the	 functional	 role	 of	 SbnI,	 I	 first	 confirmed	 its	 expression	
profile	in	WT	S.	aureus.	A	canonical	Fur	box	is	situated	upstream	of	sbnA	and,	as	such,		
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Fig.	2-1.	The	sir-sbn	locus	schematic.	The	sbnI	gene	is	situated	as	the	9th	and	terminal	gene	
of	the	operon.		
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expression	 of	 the	 genes	 within	 the	 operon	 is	 regulated	 by	 iron	 concentrations.	
Quantitative	 real-time	 PCR	 (qPCR)	 was	 used	 to	 confirm	 that	 expression	 of	 the	
predicted	terminal	gene	of	the	operon,	sbnI,	is	similarly	regulated	by	iron	levels	(Fig.	
2-2A).	Western	blot	analysis,	using	a-SbnI	antisera,	corroborated	the	qPCR	findings,	
demonstrating	 that	 SbnI	 protein	 expression	 was	 controlled	 by	 iron	 (Fig.	 2-2B).	
Western	blots	also	confirmed	that	the	sbnI	insertion	mutant	(H984)	lacked	detectable	
expression	of	SbnI	(Fig.	2-2B).		
With	 the	 confirmed	 sbnI::Tet	mutant	strain,	H984,	 growth	kinetics	were	 recorded,	
comparing	 the	 relative	 growth	 of	 the	WT,	 H984,	 H984	 +	 psbnI,	 and	 the	Δsbn	 (i.e.	
complete	 operon	 knockout)	 strains	 grown	 in	RPMI,	 an	 iron-restricted,	 chemically	
defined	medium.	In	this	medium,	and	in	comparison	to	the	WT	and	complemented	
strains,	H984	had	a	severe	growth	defect,	similar	to	the	growth	defect	observed	for	
strain	 H1342,	 the	 Δsbn	 strain	 (Fig.	 2-3).	 Since	 previous	 work	 has	 shown	 that	
production	of	SA	 is	repressed	 in	RPMI	(28),	 these	results	suggested	that	SbnI	was	
critical	for	SB-mediated	iron	acquisition.	
Since	 WT	 S.	 aureus	 strains	 have	 the	 ability	 to	 produce	 both	 SA	 and	 SB	 under	
conditions	 of	 iron	 starvation,	 and	 since	 their	 activity	 can	 be	 readily	 detected	 in	
bioassay	experiments	 (20,	21,	27,	28),	 a	disc	diffusion	bioassay	was	performed	 to	
examine	SB	production	in	RN6390	(WT),	H984,	and	the	complemented	strain	(H984	
+	 psbnI).	 For	 these	 experiments,	 bacteria	were	 grown	 in	 cTMS	medium	which,	 as	
opposed	to	RPMI,	does	not	result	in	inhibition	of	SA	or	SB.	As	shown	in	Figure	2-4,	in	
this	medium	the	growth	was	comparable	among	the	three	strains	tested,	throughout	
the	 duration	 of	 the	 experiment.	 Spent	 culture	 supernatants	 were	 taken	 at	 six	
designated	time	points,	10,	12,	16,	20,	24,	and	36	h	post-inoculation.	The	supernatants	
were	then	applied	onto	sterile	paper	discs	on	agar	seeded	with	the	sirA	or	htsA	mutant	
strains.	The	sirA	strain	is	unable	to	uptake	SB	and	thus	relies	on	SA	uptake	for	growth;	
whereas	the	htsA	strain	is	unable	to	uptake	SA,	and	thus	its	growth	is	reliant	on	SB.	
The	data	demonstrated	that,	compared	to	WT	RN6390,	H984	seemed	to	make		
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Fig.	 2-2.	 Expression	 of	 sbnI	 is	 regulated	 by	 iron.	 A.	 qPCR	data	 showing	 significant	
increase	 in	 gene	 expression	 of	 sbnA	and	 sbnI	 in	WT	RN6390	when	 grown	 in	 iron	
restricted	medium	versus	iron-replete	medium	(*P	<	0.01).	All	strains	were	grown	in	
cTMS	with	(+Fe,	solid	bars)	or	without	(-Fe,	clear	bars)	50	μM	FeCl3.	Gene	expression	
of	 strains	 grown	 in	 iron	 replete	 is	 used	 as	 comparator	 and	 is	 arbitrarily	 set	 to	 1.	
Statistics	were	performed	using	Students	unpaired	t-test.	B.	Western	blot	with	a-SbnI	
antisera	demonstrating	iron-regulated	control	of	SbnI.	WT	RN6390	cells	were	grown	
in	 cTMS	medium	with	 (+Fe)	or	without	 (-Fe)	addition	of	50	μM	FeCl3	 (left	panel).	
Immunoblotting	 also	 confirmed	 the	 lack	 of	 expression	 of	 SbnI	 in	 the	 sbnI	mutant	
strain	carrying	pCN51	(vehicle	control;	vector),	and	complementation	of	expression	
in	the	mutant	carrying	psbnI	(carries	sbnI	gene).	
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Fig.	 2-3.	 Growth	 kinetics	 of	 S.	 aureus	 strains	 in	 Roswell	 Park	 Memorial	 Institute	
medium	(RPMI).	RN6390	and	derivatives	were	grown	in	RPMI	incorporating	0.2	μM	
EDDHA	to	further	enhance	iron	restriction.	Vehicle	control	(veh)	was	empty	pCN51.	
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Fig.	2-4.	Disc	diffusion	assay	demonstrating	requirement	of	sbnI	 for	SB	production.	
RN6390	and	derivatives	were	grown	in	cTMS	medium	with	0.1	μM	EDDHA.	Triplicate	
spent	culture	supernatants	were	analyzed	at	indicated	time	points	post	inoculation.	
Supernatants	were	concentrated	and	resuspended	 in	sterile	dH2O	and	placed	onto	
sterile	paper	discs	subsequently	placed	on	cTMS	agar	seeded	with	either	the	sirA	(A)	
or	the	htsA	(B)	strain.	Growth	around	the	disc	was	an	indication	of	the	presence	of	SA	
(A),	or	SB	(B).	All	strains	were	grown	in	cTMS	medium	in	which	growth,	as	measured	
by	OD600	(right	y	axis),	was	comparable.				
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detectable	quantities	of	 SA	 sooner	 in	 the	growth	cycle	 (Fig.	2-4A).	However,	more	
striking,	and	in	agreement	with	data	in	Figure	2-3,	while	RN6390	produced	detectable	
quantities	of	SB	by	10	h,	I	was	unable	to	detect	SB	from	supernatants	of	H984	until	at	
least	the	24-h	time	point.	This	defect	was	complemented	by	supplying	sbnI	in	trans	
(Fig.	2-4B).	These	results	suggest	that	SbnI	plays	a	critical	role	in	the	synthesis	of	SB,	
particularly	at	 early	 time	points,	 and	 that	 the	 absence	of	 SbnI	does	not	hinder	SA	
production,	but	rather	may	result	in	increased	production	of	SA.	
2.3.2 Expression of the SB biosynthetic and efflux genes requires SbnI 
In	accordance	with	the	idea	that	SbnI	affected	synthesis	of	SB,	despite	having	no	clear	
enzymatic	 function	 in	 the	 biosynthetic	 pathway	 (20,	 21,	 27),	 and	 given	 that	 SbnI	
shares	 low	 sequence	 similarity	 to	 the	 DNA-binding	 proteins	 ParB	 and	 Spo0J,	 I	
theorized	that	SbnI	may	function	as	a	regulatory	protein	that	impacted	expression	of	
SB	biosynthetic	genes.	To	evaluate	this,	RNA	levels	were	measured	for	each	of	 the	
genes	throughout	the	sbn	operon,	comparing	levels	in	WT	to	those	in	H984.	Strikingly,	
these	experiments	revealed	a	dramatic	drop	(90-99%	decrease)	in	RNA	transcripts	
for	genes	sbnD	through	sbnH	in	H984	compared	to	RN6390	(Fig.	2-5).		
2.3.3 Identification of an internal promoter in the sbn operon 
Since	 SbnI	 had	 a	 drastic	 effect	 on	 the	 expression	 of	 genes	 downstream	 of	 sbnC,	 I	
theorized	that	SbnI	may	be	regulating	expression	of	genes	downstream	of	sbnC	by	
regulating	 the	 activity	 of	 a	 promoter	 internal	 to	 the	 operon.	 In	 an	 attempt	 to	
demonstrate	 this,	 I	 cloned	 several	DNA	 fragments	 spanning	 the	 region	 from	 sbnA	
through	sbnE	upstream	of	the	promoterless	luciferase	genes	in	the	vector	pGylux	(Fig.	
2-6A).	The	constructs	were	then	introduced	into	strains	RN6390	and	H984,	and	the	
bacteria	grown	in	cTMS	medium	with	or	without	added	iron.	As	expected,		
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Fig.	2-5.	Mutation	of	sbnI	 results	 in	altered	expression	throughout	the	sbn	operon.	
RN6390	 and	 its	 sbnI::Tet	 derivative	 were	 grown	 in	 cTMS	 with	 0.1	 μM	 EDDHA,	 a	
medium	in	which	growth	was	comparable	between	the	two	strains.	qPCR	was	used	
to	 measure	 RNA	 levels	 for	 each	 gene,	 where	 WT	 gene	 expression	 was	 set	 to	 1.	
Statistics	were	performed	using	the	Students	unpaired	t-test.	*P	<	0.005				
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Fig.	2-6.	Identification	of	a	promoter	within	the	sbnC	coding	region.	A.	DNA	fragments,	
spanning	genes	sbnA-E,	were	cloned	into	the	pGylux	vector	and	luciferease	activity	
was	 measured.	 Activity	 was	 expressed	 at	 cps/OD600.	 Statistical	 analyses	 were	
performed	for	each	respective	fragment,	comparing	the	luciferase	activity	of	either	
the	sbnI	strain	without	iron	(sbnI	-	Fe)	to	WT	without	iron	(WT-Fe),	or	WT	with	iron	
(WT+Fe)	 to	WT	without	 iron	 (WT-Fe).	 Statistics	were	 performed	 using	 Student's	
unpaired	 t-test;	 *P	 <	 0.01,	 ns	 =	 not	 significant.	 B.	 Identification	 of	 initiation	 of	
transcription.	Using	the	5'RACE	method	A81175	(based	on	S.	aureus	Newman	genome	
sequence)	was	identified	as	the	+1	site,	and	is	located	625-bp	downstream	of	the	sbnC	
start	 codon.	Two	PCR	products	of	 approximately	760	bp	 (AUP/GSP1)	and	117	bp	
(AUAP/GSP2)	were	generated	and	the	117-bp	product	was	cloned	into	pGEM7	and	
sequenced.	The	location	of	the	primer	GSP2	and	the	-10	and	-35	sites	are	indicated.		
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these	experiments	showed	that	there	was	robust	promoter	activity	in	the	fragment	
carrying	the	promoter	region	upstream	of	sbnA,	and	this	activity	was	approximately	
40%	decreased	in	H984	(Fig.	2-6A),	in	agreement	with	the	qPCR	data	in	Figure	2-5.		
Further,	in	agreement	with	the	presence	of	a	canonical	Fur	box	upstream	of	sbnA,	the	
activity	from	the	sbnA	promoter	was	significantly	(P<0.01)	attenuated	when	the	cells	
were	grown	in	medium	containing	iron	versus	in	the	same	medium	but	iron	deplete	
(Fig.	 2-6A).	 In	 addition	 to	 DNA	 fragment	 A	 carrying	 the	 sbnA	 promoter	 region,	 I	
observed	that	DNA	fragment	C	also	had	fairly	strong	promoter	activity	that	was	also	
significantly	 (P<0.01)	 regulated	 by	 iron	 concentrations	 in	 the	 growth	 medium.	
Moreover,	this	activity	was	abrogated	in	H984,	indicating	that	it	was	SbnI-dependent.	
This	 phenotype	 was	 complemented	 in	 the	 H984	 carrying	 sbnI	 in	 trans	 (data	 not	
shown).			
Rapid	Amplification	of	cDNA	Ends	(RACE)	was	performed	for	fragment	C	in	order	to	
elucidate	 the	 transcription	 start	 site	present	within	 the	 fragment.	The	experiment	
was	repeated	on	multiple	biological	samples	for	robustness,	and	demonstrated	the	
presence	of	a	confirmed	transcription	start	site	at	position	A82356	(based	on	genome	
S.	 aureus	Newman),	which	 is	 located	 772	 bp	downstream	of	 the	 start	of	 the	 sbnC	
coding	region	(Fig.	2-6B).	
2.3.4 SbnI forms dimers and is able to bind DNA region upstream of sbnD 
Based	on	SbnI-dependent	regulation	of	an	internal	promoter	within	the	sbn	operon,	I	
next	investigated	whether	SbnI	controlled	gene	expression	through	direct	binding	to	
nucleic	acids.	However	first,	since	DNA	binding	proteins	frequently	form	dimers	or	
oligomers,	 I	 investigated	 for	 this	property.	His6-tagged	SbnI	was	purified	by	metal	
affinity	chromatography	(Fig.	2-7A)	and	used	to	evaluate	the	oligomerization	status	
of	 the	 protein	 in	 solution.	 Size-exclusion	 chromatography	 and	 sedimentation	
velocity-analytical	ultracentrifugation	determined	that	SbnI	forms	dimers	and		
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Fig.	2-7.	SbnI	forms	dimers	and	tetramers	in	solution.	A.	Purification	of	recombinant	
His6-SbnI.	 Various	 samples	 during	 the	 purification	 process	 are	 run	 through	 a	
polyacrylamide	 gel,	 starting	 with	 pre-column	 (load),	 flowthrough	 (flow),	 wash	
fraction	(wash),	and	elution	fractions	1-4.	The	identity	of	the	three	bands	labeled	with	
an	asterisk	was	confirmed	as	SbnI	using	MALDI.	B.	Size	exclusion	chromatography	of	
SbnI.	 Chromatogram	 represents	 size-exclusion	 data	 of	 SbnI	 run	 in	 300	 mM	
ammonium	formate,	pH	7.4,	at	flow	rate	of	0.2	mL/min	across	Superdex	200	FPLC	
column.	Elution	volumes	of	known	protein	standards	are	shown	at	the	top	and	are	
used	 to	 generate	 a	 standard	 curve	 (inset).	 C-D.	 sedimentation	 velocity-analytical	
ultracentrifugation	was	performed	on	SbnI	run	in	300	mM	ammonium	formate,	pH	
7.4,	100	mM	NaCl.	In	panel	C.	10	mM	DTT	was	included.		
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tetramers	 in	non-reducing	conditions	and	primarily	monomers	with	 limited	dimer	
conformation	under	reducing	conditions	(i.e.	in	the	presence	of	10	mM	DTT)	(Fig.	2-
7	B-D).	
Electrophoretic	mobility	 shift	 assays	 (EMSAs)	were	 performed	with	 purified	His6-
SbnI,	 in	 non-reducing	 conditions	 so	 as	 to	 promote	 oligomerization	of	 the	 protein.	
Based	on	luciferase	assay	and	RACE	data	suggesting	an	internal	promoter	in	the	sbnC	
region,	I	sought	to	find	a	DNA	fragment	upstream	of	sbnD	that	could	be	bound	by	SbnI.	
Multiple	 EMSAs	were	 performed	 using	 250-300	 bp	 fragments	 located	within	 and	
upstream	of	the	region	identified	as	fragment	C	in	Figure	2-6.	A	271-bp	probe	located	
772	bp	upstream	of	the	transcription	initiation	site	internal	to	the	sbnC	coding	region	
was	identified	as	a	binding	site	for	SbnI	(Fig.	2-8).	The	inability	of	denatured	protein	
(SbnI	incubated	for	10	min	at	100℃)	and	His6-SbnG	to	bind	this	DNA	fragment	(Fig.	
2-8,	 lanes	 3	 and	 6,	 respectively),	 confirmed	 binding	 specificity	 of	 SbnI	 for	 this	
fragment,	and	ruled	out	the	possibility	of	non-specific	interactions	with	the	IRDye-
700	molecule.	Binding	specificity	to	this	probe	was	confirmed	by	showing	that	excess	
unlabeled	sbnC	DNA	fragment,	but	not	excess	non-specific	(i.e.	rpoB)	unlabeled	DNA,	
could	interfere	with	the	binding	of	SbnI	to	the	labeled	fragment.	
2.3.5 SbnI binds heme 
The	Iron	response	regulator	(Irr)	protein	of	Bradyrhizobium	spp.	is	a	DNA-binding,	
transcription	 factor	 regulating	 gene	 expression.	 The	 protein	 binds	 heme	 which	
results	in	substantially	decreased	affinity	for	DNA	(41,	42).	This	interaction	is	aided	
by	 a	 HxH	 motif	 located	 central	 to	 the	 Irr	 protein	 (43).	 Since	 SbnI	 contains	 the	
sequence	HIHEH	(i.e.	tandem	HxH	motif)	at	its	extreme	N-terminus,	I	investigated	the	
possibility	that,	in	similar	fashion	to	Irr,	SbnI	was	capable	of	an	interaction	with	heme.	
Heme	titration	experiments	were	performed	using	both	UV-Vis	spectroscopy	(Fig.	2-
9A)	and	ESI-MS	(Fig.	2-9B),	and	both	techniques	demonstrated	that	SbnI	was	indeed	
capable	of	binding	to	heme,	with	saturation	occurring	at	approximately	a	1.5:1	heme	
to	protein	ratio.		
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Fig.	2-8.	 Identification	of	 a	DNA	binding	 site	 for	SbnI.	A.	 Schematic	 identifying	 the	
location	of	a	271-bp	DNA	fragment	that	was	used	for	the	EMSA	experiment	illustrated	
in	panel	B.	The	base	numbering	 is	 from	 the	genome	sequence	 for	S.	aureus	strain	
Newman.	B.	Electrophoretic	mobility	shift	assay	demonstrating	SbnI	binding	to	DNA	
fragment	shown	in	panel	A.	Each	sample	contained	120	ng	of	fluorescently-labeled,	
270-bp,	ds-DNA,	as	well	as	the	following:	Lane:	1,	DNA	alone;	2,	25	μM	SbnI;	3,	25	μM	
denatured	SbnI;	4,	25	μM	SbnI	with	100:1	unlabeled	sbnC	probe	to	labeled	probe;	5,	
25	μM	SbnI	with	100:1	unlabeled	rpoB	probe	to	labeled	probe;	6,	25	μM	SbnG.		
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Fig.	 2-9.	 SbnI	 binds	 heme.	 A.	 UV-Visible	 difference	 absorbance	 spectra	 recorded	
following	 addition	of	 increasing	 concentrations	 of	 heme	 to	 1	 μM	 SbnI	 in	 300	mM	
ammonium	formate,	pH	7.4.		The	absorption	spectra	were	measured	at	22℃.	The	shift	
in	 spectral	maxima	coincident	with	 the	absorption	 spectrum	of	 the	protein-bound	
heme	 with	 increasing	 heme	 concentrations	 is	 indicated	 by	 the	 arrows.	 The	
concentration	of	the	heme	at	the	end	of	the	titration	was	1.6	μM,	at	which	the	increase	
in	soret	peak	is	due	to	non-specific	heme	stacking,	as	SbnI	optimally	binds	heme	at	a	
1:1	 molar	 ratio	 heme:SbnI,	 as	 indicated	 by	 ESI-MS	 data	 shown	 in	 panel	 B.	 B.	
Deconvoluted	 electrospray	 ionization	 mass	 spectral	 data	 of	 SbnI	 in	 300	 mM	
ammonium	 formate,	 pH	 7.4,	 and	 2	 mM	 DTT	 as	 a	 function	 of	 increasing	 heme	
stoichiometry	(0	mol	eq	(bottom)	to	1.5	mol	eq	added	heme	(top)).	The	heme	solution	
was	freshly	prepared	prior	to	the	measurement.	The	apo-SbnI	has	a	mass	of	29,914	
Da.	Heme	binding	to	the	holo-SbnI	results	in	a	new	mass	at	30,531	Da.	The	relative	
abundance	of	the	apo-SbnI	decreases	as	the	heme	concentration	increases.	The	holo-
SbnI	with	a	single	heme	bound	(mass	30,531	Da)	is	the	major	species	even	with	excess	
heme	(top).		
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To	 examine	 which	 amino	 acid	 residue(s)	 were	 responsible	 for	 heme	 binding,	
magnetic	circular	dichroism	(MCD)	was	performed	on	purified	SbnI.	Results	of	MCD	
did	indeed	confirm	that	a	histidine	residue	was	responsible	for	SbnI’s	interaction	with	
heme.	MCD	indicated	a	6-coordinate	 low-spin	 ferric	with	a	histidine	residue	(His),	
donated	from	SbnI,	in	the	proximal	position	and	free	amine	(donated	from	the	buffer)	
occupying	the	6th	position	(Fig.	2-10A).		
To	investigate	the	role	of	the	3HIHEH7	motif	in	binding	to	heme,	I	mutated	all	three	of	
the	histidines	to	alanine	to	create	the	sequence	3AIAEA7	in	the	N-terminus	of	SbnI.	
The	protein	was	overexpressed	and	purified,	and	used	in	heme	titration	experiments	
using	UV-Vis	spectroscopy.	These	analyses	demonstrated	that	 the	protein	was	still	
capable	of	binding	heme	as	a	Soret	peak	was	observed	as	heme	was	titrated	into	the	
protein	solution	(Fig.	2-10B).	These	data	suggest	 that	heme	binding	by	SbnI	 is	not	
attributed	to	the	presence	of	an	HxH	motif,	as	it	is	with	the	B.	japonicum	Irr	protein.	
2.3.6 Heme obviates the SbnI:DNA interaction 
Given	that	SbnI	is	capable	of	binding	both	DNA	and	heme,	I	next	sought	to	determine	
whether	the	interaction	of	SbnI	with	heme	would	alter	its	DNA	binding	properties,	as	
it	does	with	the	Irr	protein	(42).	To	examine	this,	EMSAs	were	repeated	using	SbnI	
protein	that	was	pre-incubated	with	increasing	concentrations	of	heme.	As	shown	in	
Figure	2-11,	the	ability	of	SbnI	to	bind	the	sbnC	DNA	fragment	was	diminished	with	
increasing	concentrations	of	heme.	Moreover,	at	a	1:1	molar	ratio	of	protein	to	heme,	
DNA	binding	was	completely	inhibited	(Fig.	2-11).		
2.3.7 SbnI bound to heme is primarily monomeric 
Most	DNA-binding	proteins	require	the	proper	tertiary	structure	for	interaction	with	
nucleic	acids.	Therefore,	as	heme	abrogated	the	ability	of	SbnI	to	interact	with	DNA,	I	
questioned	 if	 heme	 altered	 SbnI’s	 oligomerization	 properties.	 To	 investigate	 this,	
sedimentation	velocity-analytical	ultracentrifugation	was	performed	with	SbnI	with	
the	addition	of	heme,	at	a	1.5:1	molar	equivalence	of	heme	to	protein.	In	the		
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Fig.	2-10.	SbnI	binds	heme	through	a	histidine	residue.	A.	Overlayed	magnetic	circular	
dichroism	(MCD)	absorption	results	for	the	heme	titration	of	10	μM	SbnI	in	300	mM	
ammonium	formate.	MCD	traces	were	base	 lined	and	CD	corrected.	Assignment	of	
MCD	 indicates	 6	 coordinate	 low-spin	 ferric	with	 a	 histidine	 (His)	 in	 the	 proximal	
position	 and	 amine	 (from	 the	 buffer	 or	 from	 ammonia	 used	 to	 dissolve	 heme)	
occupying	the	6th	position.	B.	UV-Vis	absorbance	spectra	recorded	upon	titration	of	1	
μM	 mutated-SbnI	 (SbnI	 containing	 alanine	 to	 histidine	 mutations	 in	 the	 putative	
heme	 binding	 motif	 (3AIAEA7))	 in	 300	 mM	 ammonium	 formate,	 pH	 7.4,	 with	
increasing	concentrations	of	heme.	Absorbance	was	measured	at	22℃.	The	shift	in	
spectra	with	increasing	heme	concentrations	is	indicated	by	the	arrows.		
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Fig.	2-11.	Heme	decreases	affinity	of	SbnI	for	DNA.	EMSA	was	performed	as	described	
for	Fig.	2-8.	Each	sample	contained	120	ng	of	the	fluorescently-labeled,	ds	sbnC	probe.	
Lanes:	1,	DNA	alone;	2,	25	μM	SbnI;	3,	25	μM	SbnI	with	0.2:1	molar	equivalent	(eq)	of	
heme	to	SbnI;	4,	25	μM	SbnI	with	0.5:1	eq	of	heme	to	SbnI;	5,	25	μM	SbnI	with	1:1	eq	
of	heme	to	SbnI.	
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presence	of	heme,	SbnI	was	primarily	monomeric,	with	limited	dimer	formation	(Fig.	
2-12);	however,	 SbnI	did	not	 form	defined	 tetrameric	 structures,	unlike	what	was	
previously	observed	with	SbnI	in	buffer	alone	(Fig.	2-7C).	Therefore,	this	result	may	
provide	an	explanation	as	to	why	SbnI	binds	to	DNA	more	poorly	in	the	presence	of	
heme,	as	heme	prevents	SbnI	from	forming	higher	molecular	structures	that	may	be	
necessary	for	DNA	binding.	
2.3.8 Extracellular heme controls SB synthesis 
Although	previous	studies	have	demonstrated	that	S.	aureus	preferentially	uses	heme	
as	an	 iron	 source	 (12),	no	 studies	have	yet	 investigated	 the	effect	of	heme	on	 the	
synthesis	 of	 siderophores.	 Moreover,	 data	 showing	 that	 SbnI	 is	 required	 for	 SB	
synthesis,	 and	 that	 heme	 obviated	 the	 DNA-binding	 ability	 of	 SbnI,	 led	 me	 to	
investigate	how	exogenously	supplied	heme	may	affect	SB	production.		
To	investigate	the	effects	of	heme	on	SA	and	SB	production,	a	disc	diffusion	assay	was	
performed	to	determine	the	relative	amounts	of	each	siderophore	produced	during	
growth	of	WT	RN6390	in	cTMS	medium	with	either	1	μM	FeCl3	(WT	+	Fe)	or	1	μM	
heme	 (WT	 +	 heme).	 As	 previously	 described	 in	 section	 2.3.1,	 the	 spent	 culture	
supernatants	were	spotted	onto	cTMS	agar	seeded	with	either	sir	or	hts	mutants	to	
examine	 for	 the	presence	of	SA	or	SB,	respectively.	As	shown	in	Figure	2-13A,	 the	
relative	amounts	of	SA	were	comparable	between	supernatants	from	cultures	grown	
in	equivalent	concentrations	of	FeCl3	versus	heme.	However,	in	agreement	with	the	
results	 described	 above,	 spent	 supernatants	 from	 cultures	 grown	 in	heme,	 versus	
FeCl3,	showed	decreased	amounts	of	SB	during	the	early	stages	of	growth,	until	at	
least	 the	 16	 h	 time-point,	 a	 point	 at	which	 that	 cultures	were	 entering	 stationary	
phase.	As	opposed	to	the	global	suppressive	ability	of	iron	on	iron-regulated	genes,	in	
a	 Fur-dependent	 fashion,	 results	 indicate	 that	 heme	 specifically	 suppresses	 the	
synthesis	 of	 SB.	 I	 suggest	 that	 this	 regulation	 functions	 through	 heme's	 ability	 to	
inhibit	DNA-binding	of	 SbnI,	whose	 function	 is	 required	 for	 transcription	of	 genes	
within	the	sbn	operon	(i.e.	SB	biosynthesis/secretion	genes).	
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Fig.	2-12.	SbnI	forms	monomers	and	dimers	in	the	presence	of	heme.	Sedimentation	
velocity-analytical	 ultracentrifugation	 was	 performed	 on	 SbnI	 run	 in	 300	 mM	
ammonium	formate,	pH	7.4,	100	mM	NaCl,	with1.5:1	molar	equivalence	of	heme	to	
SbnI.		
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Fig.	 2-13.	 Heme	 reduces	 staphyloferrin	 B	 production.	 Disc	 diffusion	 assay	 was	
performed	as	previously	described,	and	all	strains	where	grown	in	cTMS	with	either	
the	addition	of	1	μM	FeCl3	or	1	μM	heme.	A.	Growth	radius	 from	SA	secretion	was	
comparable	between	WT	+	heme	and	WT	+	Fe	for	all	time	points.	B.	Disc	diffusion	
assay	demonstrating	reduced	amount	of	SB	in	culture	supernatants	at	10	and	12	h	of	
growth	from	WT	grown	in	1	μM	heme	when	compared	to	WT	grown	in	1	μM	FeCl3.	
Optical	 density	 of	 cultures	 at	 the	 various	 time-points	 is	 plotted	 above	 the	 disc	
diffusion	assay	results	(right	Y	axis).	
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2.3.9 SbnI regulates genes outside of the sbn operon 
RNAseq	was	performed	on	 the	H984	 (sbnI	mutant)	 to	determine	 if	 SbnI	regulated	
genes	 outside	 of	 the	 sbn	 operon.	 Unexpectedly,	 comparing	 the	 genome-wide	
transcription	 profile	 of	 H984	 to	 that	 of	WT	 RN6390,	 I	 found	 that	 34	 genes	were	
upregulated	between	3.8	to	20-fold,	and	38	genes,	other	than	those	on	the	sbn	operon,	
were	downregulated	between	3.8	to	10-fold.	I	did	not	identify,	however,	regulation	of	
genes	involved	in	heme	biosynthesis	or	heme	uptake.		
Unexpectedly,	there	was	a	substantial	(~16	fold)	increase	in	the	expression	of	arcA,	
and	downstream	genes	 in	 the	arc	operon,	 in	H984	strain.	As	an	alternative	energy	
source,	 S.	 aureus	 is	 able	 to	 transport	 and	 metabolize	 arginine	 through	 proteins	
encoded	on	the	arc	operon	(44,	45).	The	arc	operon	contains	five	genes	in	total,	arcA,	
arcB,	arcD,	arcC,	and	arcR.	ArcA,	ArcB,	and	ArcC	are	catabolic	enzymes,	that	convert	
arginine	 into	 ammonium,	 L-ornithine,	 carbon	 dioxide,	 and	 one	 molecule	 of	 ATP.	
Arginine	is	transported	into	the	cell	by	the	arginine/ornithine	antiporter	ArcD,	and	
the	entire	operon	is	regulated	by	ArcR	and,	divergently	transcribed,	ArgR	(46).	
As	also	determined	by	qPCR	analysis,	the	over-expression	of	the	arc	operon	in	H984	
was	reproduced	in	the	RNAseq	results,	and	could	be	complemented	by	providing	sbnI	
in	trans	(Fig.	2-14A,B).	I	was	interested	to	determine	if	arc	expression	was	linked	to	
SbnI	alone	or	was	a	result	of	decreased	SB.	To	examine	this,	I	performed	qPCR	on	an	
sbnA	mutant,	 a	 strain	 that	would	 still	 express	 sbnI	 but	 does	 not	 produce	 SB.	Data	
revealed	that	arcA	was	also	upregulated	in	an	sbnA	mutant	(Fig.	2-14C),	suggesting	
that	arc	is	regulated	in	response	to	SB.	arcA,	however,	is	not	regulated	in	response	to	
iron	directly,	 as	arcA	expression	did	not	 change	 in	WT	cells	 grown	either	with	or	
without	the	addition	of	30	μM	FeCl3	(Fig.	2-14D).	For	qPCR	analysis	that	involved	the	
sbnA	mutant	and	FeCl3,	gene	expression	of	sbnD	was	measured	as	a	SbnI-	and	iron-
responsive	control.	As	expected,	sbnD	expression	was	not	altered	in	a	sbnA	mutant	
but	was	downregulated	in	H984	under	the	same	growth	conditions	(Fig.	2-14C);	and	
sbnD	gene	expression	was	substantially	increased	in	iron	deplete	versus	iron-replete	
conditions	(Fig.	2-14D).			
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Fig.	2-14.	arc	operon	is	upregulated	in	a	sbnI-deficient	strain.	A.	qPCR	results	show	
significant	upregulation	of	the	arc	operon	in	H984.	B.	Complementation	of	H984	(sbnI	
+	 pSbnI)	 restores	 expression	 of	 arcA.	 C.	 Upregulation	 of	 arcA,	 in	 H984	 and	 sbnA	
mutants	 suggests	 that	 regulation	 is	 in	 response	 to	 SB	 deficiency.	 D.	 arcA	 gene	
expression	is	not	altered	in	the	presence	of	FeCl2.	A-C.	All	strains	were	grown	in	cTMS	
to	mid-exponential	phase,	and	grew	similarly.	Gene	expression	of	WT	was	arbitrarily	
set	 to	 one	 and	 gene	 expression	 of	 the	 mutants	 was	 in	 relation	 to	 WT.	 D.	 Gene	
expression	of	WT	+	Fe	was	set	to	one	and	expression	of	WT-Fe	was	in	relation	to	WT	
+	 Fe.	 All	 gene	 expression	 was	 normalized	 to	 rpoB	 expression.	Statistics	 were	
performed	using	Student's	unpaired	t-test;	*P	<	0.01,	ns	=	not	significant
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2.3.10 arc operon is not involved in SA synthesis 
As	mentioned,	a	byproduct	of	arginine	catabolism	is	ornithine,	which	is	an	essential	
substrate	 for	 the	biosynthesis	of	 staphyloferrin	A.	Therefore,	 I	postulated	 that	 the	
upregulation	of	 the	arc	pathway	 in	a	SB-deficient	 strain,	 could	be	a	 compensatory	
mechanism	 by	 which	 the	 cell	 promotes	 the	 synthesis	 of	 SA.	 To	 examine	 this,	 I	
generated	an	arcA	mutant	by	transducing	an	erythromycin	cassette	into	the	arcA	gene	
using	phage	transduction	and	performed	a	bioassay	to	look	at	the	siderophore	profile	
of	the	arcA	mutant.	Spent	culture	supernatant	was	taken	from	four	strains,	WT,	H984,	
arcA,	and	 sbnI,arcA	double	mutant,	 at	24	h	post	 inoculation.	The	 supernatant	was	
plated	onto	sterile	paper	discs	on	top	of	iron-restricted	agar	containing	the	reporter	
strains.	Two	different	reporter	strains	were	used	as	previously	described	in	section	
2.3.1:	the	sir	mutant	that	can	use	only	SA	for	growth,	and	the	hts	mutant	that	can	use	
only	 SB	 for	 growth.	 Growth	 of	 the	 reporter	 strains	 indicated	 the	 presence	 of	 the	
siderophore	in	the	supernatant.	
As	 previously	 seen	 in	 Fig.	 2-4,	 I	 observed	 heightened	 production	 of	 SA	 in	 H984;	
however,	this	was	also	observed	in	the	sbnI,arcA	double	mutant	demonstrating	that	
the	arc	operon	does	not	contribute	to	SA	production	(Fig.	2-15).	Furthermore,	there	
was	no	observable	difference	between	the	WT	and	arcA	mutant	for	either	SA	or	SB	
secretion.	Therefore	I	concluded	that	SA	synthesis	is	independent	of	the	arc	operon.			
2.3.11 Arginine catabolism does not confer sbnI mutant with a growth advantage  
To	observe	phenotypic	differences	between	the	arc	mutant	and	WT,	I	grew	the	arcA	
mutant	 microaerobically	 in	 nutrient-rich	 medium	 (TSB),	 supplemented	 with	 high	
concentrations	 of	 arginine	 (50	 mM).	 These	 were	 conditions	 previously	 shown	 to	
exacerbate	 the	arc-dependent	 phenotype	 (44).	 As	 anticipated,	 I	 observed	 that	 the	
arcA	mutant	had	a	growth	defect	under	these	conditions	compared	to	WT	and	H984.	
This	growth	defect	correlated	with	a	change	in	pH,	where	the	medium	of	the	arcA		
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Fig.	2-15.	SA	production	is	independent	of	arcA.	Disc	diffusion	assay	was	performed	
as	previously	described,	 and	all	 strains	where	grown	 in	 cTMS	 for	24	h.	Cell	 spent	
supernatant	was	taken	and	plated	onto	agar	seeded	with	reporter	strains.	Growth	
radius	from	SA	secretion	was	comparable	between	WT	and	arcA	mutant,	with	a	slight	
increase	in	SA	production	for	the	sbnI	and	sbnI,arcA	mutants.	As	previously	observed	
in	Fig.	2-4,	SB	production	was	greatly	reduced	in	the	sbnI	mutants.		
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mutant	 underwent	 acidification,	 dropping	 from	 pH	 7.4	 to	 pH	 6.0,	 whereas	 the	
medium	of	the	WT	and	H984	strains	did	not	change	in	pH	(Fig.	2-16A).	This	result	
suggested	that	arc	plays	an	important	role	in	alkalization	of	the	media	during	growth,	
potentially	 through	 the	 production	 of	 NH4+,	 a	 byproduct	 of	 arginine	 catabolism.	
However,	when	grown	in	nutrient-limited	media	(cTMS),	in	microaerobic	conditions	
with	arginine	supplementation,	all	tested	strains,	WT,	H984,	and	arcA	mutant	grew	
poorly	and	had	no	notable	differences	in	growth	(Fig.	2-16B).	Thus,	upregulation	of	
arc	in	H984	does	not	appear	to	confer	a	growth	advantage	in	nutrient	poor	medium.	
2.3.12 sbnI mutant has increased sensitivity to oxidative stress 
As	the	overexpression	of	arc	did	not	enhance	the	synthesis	of	SA,	nor	confer	a	growth	
advantage	to	H984	in	low	pH,	microaerobic	conditions,	I	tested	if	arginine	catabolism,	
and	 the	 subsequent	 production	 of	 ammonia,	 perhaps	 aided	 in	 ROS	 toxicity.	 To	
examine	this,	the	WT,	H984,	sbnI	+	psbnI,	and	arcA	strains	were	used	in	a	killing	assay	
with	methyl	viologen	(MV),	a	compound	that	induces	intracellular	production	of	ROS.	
For	the	killing	assays,	strains	were	grown	in	cTMS	overnight	and	then	inoculated	into	
cTMS	with	10	mM	MV,	and	survival	was	carried	out	 for	48	h.	Results	showed	that	
H984	displayed	 a	 notable	 sensitivity	 to	MV	 compared	 to	WT;	 this	 phenotype	was	
complementable	 by	 expressing	 sbnI	 in	 trans	 (Fig.	 2-17A).	 The	 arcA	mutant	 had	 a	
similar	survival	to	that	of	WT	(Fig.	2-17A).		
Previous	work	has	demonstrated	that	manganese	chloride	(MnCl2)	is	able	to	detoxify	
intracellular	 ROS	 and,	 as	 an	 essential	 cofactor	 to	 SodA	 and	 SodM,	 also	 enhances	
superoxide	dismutase	activity	(47).	Therefore,	to	confirm	that	decreased	survival	of	
H984	in	MV	was	due	to	ROS	production	and	not	to	other	potential	deleterious	effects	
of	the	compound,	killing	assays	were	repeated	in	the	presence	of	4	μM	MnCl2.	In	the	
presence	of	excess	manganese,	all	strains,	including	H984,	had	complete	survival	
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Fig.	 2-16.	 arcA	 mutant	 has	 a	 severe	 growth	 defect	 in	 TSB,	 but	 not	 in	 cTMS,	
supplemented	with	arginine	and	grown	in	micro-aerobic	conditions.	A,B.	Strains	were	
grown	 in	TSB	 (A)	or	 cTMS	 (B)	+	50	mM	arginine	with	 limited	oxygen	availability.	
Changes	in	pH	of	the	media	were	measured	for	TSB	growth	analysis.	
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Fig.	 2-17.	 SbnI	 has	 increased	 sensitivity	 to	 ROS.	 Methyl	 viologen	 killing	 assay	 of	
strains	grown	in	cTMS	to	stationary	phase	then	inoculated	into	cTMS	with	10	mM	MV	
(A)	or	10	mM	MV	+	4	μM	MnCl2	(B).	CFUs	were	enumerated	at	designated	time	points	
by	plating	samples	on	TSA	plates.	
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and	were	unaffected	by	MV	(Fig.	2-17B).	These	results	indicated	that	SbnI	enhances	
resistance	of	S.	aureus	 to	oxidative	 stress;	however,	 the	 role	of	arc	 in	 this	process	
remains	unclear.	
2.5 Discussion 
The	capacity	of	S.	aureus	to	establish	an	infection	is	reliant	on	its	ability	to	acquire	
iron	from	the	host.	The	expression	of	many	genes	encoding	proteins	involved	in	iron	
metabolism	is	'iron-	regulated'	through	the	activity	of	the	global	regulatory	protein,	
Fur.	Fur-mediated	regulation	of	gene	expression	is	widespread	in	both	Gram-negative	
and	 Gram-positive	 bacteria	 (29,	 30).	 Indeed,	 expression	 of	 the	 sbn	 operon	 is	
repressed	by	Fur	during	growth	in	iron-replete	media.	However,	S.	aureus	is	unlikely	
to	encounter	iron	replete	conditions	during	infection	of	the	host,	given	that	the	host	
actively	sequesters	iron	from	pathogens	(48,	49).	Moreover,	since	S.	aureus	possesses	
multiple	 iron	acquisition	 strategies,	 all	 regulated	at	 a	minimum	by	Fur,	 additional	
mechanisms	 are	 likely	 to	 exist	 for	 fine-tuning	 of	 the	 response	 of	 S.	 aureus	 to	 the	
availability	 of	 different	 iron	 chelates	 during	 iron	 starvation	 conditions.	 This	 is	
especially	true	in	light	of	previous	work	demonstrating	that	S.	aureus	prefers	to	utilize	
heme	as	an	iron	source	(12).	The	identification	of	SbnI	as	a	transcriptional	regulator	
of	 sbn	 operon	expression,	 in	 response	 to	heme,	 is	 the	 first	 such	 identification	of	 a	
molecular	mechanism	underpinning	a	manner	by	which	S.	aureus	 'senses'	heme	to	
control	 siderophore	 synthesis.	 The	 model	 provides	 some	 mechanistic	 insight	 in	
support	of	the	observations	of	Skaar	and	colleagues	who	reported	that	heme	is	the	
preferred	iron	source	of	S.	aureus	(12).	
In	 this	study	I	show	that	SbnI	 is	a	regulatory	protein	with	DNA	and	heme	binding	
capabilities.	SbnI	regulates	transcript	levels	of	genes	in	the	sbn	operon,	particularly	
genes	including	and	downstream	of	sbnD.	Thus	under	iron	starvation	conditions,	SbnI	
is	required	to	allow	expression	of	the	gene	encoding	the	SB	efflux	pump,	SbnD,	and	
essential	biosynthetic	genes,	sbnE-H,	ultimately	serving	to	increase	production	of	SB,	
but	also	to	ensure	that	once	SB	synthesis	has	been	initiated	by	the	activity	of	SbnA	
and	SbnB	enzymes	(19–21)	that	the	efflux	pump	is	expressed	so	as	to	not	result	in	
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cytoplasmic	accumulation	of	SB	and	potentially	its	intermediates.	Regulatory	control	
of	efflux	versus	biosynthesis	has	been	documented	for	the	biosynthesis/efflux	of	the	
antibiotic	 actinorhodin	 in	Streptomyces	 coelicolor	 (50).	Ensuring	expression	of	 the	
efflux	pump	prior	to	synthesis	of	the	end	product	ultimately	serves	to	‘protect’	the	
cell	from	an	overabundance	of	cytosolic	antibiotic.	SB	is	a	high-affinity	iron	chelator	
that,	if	located	in	high	abundance	in	the	cell	cytosol,	could	negatively	impact	cellular	
function	by	binding	to	 intracellular	 iron.	Thus	the	SbnI-dependent	upregulation	of	
sbnD	and	downstream	genes	may	serve	to	ensure	expression	of	the	efflux	pump	prior	
to	complete	synthesis	of	the	SB	molecule.	The	early	steps	of	SB	synthesis,	which	result	
in	the	formation	of	L-Dap	by	SbnA	and	SbnB	(20,	21),	may	also	be	important	for	SbnI	
function,	 and	 I	 am	 currently	 investigating	 the	 possibility	 that	 SB	 intermediates,	
including	L-Dap,	work	as	co-regulators	by	binding	with	SbnI.	
This	is	the	first	study	to	investigate	the	importance	of	SbnI	in	siderophore	synthesis	
and	the	data	clearly	 implicate	a	role	 for	SbnI	 in	 transcription	control	 from	regions	
within	 the	 sbn	 operon.	 The	 mechanisms	 underlying	 the	 function	 of	 SbnI	 in	 DNA	
binding	and	transcriptional	control	are	areas	of	interest.	The	similarity	of	SbnI	with	
ParB/Spo0J	may	provide	some	insight.	The	Spo0J	protein	has	been	demonstrated	to	
bind	DNA	at	disparate	locations	and,	along	with	its	ability	to	self-associate,	can	cause	
DNA	bending	within	higher	order	nucleoprotein	complexes	(51).	In	the	case	of	SbnI,	
there	may	be	additional	locations	throughout	the	sbn	operon	that	SbnI	may	bind	in	
forming	 regulatory	 complexes	 that	 control	 transcription.	 These,	 along	 with	 the	
identification	 of	 exact	 nucleotide	 binding	 sequences	 for	 SbnI,	 are	 priorities	 for	
ongoing	studies.	
Along	 with	 demonstrating	 that	 SbnI	 is	 a	 regulatory	 protein	 of	 SB	 efflux	 and	
biosynthesis	I	suggest	that	SbnI	controls	production	of	SB	in	response	to	heme	since	
in	this	study	I	showed	that	SbnI	is	capable	of	binding	to	heme,	and	when	complexed	
with	heme	is	unable	to	interact	with	nucleic	acid,	at	least	the	region	I	identified		
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Fig.	2-18.	Proposed	model	of	SbnI-mediated	gene	regulation	in	response	to	heme.	In	
conditions	of	low	iron	and	low	heme,	SbnI	dimer	binds	to	DNA	within	the	sbnC	coding	
region	and	promotes	expression	of	genes	sbnD-H.	Under	conditions	of	low	iron	and	
high	 heme,	 heme	 binds	 to	 SbnI,	 preventing	 binding	 of	 SbnI	 to	 DNA	 and	 thereby	
resulting	in	decreased	expression	of	genes	sbnD-H.			
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within	the	sbnC	coding	region.	In	this	manner,	SbnI	may	represent	a	novel	mechanism	
by	which	S.	aureus	regulates	siderophore	synthesis	and	utilization	in	response	to	the	
presence	of	heme	(Fig.	2-18),	perhaps	as	a	sophisticated	method	to	transition	from	
SB-mediated	 iron	 uptake	 to	 heme-mediated	 iron	 uptake.	 In	 support	 of	 this	
hypothesis,	I	was	able	to	demonstrate	that	providing	extracellular	heme	to	S.	aureus	
resulted	in	a	decrease	in	SB	production,	but	not	SA	production.	Although	I	favor	the	
hypothesis	 that	 this	 effect	 is	 mediated	 through	 SbnI,	 the	 data	 cannot	 as	 of	 yet	
conclusively	support	this	contention.	When	provided	exogenous	heme,	it	is	difficult	
to	determine	how	much	of	 the	heme	is	 taken	 in	to	 the	cell	and	remains	 intact	and	
capable	of	binding	to	proteins	like	SbnI.	Moreover,	it	is	as	yet	unknown	the	role	that	
intracellular	 heme	 biosynthesis	 plays	 in	 regulating	 metabolic	 processes	 such	 as	
siderophore	biosynthesis.	Ultimately,	the	ability	to	sense	intracellular	heme	may	be	a	
mechanism	 whereby	 S.	 aureus	 conserves	 energy	 by	 not	 utilizing	 siderophore-
mediated	 iron	 uptake	 unnecessarily	when	 heme	 can	 be	 used	 as	 the	 primary	 iron	
source.	 Should	heme	no	 longer	be	accessible	as	an	 iron	source,	 I	hypothesize	 that	
'active'	SbnI	would	allow	transcription	of	downstream	sbn	genes,	and	that	pre-formed	
L-Dap	in	the	cell	would	allow	for	a	rapid	transition	to	SB-mediated	iron	uptake.		
Lastly,	RNAseq	analysis	showed	that	SbnI	regulated	genes	on	the	arc	operon.	The	role	
of	arginine	catabolism	in	virulence	is	poorly	defined,	although	it	has	been	suggested	
that	the	production	of	ammonia	from	arginine	may	aid	in	alkalization	of	acidic	pH	and	
neutralization	of	ROS	(45).	In	testing	whether	Arc	affected	ROS	sensitivity,	I	observed	
that	the	sbnI	mutant	had	increased	sensitivity	to	methyl	viologen,	a	compound	that	
induces	intracellular	superoxide.	Although	it	has	been	well	established	that	increased	
intracellular	 iron	exacerbates	ROS	production	through	Fenton	chemistry	(52),	and	
thus	somewhat	contradictory	that	a	strain	with	reduced	iron	uptake	is	more	sensitive	
to	ROS,	this	result	was	not	wholly	unexpected.	Previous	work	has	shown	in	S.	aureus	
that	a	sirA	mutant	(a	strain	incapable	of	SB	uptake)	was	more	sensitive	to	oxidative	
stress	than	WT,	although	the	reason	for	this	was	not	delineated	(53).	Moreover,	a	link	
between	siderophore	production	and	ROS	sensitivity	has	been	established	in	other	
species:	 protochelin	 and	 azotochelin	 of	 Azotobacter	 vinelandii,	 salmochelin	 in	
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Salmonella	 enterica	sv.	Typhimurium,	and	enterobactin	 in	E.	coli,	 aid	 in	 resistance	
against	 oxidative	 stress	 by	 chelating	 extracellular,	 and	 more	 importantly,	
intracellular	iron	(54,	55).		
Additionally,	 many	 enzymes	 involved	 in	 the	 oxidative	 stress	 response,	 such	 as	
superoxide	dismutase	and	catalase	A	require	metal	cofactors,	like	iron.	In	the	fungi	
Aspergillus	fumigatus	and	Alternaria	alternata,	intracellular	siderophores	bring	iron	
to	catalases	and	peroxidases,	demonstrating	the	necessity	for	siderophores	in	proper	
iron	utilization	(56,	57).	Therefore,	in	the	case	of	SB	in	S.	aureus,	I	propose	that	this	
siderophore	 is	 important	 for	 oxidative	 stress	 resistance	 via	 two	 possible	
mechanisms:	i)	SB	chelates	intracellular	iron	thereby	reducing	intracellular	Fenton	
chemistry,	and	ii)	SB	delivers	iron	to	enzymes	that	aid	in	resistance	to	oxidative	stress	
such	as	SodM	(a	cambialistic	SOD	capable	of	using	either	 iron	or	manganese	as	an	
essential	cofactor	(58)).	
Therefore,	I	propose	a	model	where	SB	is	involved	in	resistance	to	oxidative	stress,	
and	 in	 the	 absence	 of	 SB,	 other	 responses,	 like	 arginine	 catabolism,	 may	 be	
upregulated.	Arginine	catabolic	enzymes,	encoded	on	the	arc	operon,	may	be	induced	
to	 increase	 the	 production	 of	 ammonia	 that	 neutralizes	 ROS,	 as	 perhaps	 a	
compensatory	mechanism	when	SB	is	not	present	(45).	Further	work	is	required	to	
fully	understand	the	mechanism	behind	SB-mediated	resistance	to	oxidative	burst.	
This	 finding	 has	 overall	 importance	 in	 the	 context	 of	 intracellular	 survival,	where	
oxidative	burst	by	neutrophils	 and	other	 innate	 immune	cells	offers	a	 challenging	
growth	obstacle.	Thus,	future	work	in	this	area	would	be	to	examine	the	survival	of	
SB	 deficient	 strains	 in	 neutrophils,	 where	 I	 would	 expect	 a	 marked	 growth	
disadvantage	due	to	heightened	ROS	sensitivity.	
From	this	study,	I	have	identified	SbnI	as	a	heme-binding	transcriptional	regulator	of	
the	sbn	operon,	whereby	it	fine-tunes	expression	of	SB-mediated	iron-acquisition	in	
response	to	intracellular	heme.	The	fine	tuning	of	SB	and	heme	uptake	systems	in	S.	
aureus	is	of	interest	since	both	sbn	and	isd	genes	have	been	implicated	in	virulence	in	
S.	aureus	models	of	infection	(16,	25,	26,	59–62).	Furthermore,	I	demonstrate	a	role	
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for	 SbnI,	 or	 rather	 the	 utilization	 of	 SB,	 in	 resistance	 to	 ROS,	 which	 may	 have	
important	implications	for	S.	aureus	intracellular	survival	and	resistance	to	oxidative	
burst.		
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Chapter 3 
3 Characterization of copper efflux systems in S. aureus 
3.1 Introduction 
Copper	is	an	essential	nutrient	for	most	microorganisms	and	is	a	required	cofactor	
for	many	metalloproteins	involved	in	metabolism	(1).	Despite	this,	like	many	other	
transition	metals,	copper	 is	 toxic	 to	biological	systems	at	high	concentrations	as	 it	
readily	accepts	and	donates	electrons	in	the	transition	from	cuprous	(Cu+)	to	cupric	
(Cu2+)	states.	This	reactivity	results	in	membrane	damage,	intracellular	formation	of	
reactive	 oxygen	 species	 (ROS)	 and	 subsequent	 DNA	 damage,	 and	 irreversible	
displacement	of	Fe	in	Fe-S	binding	enzymes,	abrogating	enzymatic	activity	(2–4).	Due	
to	these	toxic	effects,	copper	is	a	potent	antimicrobial	agent.	In	select	settings,	copper	
is	used	in	water	treatment	and	as	a	coating	for	hospital	surfaces	and	medical	devices,	
where	 it	has	 been	 shown	 to	 reduce	 bacterial	 counts	 and	 risk	of	hospital	 acquired	
infections	(2,	5,	6).		
In	addition	to	copper	being	used	as	an	antimicrobial	agent	in	the	environment,	copper	
toxicity	is	also	exploited	at	the	host-pathogen	interface	by	the	efflux	of	copper	into	
pathogen-containing	 phagosomes	 (7–9).	 Following	 macrophage	 phagocytosis,	
interferon-g	 (IFN-g)	 induces	 the	 expression	 of	 the	 Cu+	 importer	 copper	 transport	
protein	receptor	1	(CTR1),	which	transports	copper	from	the	extracellular	milieu	into	
the	macrophage	cytoplasm.	Inside	the	macrophage,	Cu+	is	picked	up	by	the	copper	
chaperone	 ATOX1,	 where	 it	 is	 brought	 to	 the	 ATPase	 copper	 efflux	 transporter,	
ATP7A,	 located	 on	 the	 phagosomal	membrane.	 ATP7A	 then	 effluxes	 Cu+	 into	 the	
bacteria-containing	phagosome	where	it	exerts	bactericidal	effects	(7,	10).		
To	combat	this	process,	many	pathogens	have	developed	sophisticated	mechanisms	
to	 avoid	 copper	 intoxication.	 Previously	 shown	 during	 growth	 in	 the	 phagosome,	
Escherichia	coli,	Mycobacterium	spp.,	and	Salmonella	enterica	sv.	Typhimurium	rely	
on	 copper-responsive	 ATPase	 efflux	 pumps,	 in	 concert	 with	 copper-binding	
chaperones,	 to	pump	excess	 intracellular	 copper	outside	of	 the	 cell	 (7,	9,	11).	The	
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notorious	 human	 pathogen	 Staphylococcus	 aureus	 survives	 and	 replicates	
intracellularly	in	macrophages	(12),	and	thus	its	ability	to	remove	excess	copper	from	
the	cell	cytoplasm	may	contribute	to	its	survival	within	the	phagosome.	
S.	aureus	contains	the	copAZ	 locus,	which	encodes	CopA,	a	copper-translocating	P-
type	 ATPase,	 and	 CopZ,	 a	 cytoplasmic,	 copper-binding	 chaperone	 (13;	 Fig.	 3-1).	
Previous	work	has	shown	that	deletion	of	copA	in	S.	aureus	renders	the	cell	sensitive	
to	high	concentrations	of	copper,	and	to	a	lesser	extent,	lead	and	iron	in	vitro	(13).	
The	copAZ	 locus	 is	 regulated	by	 the	 copper-sensitive	operon	 repressor,	CsoR,	 that	
represses	 the	 copAZ	 operon	 in	 copper-deplete	 conditions,	 but	 derepresses	 copAZ	
after	binding	to	cytoplasmic	copper	in	copper	replete	conditions	(14,	15).		
S.	aureus	strain	USA300	is	a	highly	transmissible	and	virulent	strain	of	S.	aureus	that,	
since	2011,	has	become	the	most	common	cause	of	MRSA	infections	in	all	bodily	sites	
(16).	The	ability	of	USA300	to	cause	such	severe	infections	is	thought	to	be	due	to	its	
acquisition	 of	 novel	 virulence	 factors.	 Unique	 to	 USA300	 is	 the	 arginine	 catabolic	
mobile	element	(ACME)	cassette	(17–19).	The	contribution	of	the	ACME	cassette	to	
USA300	virulence	is	poorly	defined.	Located	on	the	ACME	cassette	is	an	additional	
putative	copper	transporter	(Fig.	1),	that	has	a	36%	identity	to	the	chromosomal	copA	
gene	and	99%	identity	to	copB	from	Staphylococcus	capitis.	This	putative	efflux	pump,	
here	named	copB,	has	been	characterized	on	the	staphylococcal	cassette	chromosome	
(SSC)	mec	mobile	 genetic	 element	 found	 in	many	 livestock-associated	 (LA)	MRSA	
strains,	where	 it	provides	these	strains	with	greater	resistance	to	copper	(20,	21).	
Immediately	downstream	of	copB	is	a	putative	lipoprotein	of	unknown	function.	The	
function	of	copB	and	associated	lipoprotein	has	previously	not	been	characterized	in	
a	 human-infectious	 strain	 of	 MRSA.	 Moreover,	 the	 contribution	 of	 copper	
detoxification	systems	to	S.	aureus	intracellular	survival	in	the	macrophage	has	not	
been	investigated.		
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Fig.	3-1.	Schematic	of	copper	detoxification	pathways.	Copper	efflux	ATPase,	CopA,	
and	copper	 chaperone,	CopZ,	 are	 common	 to	 strains	of	S.	aureus.	 	USA300	has	an	
additional	putative	copper	efflux	transporter,	CopB,	and	associated	lipoprotein,	CopL,	
encoded	on	the	ACME	cassette.		
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Thus	in	this	study,	I	provide	the	first	evidence	of	copper	detoxification	machinery	on	
the	 ACME	 cassette	 that	 confers	 USA300	 with	 increased	 resistance	 to	 copper	
compared	to	other	S.	aureus	strains.	Furthermore,	I	demonstrate	that	the	cop	genes	
play	a	key	role	in	intracellular	survival	of	USA300	inside	the	macrophage.				
3.2 Experimental procedures 
3.2.1 Bacterial strains, plasmids, and growth media 
All	bacterial	strains	and	plasmids	used	in	this	study	are	listed	and	described	in	Table	
3-1.	 Strains	 were	 stored	 in	 15%	 glycerol	 stocks	 at	 -80℃	 and,	 prior	 to	 use,	 were	
streaked	onto	tryptic	soy	broth	(TSB)	(Difco)	agar	plates	containing	the	appropriate	
antibiotic.	Solid	media	were	prepared	with	addition	of	1.5%	w/v	Bacto	agar	(Difco).	
Concentrations	 of	 antibiotics	 used	 were	 as	 follows:	 50	 μg/mL	 kanamycin	 and	
100	μg/mL	ampicillin	 for	Escherichia	coli	 selection,	4	μg/mL	tetracycline,	5	μg/mL	
chloramphenicol,	 and	 3	 μg/mL	 erythromycin	 for	 S.	 aureus	 selection.	 E.	 coli	were	
grown	 in	 Luria	 Broth	 (Difco)	 and	 S.	 aureus	 strains	 were	 grown	 in	 TSB,	 or	 either	
chelex-100-treated	 Tris	 minimal	 succinate	 (cTMS)	 or	 Roswell	 Park	 Memorial	
Institute	(RPMI)	(Gibco)	media	for	growth	under	metal	restriction.	All	solutions	and	
media	 were	 made	 using	 water	 purified	 with	 Milli-Q	 water	 purification	 system	
(Millipore).	
Table	3-1.	Bacterial	strains,	plasmids,	and	primers	used	in	this	study.		
Bacterial	strains,	
plasmids,	
oligonucleotides	
Description	 Reference	
E.	coli	 	 	
DH5α	 F-Ф80	 dLacZΔM15	 recA1	 endA1	 nupG	 gyrA96	 glnV44	
thi-1	 hsdR17(rk-	 mk+)	 λ-supE44	 relA1	 deoR	 Δ(lacZYA-
argF)U169	
Promega	
BL21(DE3)	 F-	ompT	gal	dcm	lon	hsdSB	(rB-	mB+)	λ	(DE3	[lacI	lacUV5-
T7	gene	1	ind1	sam7	nin5])	
Novagen	
S.	aureus	 	 	
RN4220	 rk-mk+	accepts	foreign	DNA	 (27)	
USA300	 USA300	LAC	cured	of	antibiotic	resistance	 (28)	
RN6390	 Wild-type	prophage-cured	laboratory	strain	 (29)		
Newman	 Wild-type	clinical	osteomyelitis	isolate	 (30)	
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Mu50	 Wild-type	surgical	wound	isolate		 (31)	
Mn8	 Wild-type	clinical	isolate	from	patient	with	toxic	shock	
syndrome	
(32,	33)	
MW2	 Wild-type	CA-MRSA	USA400	 (34,	35)	
SH1000	 Wild-type	NCTC	8325-4	rsbU+	laboratory	strain	 (36)	
copAZ	 USA300	∆copAZ	(SAUSA300_2494-5)	 This	study	
copB	 USA300	∆copB	(SAUSA300_0078)	 P.	Planet	
copL	 USA300	∆copL	(SAUSA300_0079)	 P.	Planet	
copBL	 USA300	∆copBL	 P.	Planet	
copAZB	 USA300	∆copAZ,	copB::ΦΝΕ:	EryR	 This	study	
copA	 RN6390	copA::	ΦΝΕ;	EryR	 This	study	
csoR	 USA300	csoR::	ΦΝΕ:	EryR	 This	study	
	 	 	
Plasmids	 	 	
pET28a(+)	 Overexpression	vector	for	6xHis-tagged	proteins;	KmR	 Novagen	
pET28a(+):csoR	 Vector	for	overexpression	of	recombinant	His6-CsoR	 This	study	
pALC2073	 E.	coli/Staphylococcus	shuttle	vector:	AmpR	CmR	 (37)	
pcopAZ		 pALC2073-copAZ;	vector	for	expression	of	copAZ;	CmR	 This	study	
pcopBL	 pALC2073-copBL;	vector	of	expression	of	copBL;	CmR	
	
This	study	
Oligonucleotides	 	 	
Cloning	 of	 ∆copAZ	
for	pKOR1	
GGG	GAC	AAG	TTT	GTA	CAA	AAA	AGC	AGG	CTA	TGG	
AAA	 TTA	 AGT	 GGA	 TGT	 GTC	 G	 (Upstream	 arm	
forward)	
GGA	CCT	CCG	CGG	CAC	AAC	AAT	CTC	TCT	ACT	TAG	
CAT	C	(Upstream	arm	reverse)	
GGA	CCT	CCG	CGG	GAT	GAC	AGT	AAA	GTT	GCT	GTA	TC	
(Downstream	arm	forward)	
GGG	GAC	CAC	TTT	GTA	CAA	GAA	AGC	TGG	GTG	AGT	
GTA	 CGT	 GAT	 GAA	 GAT	 AGT	 C	 (Downstream	 arm	
reverse)	
	
	
Cloning	 of	 csoR	
from	for	pET28a(+)	
TTT	TTT	GCT	AGC	GCT	ATG	ACT	GAA	CAA	GAT	AAT	GC	
(forward)	
TTT	TTT	CTC	GAG	CTC	CTT	TAG	TCT	TTA	ATC	AAT	
TTT	TGA	AA	(reverse)	
	
	
Cloning	of	copAZ	for	
complementing	
vector	(pcopAZ)	
GAT	 CGA	GCT	 CGA	ATC	ACA	GGG	AGG	 CAA	TAA	TG	
(forward)	
GAT	 CGA	 ATT	 CGT	 TGG	 GAT	 TCT	 CAT	 CAG	 TTC	 G	
(reverse)	
	
	
Cloning	of	copBL	for	
complementing	
vector	(pcopBL)	
GAT	CGG	TAC	CGA	GCA	TAA	TCA	TCA	AAA	TCA	CAT	
GAA	TC	(forward)	
	
TTT	 TGA	 GCT	 CCG	 TAT	 CGG	 TTA	 ATG	 ATG	 CGG	
(reverse)	
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RT-PCR:	copA	 GAT	ATC	ACT	GGT	ATG	ACT	TGT	GC	(forward)	
GGT	TAT	ACT	CAA	CAG	TTG	CTT	TCT	(reverse)	
	
	
RT-PCR:	copZ	 TTA	AAT	GTT	GAA	GGT	ATG	AGC	TGT	G	(forward)	
GAG	ATA	CAG	CAA	CTT	TAC	TGT	CAT	(reverse)	
	
	
RT-PCR:	copB	 CAT	TCC	AAT	CAA	ATG	CAT	CAT	GAT	AAC	(forward)	
AGG	TAA	GTT	AAC	ACC	CAT	CAG	T	(reverse)	
	
	
RT-PCR:	copL	 GGA	TCA	TTA	CTA	ATA	TTA	TCA	GCT	TGC	(forward)	
CTT	TAA	ATT	CAC	CCT	CAT	TAG	TCG	(reverse)	
	
	
EMSA:	copA	
promoter	
CAA	TGT	TTG	CAC	GGC	AAT	(forward)	
CAC	ATT	ATT	GCC	TCC	CTG	T	(reverse)	
	
	
EMSA:	copB	
promoter	
GGA	CGT	GTA	GAT	ATA	AGG	TTC	G	(forward)	
TCA	AAT	TAA	CCC	CTC	CTA	ATG	AAA	ATG	(reverse)	
	
Abbreviations:	 AmpR	 –	 ampicillin	 resistance;	 CmR	 –	 chloramphenicol	 resistance;	 EryR	 –	
erythromycin	resistance;	KmR	–	kanamycin	resistance	
	
3.2.2 S. aureus growth curves 
To	 determine	 the	 metal	 minimum	 inhibitory	 concentation	 (MIC),	 bacteria	 were	
cultured	on	TSB	agar	 (TSA),	 then	several	 single	 isolated	 colonies	were	picked	and	
inoculated	 into	 2	mL	RPMI	with	 0.3	 µM	EDDHA	 (flask:	 volume	 ratio	 of	 10:1)	 and	
grown	for	approximately	8	h	at	37℃	with	shaking	at	220	rpm.	The	bacteria	were	then	
harvested,	washed,	and	resuspended	in	fresh	RPMI	medium,	and	inoculated	into	2	mL	
RPMI	with	0.2	µM	EDDHA	medium	(flask:	volume	ratio	10:1)	to	a	starting	OD600	0.01.	
Metals	used	for	MIC	analysis	were	purchased	from	Sigma-Aldrich:	cadmium	chloride	
(CaCl2),	cobalt	chloride	(CoCl2),	copper	sulfate	(CuSO4),	nickel	chloride	(NiCl2),	lead	
nitrite	(Pb(NO3)2),	and	silver	nitrate	(AgNO3).				
3.2.3 Cloning and mutagenesis of S. aureus  
Oligonucleotides	used	to	generate	the	copAZ	mutation	are	listed	in	Table	3-1.	An	in-
frame,	markerless	deletion	was	generated	using	the	pKOR1	plasmid	using	methods	
previously	 described	 (22).	 Briefly,	 ~800	 bp	 regions	 located	 just	 upstream	 and	
downstream	of	the	copAZ	genes	were	PCR	amplified	with	primers	listed	in	Table	3-1.	
The	 upstream	 reverse	 primer	 and	 downstream	 forward	 primer	 encoded	 for	SacII	
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restriction	sites,	allowing	the	two	fragments	to	be	digested	and	ligated	together	using	
SacII	 restriction	 enzyme	 (New	 England	 Biolabs	 (NEB))	 and	 T4	 DNA	 ligase	 (NEB),	
respectively.	 Both	 the	 forward-upstream	 primer	 and	 reverse-downstream	 primer	
contained	attB	sites	that	then	allowed	the	ligated	upstream	and	downstream	product	
to	 be	 introduced	 into	 pKOR1	 using	 site-specific	 recombination,	 generating	 a	
pKOR1∆copAZ	 clone.	 The	 vector	 was	 constructed	 in	 E.	 coli	 DH5	 and	 passaged	
through	 S.	 aureus	 RN4220	 at	 30℃	 before	 being	 electroporated	 into	 USA300.	
Recombination	was	performed	as	previously	described	(22)	and	formed	a	3.035	kb	
deletion	 of	 the	 copAZ	 genes.	 Successful	 mutants	 were	 chloramphenicol-sensitive,	
indicating	the	removal	of	the	pKOR1	backbone	following	homologous	recombination.	
Mutation	of	copAZ	was	confirmed	using	PCR	with	primers	located	just	outside	of	the	
region	of	deletion.		
The	copAZB	mutant	was	generated	by	transducing	an	erythromycin	cassette,	located	
within	the	copB	gene,	into	the	copAZ	mutant	background.	The	copB	transposon	was	
taken	from	the	Nebraska	transposon	library	and	transduced	by	Φ80α	bacteriophage	
such	that	it	produced	a	polar	mutation	that	also	prevented	the	functional	expression	
of	downstream	gene,	copL.	The	copA	and	csoR	mutants	were	also	generated	through	
transduction	 of	 an	 erythromycin	 cassette,	 taken	 from	 the	 Nebraska	 transposon	
library,	into	our	WT	RN6390	and	USA300	background	strains,	respectively	(23,	24).	
Proper	transduction	of	the	transposons	was	confirmed	using	PCR.	The	copB,	the	copL,	
and	the	copBL	mutants	were	markerlessly	deleted	similar	to	protocol	described	and	
donated	to	us	by	Paul	Planet	(25).	
3.2.4 Complementation of copAZ and copBL genes 
Complementation	 vectors	 were	 designed	 using	 plasmid	 pALC2073	 (26).	
Complementation	was	 performed	using	 the	 annotated	 copAZ	and	 copBL	 loci	 from	
USA300.	The	genes	were	PCR	amplified	using	primers	(containing	either	SacI	or	KpnI	
restriction	sites)	listed	in	Table	3-1.	Gene	products	were	digested	with	SacI	and	KpnI	
(NEB)	and	ligated	into	digested	pALC2073	using	T4	DNA	ligase	(NEB).	As	with	the	
pKOR1	plasmid,	pALC2073	clones	were	 constructed	 in	E.	 coli	DH5α	and	passaged	
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through	S.	aureus	RN4220	strain	at	37℃	before	electroporation	into	target	USA300	
strains.		
3.2.5 RNA isolation and qPCR 
S.	aureus	strains	were	grown	in	2	mL	Tris	minimal	succinate	(TMS)	or	RPMI	media	
for	 8	 h.	 Cultures	 were	 then	 harvested	 and	 subcultured	 at	 OD600	 0.005	 in	 10	 mL	
minimal	medium	and	grown	to	mid-exponential	phase	(OD600	~1.0).	Cells	equating	to	
an	OD600	of	3.0	were	harvested	for	each	culture	and	RNA	extraction	was	performed	
by	Aurum™Total	RNA	Mini	Kit	(Bio-Rad)	according	to	the	manufacturer’s	instructions	
with	the	addition	of	0.25	µg/mL	of	lysostaphin	to	the	lysis	solution.	RNA	purity	was	
determined	by	agarose	gel	and	RNA	concentration	was	determined	by	NanoDrop®	
ND-1000	UV-Vis	Spectrophotometer.	cDNA	preparation	was	performed	using	500	ng	
of	total	cellular	RNA	reverse-transcribed	using	SuperscriptTM	II	reverse	transcriptase	
(Invitrogen)	according	to	manufacturer’s	instructions.	For	each	qPCR	reaction,	1	µg	
of	cDNA	was	amplified	in	a	Rotor-Gene	6000	(Corbett	Life	Science)	using	the	iScript	
One-Step	RT-PCR	Kit	with	SYBR	Green	(BioRad).	Gene	expression	 for	each	sample	
was	quantified	 in	relation	to	rpoB	expression.	A	standard	curve	was	generated	 for	
each	gene	examined.		
3.2.6 Protein expression and purification  
Recombinant	 His6-CsoR	 protein	 was	 overexpressed	 and	 purified	 essentially	 as	
previously	described	(38).	In	brief,	cells	were	grown	to	mid-log	phase	at	37℃	with	
aeration	before	the	addition	0.4	mM	isopropyl-b-D-thiogalactopyranoside	(IPTG);	the	
cells	were	then	grown	for	an	additional	16	h	at	room	temperature	with	shaking	before	
harvesting.	Cells	were	resuspended	in	50	mM	Tris,	pH	7.4,	and	1	mM	dithiothreitol	
(DTT),	prior	to	lysis	at	30	kpsi	in	Cell-Disruptor	(Constants	Systems	Ltd.).	Cell	debris	
was	pelleted	by	15-min	centrifugation	at	3000	rpm	in	a	Beckman	Coulter	Allegra®	
6R	Benchtop	Centrifuge,	followed	by	ultracentrifugation	at	50,000	rpm	in	a	Beckman	
Coulter	Optima®	 L-900K	ultracentrifuge	 for	 45	min.	 The	 lysate	was	 filtered	with	
0.45	μM	 nylon	 filter	 (VWR)	 and	 then	 applied	 to	 a	 1	 mL	 HisTrap	 column	 (GE	
Healthcare)	equilibrated	with	buffer	A	(50	mM	Tris,	300	mM	NaCl,	1	mM	DTT,	and	
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50	mM	imidazole,	pH	7.4).	The	His6-CsoR	was	eluted	with	0-80%	concentration	of	
buffer	B	 (50	mM	Tris,	300	mM	NaCl,	1	mM	DTT,	 and	500	mM	 imidazole,	pH	7.4).	
Protein	was	dialyzed	in	50	mM	Tris,	300	mM	NaCl,	1	mM	DTT,	and	4	mM	EDTA	pH	
7.4,	at	4℃.	Protein	purity	was	assessed	by	SDS-PAGE.	Protein	concentrations	were	
determined	through	Bradford	assay	using	the	Bio-Rad	Protein	Assay	Dye	(Bradford)	
Reagent	Concentrate	(5´),	and	samples	were	read	at	absorbance	OD595.	A	standard	
curve	was	made	for	each	concentration	determination	with	1	mg/mL	BSA.		
3.2.7 DNA-binding assays 
Electrophoretic	mobility	shift	assays	(EMSA)	were	performed	with	purified	CsoR	and	
double	stranded	DNA.	The	DNA	probe	was	amplified	through	PCR	with	primers	listed	
in	 Table	 3-1.	 	 Protein	 and	DNA	were	 incubated	 in	 a	 25	 μL	 volume	 that	 contained	
100	ng	 DNA,	 50	 mM	 Tris,	 240	 μg/mL	 bovine	 serum	 albumin	 (BSA),	 15.2	 μg/mL	
Poly[d(I-C)],	 and	 CsoR,	 at	 room	 temperature	 for	 15	 min.	 Following	 this	 15-min	
incubation,	 samples	with	metal-loaded	CsoR	underwent	 a	 10-min	 incubation	with	
CuSO4	or	ZnCl2,	or	equal	amount	of	sterile	water	for	samples	with	apo-CsoR.	Samples	
were	 separated	on	6%	non-denaturing	polyacrylamide	gels	 in	TBE	buffer	 (10	mM	
Tris,	 89	 mM	 Tris	 Borate,	 2	 mM	 EDTA,	 pH	 8.3)	 at	 120	 volts	 for	 1.5	 h.	 DNA	 was	
visualized	by	incubating	gel	in	0.5	μg/mL	ethidium	bromide	for	15	min,	followed	by	
two	 washes	 with	 water	 and	 10	 min	 submergence	 in	 1	 mM	 MgSO4	 to	 reduce	
background	signal.		
3.2.8 Mammalian cell culture  
RAW	264.7	macrophages	from	the	American	Type	Culture	Collection	were	grown	in	
RPMI	 1640	 buffered	 with	 sodium	 bicarbonate	 and	 25	 mM	 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic	 acid	 (HEPES)	 supplemented	with	 5%	 (v/v)	 Fetal	 Bovine	
Serum	(FBS).	Macrophages	were	cultured	in	37℃	with	5%	CO2.	RAW264.7	∆ATP7A	
were	 generated	 using	 CRISPR-CAS	 system	 to	 remove	 the	 ATP7A	 gene,	 and	 were	
generated	and	donated	to	us	by	Michael	Petris	(25).	
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3.2.9 Gentamicin protection assays  
RAW264.7	 WT	 and	 ΔATP7A	 macrophages	 were	 activated	 with	 10	 μg/mL	 IFN-γ	
(PeproTech	Inc.)	for	20	h	prior	to	infection.	S.	aureus	strains	precultured	overnight	in	
TMS	with	0.2	μM	EDDHA	and	20	μM	CuSO4	were	harvested,	washed	and	re-suspended	
in	fresh	TMS	to	an	OD	0.1.	Infections	were	done	at	an	MOI	of	0.1.	Cells	were	infected	
for	30	mins	in	serum-free	RPMI,	washed	with	sterile	PBS,	and	treated	with	serum-
free	RPMI	with	100	ng/mL	gentamicin	for	1	hour.	Following	gentamicin	treatment,	
macrophages	were	washed	twice	with	PBS	and	then	incubated	with	RPMI	with	5%	
(v/v)	 FBS	 at	 37℃	 with	 5%	 CO2.	 At	 designated	 time-points	 gentamicin-protected	
bacteria	were	enumerated	by	lysing	infected	macrophages	with	0.1%	(v/v)	Triton	X-
100	in	PBS.	Macrophage	lysates	were	serially	diluted	and	plated	on	TSA	plates.					
3.3 Results 
3.3.1 CopB is homologous to other copper ATPases 
HHpred	analysis	of	the	predicted	product	of	the	ACME-encoded	copB,	USA300	strain	
FPR3757	 gene	 SAUSA300_0078,	 showed	 that	 it	 had	 high	 structural	 similarity	 to	
cation-transporting	 P1B-ATPases	 (Table	 3-2;	 Fig.	 3-2;),	 and	 a	 36%	 amino	 acid	
identity	to	copper-transporting	ATPase	copA	(SAUSA300_2495).	CopB	possesses	two	
of	 the	 common	motifs	 to	 P-type	ATPases:	 the	 conserved	GDGINDAP	 (G577-P584)	
nucleotide	binding	motif	and	a	CPH	intramembranous	motif	(C336-H338),	conserved	
among	 P-type	 ATPases	 and	 essential	 to	 metal	 transport.	 ACME	 encoded	 CopB,	
however,	does	not	have	the	canonical	CXXC	metal-binding	motif.	Downstream	of	copB	
on	the	ACME	cassette	is	a	YdhK-family	lipoprotein	(SAUSA300_0079),	herein	named	
copper-responsive	lipoprotein	(copL)	(Fig.	3-2;	Table	3-2).	CopL	contains	a	lipobox	
motif,	 LSAC	 (L16-C19),	 essential	 for	 membrane	 anchoring	 (40).	 YdhK-family	
lipoproteins	 have	 been	 observed	 in	 other	 species,	 such	 as	C.	 glutamicum,	 Listeria	
monocytogenes,	and	E.	faecalis,	in	the	same	operon	as	copB	(41).		
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Table	3-2.	HHpred	 analysis	of	CopB	 (SAUSA300_0078)	and	downstream	 lipoprotein,	CopL	 (SAUSA300_0079)	 from	USA300	
strain	FPR3757	(18)	
Protein	 Organism	 Similar	Protein	 PDB	ID	 Identity	
(%)	
Similarity	 E	value	
SAUSA300_0078	
(CopB)	
Legionella	pneumophila	 Copper	Efflux	ATPase	 4BBJ	 36	 0.602	 3.7e-110	
Archaeoglobus	fulgidus	 CopA,	copper-exporting	P-type	
ATPase	A	
3J08	 32	 0.579	 4.4e-100	
	 Shigella	sonnei	 Zinc-transporting	ATPase	 4UMW	 25	 0.378	 8e-92	
	 Arabidopsis	thaliana	 P-type	ATPase	proton	transport	 5KSD	 23	 0.298	 1.3e-73	
	 Sus	scrofa	 Potassium-transporting	ATPase	
alpha	
3IXZ	 20	 0.246	 1.6e-70	
	 Squalus	acanthias	 Na,	K-ATPase	alpha	subunit	 2ZXE	 20	 0.242	 2.8e-70	
	 Oryctolagus	cuniculus	 Sarcoplasmic/endoplasmic	
reticulum	calcium	ATPase	
3AR4	 22	 0.230	 5.4e-69	
	 Neurospora	crassa	 Proton	pump,	plasma	membrane	
ATPase	
1MHS	 21	 0.303	 7.5e-70	
	 Sulfolobus	solfataricus	 Copper-transporting	ATPase	 2YJ3	 31	 0.501	 3.9e-28	
	 Homo	sapiens	 Copper-transporting	ATPase	1	 2KIJ	 36	 0.562	 2.2e-24	
	 Escherichia	coli	 Potassium-transporting	ATPase	B	
chain	
1SVJ	 18	 0.194	 8.2e-18	
	 Mycobacterium	avium	 Phosphoserine	phosphatase	 5IS2	 17	 0.276	 3.7e-12	
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SAUSA300_0079	
(CopL)	
Bacillus	subtilis	 Uncharacterized	protein	YdhK	 4MDW	 48	 0.820	 1e-60	
	 Homo	sapiens	 AT-rich	interactive	domain-
containing	protein	4A	
2MAM	 19	 0.217	 0.16	
	 Escherichia	coli	 Tran	protein;	cell	adhesion,	
bacterial	secretion	
3ZBI	 39	 0.814	 0.029	
	 Streptococcus	penumoniae	 Lipoprotein	 5CYB	 18	 0.309	 0.025	
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Fig.	3-2.	Schematic	representation	of	SAUSA300_0078	and	0079,	designated	copB	and	
copL,	respectively,	on	the	ACME	cassette	downstream	of	opp3.	Open	reading	frame	
numbers	are	from	sequence	USA300	strain	FPR3757	complete	genome	(44).				
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Immediately	upstream	of	copB,	is	a	putative	oligopeptide	permease	(opp3)	transport	
system	that	is	suggested	to	be	responsible	for	transport	of	peptides	and	potentially	
metals	(Fig.	3-2)	(42).	Copper	irreversibly	displaces	iron	in	Fe-S	clusters,	which	are	
essential	cofactors	in	many	enzymes	that	synthesize	amino	acids	(4,	43).	Therefore,	
the	proximity	of	the	opp3	system	to	copBL	may	suggest	an	increase	in	peptide	import	
to	 compensate	 for	 potential	 loss	 of	 amino	 acid	 biosynthesis	 as	 a	 result	 of	 copper	
toxicity,	although	further	investigation	is	required.	qPCR	analysis	of	opp	genes	in	WT	
USA300	grown	in	the	presence	of	copper,	however,	did	not	suggest	that	this	operon	
is	copper-regulated	(data	not	shown).	 
3.3.2 USA300 has increased copper resistance  
To	determine	if	copBL	conferred	USA300	with	increased	resistance	to	copper	toxicity	
and	perhaps	a	growth	advantage	in	copper-rich	environments,	minimum	inhibitory	
concentration	 (MIC)	 analysis	 was	 performed	 with	 eight	 S.	 aureus	 strains	 and	
increasing	 concentrations	 of	 copper	 sulfate	 (CuSO4).	 The	 growth	 of	 USA300	 was	
compared	 to	 other	 MRSA	 and	 MSSA	 S.	 aureus	 isolates:	 Mu50,	 RN6390,	 RN4220,	
Newman,	 SH1000,	 MW2,	 and	 MN8,	 strains	 that	 possess	 copAZ	 as	 the	 only	
characterized	copper	detoxification	system.	In	chemically	defined	minimal	medium,	
RPMI,	 I	observed	that	USA300	had	a	1-fold	greater	MIC	(2000	μM)	than	the	other	
seven	 S.	 aureus	 strains	 tested	 (MIC	 of	 1000	 μM)	 (Fig.	 3-3),	 suggesting	 that	 the	
additional	 putative	 copper	 efflux	 pump	 (CopB)	 and	 lipoprotein	 (CopL)	 may	 play	
additive	roles	in	copper	resistance.		
3.3.3 CopBL enhances copper resistance in S. aureus 
As	 I	 hypothesized	 that	 CopBL	 is	 directly	 responsible	 for	 USA300’s	 increased	
resistance	 to	 copper,	 I	 measured	 the	 MIC	 of	 isogenic	 USA300	 strains	 containing	
mutations	 to	 the	 copper	 detoxification	 proteins.	 All	 USA300	 experimental	 strains,	
WT,	 copAZ,	 copB,	 copL,	 copBL,	 and	 copAZB,	 plus	 complemented	 strains,	
copAZ+pCopAZ,	copBL+pCopBL,	copAZB+pCopAZ,	and	copAZB+pCopBL,	were	grown	
in	RPMI	with	increasing	concentrations	of	copper	sulfate	(CuSO4)	to	determine	MICs.	
Minimal	medium	was	used	for	all	MIC	growth	analysis,	as	growth	in	nutrient	rich		
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Fig.	 3-3.	 USA300	 has	 a	 higher	 copper	 MIC	 compared	 to	 other	 S.	 aureus	 isolates.	
Minimal	inhibitory	concentration	(MIC)	growth	analysis	with	copper	sulfate	(CuSO4)	
taken	24	h	post	 inoculation	showed	increased	resistance	of	USA300	strain	(MIC	of	
2000	μM)	compared	to	seven	other	S.	aureus	isolates	(MIC	of	1000	μM).	
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media,	tryptic	soy	broth	(TSB),	resulted	in	heightened	resistance	to	copper	with	MIC	
concentrations	greater	than	4	mM	for	all	strains	(data	not	shown).	In	RPMI,	mutants	
copAZ,	copL,	and	copBL	had	an	MIC	of	1000	μM,	a	1-fold	lower	MIC	than	that	of	WT	
and	the	copB	single	mutant	at	2000	μM	.	The	copAZB	mutant	had	a	4-fold	lower	MIC	
(125	μM)	compared	to	WT.	Mutations	were	complemented	by	providing	genes	back	
in	 trans	(Fig.	3-4A).	These	results	demonstrate	that	CopBL	 is	 important	 for	copper	
resistance,	but	 that	 it	 is	CopL,	and	not	CopB,	 that	provides	USA300	with	 increased	
resistance	to	copper.			
In	 addition	 to	 examining	 the	 ability	 of	USA300	 strains	 to	grow	 in	 the	 presence	 of	
copper,	I	wanted	to	explore	the	bactericidal	effects	of	copper.	A	kill	curve	analysis	was	
performed	with	 the	WT,	copAZB,	and	complemented	 strain,	copAZB+pCopAZ,	with	
increasing	 concentrations	 of	 copper.	 The	 CuSO4	 concentrations	 ranged	 from	 25-
400	μM,	 which	 correlated	 to	 the	 copper	 concentrations	 calculated	 within	 the	
phagosome	during	infection	(45).	I	observed	that	the	WT	and	complemented	strain	
had	 a	 slight	 reduction	 in	 survival	 at	 200	 and	400	 μM	CuSO4,	whereas	 the	copAZB	
mutant	displayed	reduced	survival	in	as	low	as	25	μM	with	no	detectable	viability	at	
concentrations	above	100	μM	CuSO4	(Fig.	3-4B).	These	results	demonstrate	an	acute	
copper	sensitivity	of	the	copAZB	mutant,	and	suggest	a	decreased	survival	inside	the	
phagosome.				
3.3.4 ACME-encoded CopBL complements copA mutation in RN6390  
To	determine	if	the	ACME-encoded	genes	copBL	could	be	utilized	by	other	S.	aureus	
strains,	an	MIC	was	performed	with	RN6390.	RN6390	is	a	MSSA	isolate	that	contains	
copAZ	 as	 the	 sole	 characterized	 copper	 detoxification	 pathway.	 As	 previously	
observed,	 the	CuSO4	MIC	of	WT	RN6390	 is	1000	μM,	1-fold	 lower	than	that	of	WT	
USA300	 (Fig.	 3-5).	 To	 my	 surprise,	 expressing	 copBL	 in	 trans	 in	 WT	 RN6390	
(WT+pCopBL)	did	not	confer	this	strain	with	greater	copper	resistance	compared	to	
RN6390	WT	alone.	This	may	be	due	to	additional	intrinsic	factors	used	by	USA300	to	
overcome	 copper	 toxicity	 that	 are	 not	 present	 in	 RN6390.	 copBL,	 however,	
complemented	the	copA	mutant	(MIC	of	62.5	μM)	to	a	growth	phenotype	the	same	as		
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Fig.	 3-4.	 CopBL	 confers	 resistance	 to	 copper	 toxicity	 in	 chemically	 defined,	metal-
chelated	media,	RPMI.	A.	USA300	background	strains	were	grown	in	RPMI	+	0.2	μM	
EDDHA	 for	 24	 h	 with	 increasing	 concentrations	 of	 copper	 sulfate	 (CuSO4)	 to	
determine	 the	 minimal	 inhibitory	 concentration	 (MIC).	 B.	 A	 kill	 curve	 assay	
performed	in	sterile	saline	with	increasing	concentrations	of	CuSO4		for	24	h	showed	
increased	sensitivity	of	the	copAZB	mutant	to	physiological	concentrations	of	copper.	
Statistics	were	performed	using	Student’s	unpaired	t-test;	*P	<	0.01.					
* 
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Fig	3-5.	ACME-encoded	copBL	complements	copA	mutation	in	RN6390.	MIC	growth	
analysis	 with	 copper	 (CuSO4)	 taken	 24	 h	 post	 inoculation	 showed	 decreased	
resistance	of	copA	mutant	(MIC	of	62.5	μM)	compared	to	WT.	This	phenotype	was	
complementable	when	either	copAZ	or	copBL	were	provided	in	trans.	The	addition	of	
copBL	in	WT	(WT+pCopBL)	did	not	increase	the	MIC	above	normal	WT.		
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WT	 (MIC	 of	 1000	 μM),	 establishing	 that	 RN6390	 can	 utilize	 CopBL	 in	 copper	
detoxification	in	lieu	of	CopAZ	(Fig.	3-5).		
3.3.5 Cop efflux pumps increase resistance to lead, cadmium, and silver  
Many	copper-translocating	ATPases	are	not	dedicated	copper	transporters	but	are	
able	to	secrete	additional	transition	metals	(46).	To	examine	CopA	and	CopB	efflux	
substrates,	MIC	 growth	 analyses	with	 five	 different	metals,	 cadmium,	 cobalt,	 lead,	
nickel,	 and	 silver,	were	 performed	with	 the	USA300	WT	 and	 copAZB	mutant.	Not	
surprisingly,	the	copAZB	mutant,	compared	to	WT,	had	a	slightly	increased	sensitivity	
to	lead,	consistent	with	what	has	been	previously	observed	with	the	copA	mutant	in	
SH1000	strain	(Fig.	3-6C;	47).	Sensitivity	to	lead	decreased	at	higher	concentrations	
due	to	precipitation	of	the	Pb(NO3)2	in	the	medium	after	24	h,	permitting	growth	of	
both	strains.			 
I	 also	 observed	 an	 increased	 sensitivity	 for	 copAZB	 strain	 with	 increasing	
concentrations	of	cadmium	and	silver.	For	growth	in	cadmium,	copAZB	had	an	MIC	of	
25	nM,	with	a	severe	reduction	in	growth	at	12.5	nM	CdCl2,	whereas	the	WT	MIC	was	
50	nM	(Fig.	3-6A).	Silver	MIC	for	copAZB	was	2000	nM,	1-fold	lower	than	that	of	WT	
which	had	reduced	but	detectable	growth	at	4000	nM	AgNO3	(Fig.	3-6E).	Previous 
work	observed	that	the	CopA	metal	binding	site	is	capable	of	binding	both	cadmium	
and	 silver	 in	 vitro	 (47),	 although	 no	 analysis	 had	 yet	 to	 show	 a	 role	 for	 CopA	 in	
cadmium	and	 silver	 detoxification	 during	 growth.	 Therefore,	 these	 results	 are	 the	
first	 to	 demonstrate	 that	 copAZ	 and	 copBL	 are	 needed	 for	 detoxification.	 Further	
investigation,	 however,	 is	 required	 to	 determine	 the	 role	 that	 each	 ATPase	 efflux	
pump	plays	individually,	and	their	ability	to	transport	heavy	metals	in	the	presence	
of	copper.	No	notable	differences	 in	sensitivity	between	strains	were	observed	for	
cobalt	and	nickel	(Fig.	3-6B,	D).	
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Fig.	3-6.	Cop	efflux	pumps	confer	increased	resistance	to	cadmium,	lead,	and	silver.	
WT	 (black	bars)	and	copAZB	double	mutant	 (clear	bars)	grown	 in	RPMI	+	0.2	μM	
EDDHA	with	 increasing	concentrations	of	cadmium	(CdCl2)	(A),	cobalt	(CoCl2)	 (B),	
lead	(Pb(NO3))	(C),	nickel	(NiCl2)	(D),	and	silver	(AgNO3)	(E),	24	h	post-inoculation.		
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3.3.6 Copper induces expression of cop genes 
Previous	work	showed	that	the	copAZ	genes	in	S.	aureus	were	regulated	in	response	
to	copper	via	the	transcriptional	repressor,	CsoR.	Real	time	quantitative	PCR	(qPCR)	
analysis	in	S.	aureus	strain	SH1000	showed	that,	in	the	presence	of	copper	salts,	copA	
expression	increased	roughly	6-fold;	furthermore,	studies	with	∆csoR	mutant	showed	
a	15-fold	induction	of	copA	suggesting	that	CsoR	is	a	key	repressor	in	copA	expression	
(15).	To	examine	if	copBL	was	also	induced	in	response	to	copper	via	CsoR,	qPCR	was	
performed	on	WT	USA300	grown	in	metal	deplete	(MD)	RPMI	with	the	addition	of	
50	μM	CuSO4	and	250	μM	CuSO4.	Similar	to	copAZ,	copB	and	copL	were	upregulated	
roughly	2.5-	to	7-fold	in	the	presence	of	50	μM	and	250	μM	CuSO4,	respectively	(Fig.	
3-7A).			
Previous	work	in	C.	glutamicum	demonstrated	that	copB	and	downstream	lipoprotein	
were	upregulated	in	response	to	zinc	(41),	and	showed	a	clear	cross-talk	occurring	
between	zinc	and	copper	for	multiple	cation-translocating	ATPases	in	Acinetobacter	
baumannii	(48).	Therefore,	to	assess	if	zinc	affected	the	expression	of	cop	genes,	WT	
USA300	was	also	 induced	with	5	μM	ZnCl2.	Unexpectedly,	copAZ	and	copBL	genes	
were	upregulated	10-	to	30-fold	in	the	presence	of	zinc	(Fig.	3-7A).	It	was	unclear,	
however,	whether	zinc	interacts	with	CsoR	directly	and	thereby	causes	depression	of	
genes	in	a	similar	mechanism	to	copper,	or	if	another	transcriptional	regulator	was	
involved.	Additionally,	qPCR	was	performed	on	a	csoR	mutant,	where	I	anticipated	
drastic	upregulation	of	the	cop	genes.	The	csoR	mutant	grown	in	TMS	in	the	absence	
of	 copper	or	 zinc	had	 increased	gene	expression	of	copA	and	copB,	 7	 and	18-fold,	
respectively,	compared	to	WT	(Fig.	3-7B).	This	data	suggests	that	both	loci,	copAZ	and	
copBL,	are	regulated	in	response	to	copper	via	the	CsoR	regulator.		
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Fig.	3-7.	cop	genes	are	upregulated	in	response	to	copper	and	zinc,	and	in	the	csoR	
mutant.	A.	qPCR	analysis	of	WT	USA300	grown	in	metal	deplete	(MD)	RPMI	to	early	
exponential	phase	and	then	either	kept	in	MD	media	or	induced	for	2	h	with	50	μM	
CuSO4,	250	μM	CuSO4,	or	5	μM	ZnCl2.	MD	gene	expression	is	arbitrarily	set	to	1	and	
gene	expression	of	WT	grown	in	copper	or	zinc	is	in	relation	to	MD.	B.	qPCR	analysis	
of	WT	and	csoR	mutant	grown	in	MD	media.	Gene	expression	of	WT	is	arbitrarily	set	
to	 1	 where	 gene	 expression	 of	 csoR	 strain	 is	 in	 relation	 to	 WT.	 Statistics	 were	
performed	using	multiple	Student’s	t-test,	*P	£	0.05;	for	all	samples	significance	was	
determined	in	relation	to	the	WT	gene	expression.		
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	3.3.7 CsoR binds the promoter of copAZ and copBL operons 
To	further	explore	CsoR-regulation	of	copBL,	DNA	binding	assays	were	performed	to	
determine	 if	CsoR	regulation	of	cop	genes	was	through	direct	binding	to	promoter	
regions.	Using	nickel-affinity	chromatography,	recombinant	(His6)-CsoR	was	purified	
and	stored	in	4	mM	EDDHA	to	chelate	excess	metal	ions.	Identified	upstream	of	the	
copZ	 locus	 in	B.	subtilis	was	25	bp	DNA-binding	sequence	 for	CsoR	(49,	50),	and	a	
similar	 CsoR-binding	 sequence	was	 identified	 in	 S.	 aureus	upstream	 of	 the	 copAZ	
operon	(15).	Upstream	of	copBL	I	pinpointed	a	similar	25	bp	sequence	that	I	predicted	
to	be	the	DNA-binding	site	of	CsoR	(Fig.	3-8C).	Therefore,	for	the	DNA-binding	assays,	
I	 designed	 120	 bp	 oligonucleotide	 fragments	 upstream	 of	 copAZ	 and	 copBL	 that	
encompassed	the	predicted	CsoR	binding	sites	(primers	listed	in	Table	3-1).			
Recombinant	apo-CsoR	was	 incubated	with	 the	promoter	 sequences	of	copAZ	and	
copBL	 operons	 and	 binding	 was	 observed	 through	 electrophoretic	 mobility	 shift	
assays	(EMSA).	I	observed	that	CsoR	bound	to	both	the	copAZ	and	copBL	promoters;	
furthermore,	DNA-binding	was	abrogated	 in	the	presence	of	copper	 in	a	2:1	molar	
equivalence	of	copper	to	protein.	Binding	was	unaffected	in	response	to	zinc	at	a	2:1	
molar	equivalence	of	zinc	to	CsoR	(Fig.	3-8A,B).	These	data	suggest	that	CsoR	binds	
DNA	directly	upstream	of	cop	genes	and	that	this	regulation	is	responsive	to	copper.	
The	drastic	upregulation	of	the	cop	genes	in	response	to	zinc	observed	through	qPCR	
(Fig.	3-8A);	however,	is	mostly	likely	not	due	to	the	derepression	of	CsoR,	but	perhaps	
through	activation	by	an	alternative	regulatory	element.	
	3.3.8 The copAZB mutant has attenuated growth in murine macrophages 
Copper-detoxification	 systems	 are	 critical	 for	 the	 intracellular	 survival	 of	 many	
pathogens;	 this	 is	 due	 to	 the	 import	 of	 free	 copper	 into	 the	 phagosome	 through	
ATPase	copper	transporter,	ATP7A,	localized	on	the	phagosomal	membrane	(7,	9,	11).	
To	evaluate	whether	S.	aureus	experiences	copper	toxicity	within	the	phagosome	and	
thus	requires	copper	efflux	for	survival,	infections	were	performed	with	WT	and	the	
cop	mutants	in	murine	macrophage	cell	line,	RAW264.7.	Results	showed	that	WT	had	
a	significantly	greater	fold	increase	in	CFUs	from	the	1.5	h	to	10	h	time-point	versus		
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Fig.	3-8.	CsoR	binds	to	copA	and	copB	promoter	regions.	A,B.	Electrophoretic	mobility	
shift	 assay	 (EMSA)	with	100	ng	of	120	bp	DNA	 fragment	and	 recombinant	 (His6)-
CsoR.	DNA	was	visualized	using	ethidium	bromide	stain.	Lanes:	1,	DNA	alone;	2,	2	μM	
apo-CsoR;	3,	3	μM	apo-CsoR;	4,	3	μM	CsoR	+	6	μM	CuSO4;	5,	3	μM	CsoR	+	6	μM	ZnCl2.	
C.	Sequence	alignment	of	predicted	CsoR	binding	region	in	S.	aureus	copB	promoter	
(Sa	copB)	to	the	identified	CsoR	binding	sites	in	copZ	promoter	of	B.	subtilis	(Bs	copZ)	
and	S.	aureus	copA	promoter	(Sa	copA).		
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	the	copAZB	mutant.	The	growth	phenotype	of	the	copAZB	stain	was	complemented	
by	providing	copAZ	in	trans	(copAZB+pCopAZ)	(Fig.	3-9A).	The	single	mutants,	copAZ	
and	copBL,	had	a	similar	fold	change	in	CFU	to	WT	(Fig.	3-9A).	These	results	showed	
that	USA300	relies	on	copper	efflux	in	the	phagosome,	and	that	either	copAZ	or	copBL	
are	necessary	for	fitness	inside	the	macrophage.			
I	predicted	that	the	growth	phenotype	of	the	copAZB	mutant	was	due	to	copper	efflux	
into	the	phagosome	mediated	by	the	copper	transporter,	ATP7A.	Thus,	to	determine	
the	 role	 ATP7A	 plays	 in	 S.	 aureus	 intracellular	 survival,	 I	 performed	 infections	 in	
ATP7A-deficient	macrophages.	Unexpectedly,	the	copAZB	strain	still	had	a	lower	fold	
change	 in	 CFUs	 compared	 to	 the	 WT	 (Fig.	 3-9B),	 and	 furthermore,	 the	 growth	
phenotype	of	all	strains	in	ΔATP7A	RAW264.7	was	similar	to	what	was	observed	in	
WT	RAW264.7.	This	suggested	that	factors	in	the	phagosome	are	responsible	for	the	
copAZB	growth	defect	inside	the	macrophage.		
3.4 Discussion 
USA300	 is	 the	 predominant	 CA-MRSA	 worldwide	 and	 is	 the	 causative	 agent	 of	
moderate	to	severe	infections	in	humans	(51).	Unique	to	USA300	is	the	presence	of	
the	ACME	cassette,	 for	which	 its	 exact	 role	 in	USA300	virulence	 is	poorly	defined.	
Encoded	within	the	ACME	cassette,	I	identified	a	putative	copper	efflux	pump,	named	
copB,	and	a	downstream	lipoprotein	of	unknown	function,	designated	copL.	Due	to	its	
high	 redox	 potential,	 copper	 homeostasis	 is	 critical	 to	 survival	 of	 pathogens,	
especially	 in	 an	 intracellular	 context	 as	 macrophages	 utilize	 copper	 as	 an	
antimicrobial	agent	inside	the	phagosome	(52,	53).	S.	aureus	is	capable	of	flourishing	
inside	the	macrophage	(12),	although	the	mechanisms	behind	this	survival	have	not	
been	fully	characterized.	Thus,	this	study	set	out	to	determine	if	the	additional	copper	
detoxification	 mechanisms	 on	 the	 ACME	 cassette	 conferred	 USA300	 with	 greater	
resistance	 to	 copper,	 and	 if	 copper	 efflux	 plays	 a	 role	 in	 S.	 aureus	 intracellular	
survival.		
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Fig.	3-9.	cop	genes	are	important	for	intracellular	survival	in	murine	macrophages.	
A,B.	Gentamicin	protection	assays	with	RAW264.7	WT	(A)	and	ΔATP7A	(B)	murine	
macrophages	infected	with	USA300	strains.	Dotted	line	represents	CFU	enumeration	
1.5	 h	 post-infection	 (normalized	 to	 log	 1),	 where	 data	 points	 represent	 the	 fold	
change	in	CFU	from	1.5	h.	Statistics	were	performed	using	Student’s	t-test;*P	≤	0.01.	
+pCopAZ	 is	 background	 copAZB	 strain	 containing	 the	 complementing	 vector,	
pALC2073-pCopAZ.		
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In	this	study,	I	demonstrated	that	the	copBL	locus,	in	concert	with	copAZ,	contributed	
to	 copper	 detoxification	 in	 vitro	 using	 MIC	 analysis	 with	 copper	 sulfate.	 This	
contribution,	 however,	was	 largely	due	 to	 the	 copper-regulated	 lipoprotein,	 CopL,	
and	not	the	efflux	pump,	CopB.	The	necessity	of	CopL	in	copper	detoxification	was	
unexpected	as	it	has	no	clear	mechanistic	role	in	copper	efflux.	CopL	homologs	have	
been	 observed	 in	 other	 species,	 namely	 C.	 glutamicum,	Macrococcus	 caseolyticus,	
Listeria	monocytogenes,	and	E.	faecalis,	where	it	is	also	encoded	in	the	same	locus	as	
copB	(41).	Its	role	in	these	species	in	connection	to	heavy	metal	toxicity,	however,	is	
unresolved.	I	theorize	that	CopL	may	decorate	the	cell	surface	with	copper	binding	
activity	and,	thus,	protect	against	the	influx	of	copper.		
Through	qPCR	and	EMSAs,	I	showed	that	both	cop	loci	were	regulated	in	response	to	
copper	 via	 CsoR.	 Since	 its	 initial	 discovery	 in	 M.	 tuberculosis,	 CsoR	 has	 been	
characterized	 in	 many	 other	 bacterial	 species	 as	 a	 copper-responsive,	 one-
component	regulator	of	copper	detoxification	pathways	(14,	54).	 Interestingly,	 the	
cop	genes	were	also	 regulated	 in	 response	 to	zinc.	EMSAs	clearly	showed	 that	 the	
copper-dependent	regulation	was	through	CsoR	binding	to	the	promoter	regions	of	
copAZ	and	copBL	operons,	where	CsoR	binding	to	copper	abrogated	its	DNA-binding	
ability.	It	is	unclear	if	CsoR	is	able	to	interact	with	zinc	directly,	or	if	a	different	zinc-
responsive	 transcriptional	 regulator	 is	 involved.	 Binding	 of	 zinc	 by	 copper-
detoxification	 regulators	 has	 been	 previously	 characterized,	 including	 CsoR	 in	 C.	
glutamicum,	and	CopY	in	E.	hirae	(41,	55).	Therefore,	the	possible	role	of	the	cop	genes	
in	 zinc	 detoxification	 requires	 further	 investigation,	 in	 particular	 inside	 the	
phagosome.	
This	 is	 the	 first	study	to	demonstrate	that	copper	detoxification	pathways	aid	 in	S.	
aureus	survival	inside	the	macrophage.	I	show	that	both	copAZ,	in	concert	with	copBL,	
contribute	 to	 S.	 aureus	 survival	 in	 the	 phagosome,	 as	 a	 strain	 deficient	 in	 both	
pathways	(copAZB	mutant)	had	a	significant	reduction	in	recoverable	CFUs	in	murine	
macrophage	cell	 line,	RAW264.7.	The	 importance	of	copper	detoxification	systems	
has	been	shown	in	other	pathogens,	such	as	M.	tuberculosis,	E.	coli,	and	S	enterica	sv.	
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Typhimurium	where	deletion	of	copper-resistance	pathways	resulted	in	attenuation	
of	 growth	 inside	 the	 macrophage	 (7,	 56,	 57).	 In	 these	 studies,	 the	 attenuated	
phenotype	of	 the	 copper	detoxification	mutants	 could	be	 restored	 to	WT	 levels	 in	
macrophages	lacking	ATP7A.	This	was	anticipated,	as	the	ability	of	macrophages	to	
transport	copper	into	the	phagosome	is	largely	dependent	on	this	copper	transporter	
localized	to	the	phagosomal	membrane	(7,	56–58).		
Unexpectedly,	 the	 copAZB	 mutant	 phenotype	 in	 murine	 macrophages	 was	 not	
restored	 to	 WT	 levels	 but	 was	 still	 attenuated	 in	 an	 ΔATP7A	 deficient	 line	 of	
RAW264.7.	 This	 suggested	 that	 the	 growth	 defect	 in	 the	 phagosome	was	 not	 due	
solely	to	copper	toxicity,	but	perhaps	due	to	toxicity	of	some	other	molecule	or	metal	
inside	the	phagosome.	Although	there	is	a	plethora	of	antimicrobial	effectors	present	
in	the	phagosome,	the	copAZB	mutant	phenotype	may	be	linked	to	zinc	toxicity.	As	
mentioned,	 I	 demonstrate	 that	 all	 four	 genes,	 copAZ	 and	 copBL	 are	 regulated	 in	
response	 to	 both	 copper	 and	 zinc,	 suggesting	 cross-talk	 between	 copper	 and	 zinc	
homeostasis	 in	 S.	 aureus.	 Additionally,	 like	 copper,	 macrophages	 utilize	 the	
antimicrobial	properties	of	 zinc	 to	kill	 engulfed	pathogens	 in	 the	phagosome.	Zinc	
accumulation	in	the	phagosome	was	observed	in	murine	macrophages	infected	with	
Mycobacterium	avium	in	response	to	pro-inflammatory	cytokines	TNFα	and	IFNγ,	and	
also	 in	 phagosomes	 containing	Mycobacterium	 tuberculosis	 (59,	 60).	 Furthermore,	
Mtb	zinc	efflux	pump,	CtpC,	was	induced	inside	the	macrophage	(60),	and	the	ZntA	
zinc	exporter	in	E.	coli	was	essential	for	optimal	resistance	to	bacterial	killing	inside	
the	macrophage,	suggesting	a	high	zinc	environment	inside	the	phagosome	(61,	62).		
Although	 not	 fully	 characterized,	 zinc	 transport	 in	 mammalian	 cells	 is	 facilitated	
through	ZnT-	or	ZIP-family	transporters,	and	is	independent	of	ATP7A	(62).	Although	
zinc	is	generally	regarded	as	less	toxic	than	copper,	it	may	exert	bactericidal	activity	
by	 functioning	as	a	metal	 antagonist	 in	 the	 cell.	 Such	 is	 the	 case	 in	S.	pneumoniae,	
where	 zinc	 is	 shown	 to	 irreversibly	 bind	 to	 the	 extracellular	 manganese	 binding	
protein,		PsaA,		preventing	Mn2+	transport			(63,	64).			Whether	or	not		zinc	is	a	
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Fig.	3-10.	Schematic	of	copper	transport	in	macrophages	and	the	S.	aureus	USA300	
copper,	and	potentially,	zinc	detoxification	mechanisms	during	intracellular	growth	
in	the	phagosome.	Copper	is	shuttled	from	the	serum	by	CTR1	and	shuttled	by	copper	
chaperone	 ATOX1	 to	 ATPase	 transporter,	 ATP7A,	 on	 the	 phagosomal	 membrane.	
ATP7A	 effluxes	 copper	 into	 the	 phagosome	 containing	USA300.	 USA300	 combats	
copper	toxicity	by	potentially	binding	free	copper	outside	of	the	cell	by	lipoprotein	
CopL,	or	effluxing	copper	from	the	cytoplasm	through	ATPases	CopA	and	CopB.	Zinc	
effluxed	into	the	phagosome	may	be	bound	on	the	cell	surface	by	CopL,	or	be	taken	
up	by	S.	aureus,	and	in	a	manner	similar	to	copper,	removed	from	the	cytoplasm	by	
CopA	and	CopB	efflux	pumps.						
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contributing	factor	to	S.	aureus	survival	in	the	phagosome	is	an	interesting	aspect	that	
warrants	further	investigation	(Fig.	3-10).		
As	the	contribution	of	the	iron-regulated	lipoprotein,	CopL,	to	copper	resistance	was	
a	 novel	 discovery,	 future	 work	 will	 focus	 on	 examining	 the	 properties	 of	 this	
lipoprotein	and	its	metal-binding	capabilities.	CopL	is	most	likely	capable	of	binding	
to	copper,	and	perhaps	zinc,	at	the	surface	of	the	cell.	The	USA300	Latin-American	
Variant	 (USA300-LV),	 as	well	 as	a	human	MRSA	 isolate	 from	West	Australia,	both	
encode	 copB	and	 additionally	 the	 downstream	 copL,	 yet	 do	 not	 contain	 any	 other	
genes	from	the	ACME	cassette.	Thus,	the	retention	of	both	copB,	and	perhaps	more	
importantly,	copL,	in	these	strains	suggests	that	this	locus	may	play	important	role	in	
virulence	in	animal	models	of	infection	(42,	65,	66).	In	collaboration	with	Paul	Planet,	
I	plan	to	look	at	the	contribution	of	the	cop	genes	in	vivo	in	murine	infection	models.	
Of	particular	interest	is	the	role	of	the	ACME	encoded	copBL	genes	in	virulence.					
In	this	study,	I	show	that	ACME	encoded	CopBL	functions	additively	with	CopAZ	to	
combat	copper	overload	in	vitro,	and	thus	provides	USA300	with	increased	resistance	
to	copper	compared	to	other	S.	aureus	isolates.	This	work	thus	shows	greater	insight	
into	the	role	of	ACME	cassette	in	USA300	virulence.	In	addition,	I	am		the	first	to	report	
a	 role	 for	 the	 cop-encoded,	 copper-detoxification	 systems	 in	S.	 aureus	phagosome	
survival.	This	finding	demonstrates	that	copper-translocating	ATPases,	and	copper-
responsive	 lipoprotein,	 are	 key	 virulence	 factors	 in	 intracellular	 survival,	 and,	
furthermore,	may	confer	USA300	with	greater	resistance	inside	the	phagosome.	The	
ability	of	microbes	to	remove	excess	copper	is	important	for	virulence	and	is	a	key	
characteristic	of	professional	pathogens	 (7,	10,	11).	Thus,	 this	work	highlights	 the	
adaptability	of	the	human	pathogen	S.	aureus	to	overcome	defenses	posed	by	the	host,	
and	sheds	light	on	the	enhanced	virulence	of	the	epidemic	CA-MRSA	USA300	strain.	 
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Chapter 4 
4 General Discussion 
4.1 Characterizing the heme-responsive regulator SbnI 
The	ability	of	S.	aureus	to	adapt	to	such	different	environmental	niches	is	undoubtedly	
due,	 in	 part,	 to	 its	 profound	 capacity	 to	 acquire	 essential	 nutrients	 such	 as	 iron.	
S.	aureus	 produces	 two	 siderophores,	 staphyloferrin	 A	 and	 staphyloferrin	 B,	 that	
function	to	acquire	free	ferric	iron	or	remove	ferric	iron	from	human	glycoproteins.	
In	 this	 study,	 I	 characterize	 the	 regulation	 of	 SB	 biosynthesis.	 The	 biosynthetic	
enzymes	 for	SB	are	encoded	on	the	sbn	operon,	which	encodes	nine	genes,	sbnA-I.	
Prior	 to	 this	 study,	 the	 biological	 function	 of	 only	 the	 first	 8	 genes	 had	 been	
characterized:	sbnA,	sbnB,	sbnC,	sbnE,	sbnF,	sbnG,	and	sbnH	all	encode	for	biosynthetic	
enzymes,	 and	 sbnD	encodes	 the	 SB-specific	 transporter	 (1–3).	 The	 function	of	 the	
terminal	gene	in	this	operon,	sbnI,	was	previously	unknown,	and	although	appearing	
to	 have	 no	 biosynthetic	 enzymatic	 function,	 was	 highly	 conserved	 among	
Staphylococcal	 strains	 that	 possessed	 the	 sbn	operon.	 Therefore,	 the	 foundational	
question	of	this	study	was	to	elucidate	the	role	of	SbnI.						
4.1.2 Regulation of the sbn operon by SbnI 
In	this	work,	I	discovered	that	SbnI	is	a	transcriptional	regulator	of	the	sbn	operon.	
Growth	kinetic	assays	showed	that	the	sbnI	mutant	was	unable	to	grow	in	medium	
where	 SB	 was	 required	 for	 iron	 acquisition.	Moreover,	 disc	 diffusion	 assays	 that	
examined	 siderophore	 profiles	 revealed	 that	 at	 12	 hours	 post-infection	 the	 sbnI	
mutant	had	no	detectable	 levels	of	 SB,	 in	 contrast	 to	WT.	The	 inability	of	 the	 sbnI	
mutant	to	produce	SB	to	the	same	levels	as	WT	was	explained	through	qPCR	analysis,	
where	 I	 determined	 that	 SbnI	 significantly	 affected	 the	 expression	 of	 genes	
downstream	and	 including	sbnD.	Using	multiple	biochemical	assays,	namely	RACE,	
luciferase	assays,	and	EMSAs,	I	discovered	a	promoter	region	located	just	upstream	
of	sbnD	that	contained	a	SbnI	binding	site.	This	finding	suggested	that	SbnI	specifically	
regulated	the	efflux	pump,	SbnD,	and	enzymes	in	the	final	steps	of	SB	synthesis.		
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Directed	regulation	of	efflux	pumps	has	been	observed	in	the	biosynthesis	of	other	
molecules,	 particularly	 in	 the	 case	 of	 antibiotics	 where	 high	 intracellular	
concentrations	would	be	detrimental	to	the	cell	(4,	5).	In	Streptomyces	coelicolor	the	
antibiotic,	actinorhodin,	is	regulated	by	a	positive	feedback	loop.	The	efflux	pump	of	
actinorhodin,	ActA,	and	downstream	gene	that	encodes	the	final	biosynthetic	enzyme	
in	 the	 actinorhodin	 synthesis	 pathway,	 ActII-ORF3,	 are	 regulated	 by	ActR.	 ActR,	 a	
TetR-like	regulator,	binds	to	an	intermediate	precursor	to	initiate	expression	of	ActA	
and	ActII-ORF3;	 thus	production	of	complete	actinorhodin	 is	coordinated	with	the	
expression	of	 the	efflux	pump	and	final	biosynthetic	enzyme	to	avoid	 intracellular	
accumulation	of	the	active	form	of	the	antibiotic	(6,	7).	Other	examples	include	the	
secretion	and	final	biosynthetic	steps	of	gougerotin	in	Streptomyces	graminearus	(8),	
simocyclinone	 D8	 in	 Streptomyces	 antibioticus	 (9),	 the	 phenazine	 pyocyanin	 in	
Pseudomonas	 aeruginosa	 (10),	 and	 intracellular	 metabolites,	 like	 indole,	 in	 Vibrio	
cholerae	 (11).	SB	 is	 a	 high-affinity	 iron	 chelator	 and	 intracellular	 accumulation	 of	
functional	 siderophore	 would	 be	 detrimental	 to	 cell	 physiology	 (12–14).	 Thus,	 I	
speculate	that	the	product	of	SbnA	and	SbnB,	L-DAP,	may	serve	as	a	binding	partner	
to	 SbnI	 to	 signal	 upregulation	 of	 the	 efflux	 pump,	 SbnD,	 thereby	 preventing	
accumulation	of	 SB	 inside	 the	 cytoplasm	and	deleterious	 chelation	of	 intracellular	
iron.			
 4.1.3 The role of heme in SbnI-mediated regulation 
Additionally,	 I	 discovered	 that	 SbnI	 regulated	 expression	 of	 the	 sbn	 operon	 in	
response	to	heme.	SbnI	interacts	with	heme	via	binding	to	the	coordinating	ferric	iron	
through	an	unidentified	histidine	residue.	Binding	to	heme	abrogates	the	ability	of	
SbnI	to	interact	with	nucleic	acid,	possibly	by	preventing	tetrameric	oligomerization	
of	the	protein.	This	finding	has	striking	similarity	to	the	iron	response	regulator	(Irr)	
of	Bradyrhizobium	spp.	Irr	is	a	member	of	the	Fur	superfamily	and,	like	SbnI,	is	active	
in	iron-deplete	conditions,	capable	of	interacting	with	heme	and,	when	complexed	to	
heme,	loses	DNA-binding	capacity	(15,	16).	Irr	in	B.	japonicum	interacts	with	heme	
through	 an	 HxH	motif	 (15)	 and,	 thus,	 a	 putative	 HxH	motif	 in	 tandem	 at	 the	 N-
terminus	of	SbnI,	sequence	3HIHEH7,	led	me	to	propose	that	SbnI-heme	interaction	
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may	 occur	 through	 the	 same	motif	 as	 Irr.	 Site	 directed	 mutagenesis	 of	 SbnI	 that	
converted	 histidines	 to	 alanines,	 generating	 the	 sequence	 3AIAEA7,	 demonstrated	
that	even	in	the	absence	of	this	motif,	SbnI	could	still	bind	heme.	Thus,	a	binding	motif	
different	than	that	utilized	by	Irr	is	responsible	for	heme	binding.	
S.	aureus	grown	in	the	presence	of	heme	had	reduced	secretion	of	SB	similar	to	what	
I	 observed	 with	 the	 sbnI	mutant	 under	 normal	 growth	 conditions.	 This	 finding	
strongly	suggested	that	SbnI	was	not	active	when	the	cells	were	grown	in	heme,	and	
indicated	that	SbnI	is	a	regulatory	switch	for	iron	acquisition.	Therefore	under	iron	
(and	 heme)	 deplete	 conditions,	 SbnI	 binds	 within	 the	 sbn	 operon,	 leading	 to	
upregulation	of	genes	sbnD-I	and	enhanced	SB	synthesis.	 In	 the	presence	of	heme,	
perhaps	 transported	by	 the	 Isd	 system,	SbnI	binds	 to	heme,	preventing	SbnI	 from	
binding	to	nucleic	acid,	resulting	in	decreased	SB	synthesis	(Fig.	4-1).			
An	 aspect	 of	 iron	metabolism	 that	 is	 not	 directly	 examined	 in	 this	 study,	 but	 has	
important	implications	in	iron	utilization,	is	the	biosynthesis	of	heme.	Like	iron,	heme	
is	 essential	 for	 proteins	 involved	 in	 oxidative	 respiration,	 and	 thus	 S.	 aureus	
endogenously	produces	its	own	heme	through	a	series	of	enzymes	encoded	by	hem	
genes	(17,	18).	Also	 like	 iron,	heme	is	 toxic	 to	 the	cell	at	high	concentrations	as	 it	
causes	 production	 of	 ROS.	 Therefore,	 in	 addition	 to	 binding	 exogenous	 heme	
imported	through	the	Isd	system,	SbnI	may	bind	to	excess	amounts	of	cytoplasmic,	
endogenously	synthesized,	heme.	This	may	play	a	role	in	reducing	intracellular	ROS,	
where	SbnI	may	bind	to	endogenously	produced	heme	to	both	sequester	excess	free	
heme	found	in	the	cytoplasm	and	reduce	SB-mediated	iron	uptake	to	limit	excess	iron	
inside	the	cell.			
4.1.4 Future directions   
Oligomerization	studies	of	purified	SbnI	demonstrated	that	it	forms	higher	molecular	
weight	structures,	namely	tetramers	or	dimer	of	dimers.	SbnI	has	low	homology	to	
ParB	and	Spo0J	 transcriptional	 regulators,	which	also	 form	high	molecular	weight	
oligomers.	Indeed,	a	distinctive	feature	of	ParB	homologs	is	their	ability	to	form	large	
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Fig.	 4-1.	 Proposed	 schematic	 of	 SbnI-mediated	 regulation	 of	 SB	 synthesis.	 During	
growth	 in	heme-deplete,	 iron-poor	environments,	 SbnI	 is	 “active”	and	upregulates	
transcription	of	the	sbn	operon,	specifically	efflux	pump	SbnD,	and	downstream	genes	
(sbnD-I).	When	heme	is	present	 in	 the	environment,	heme	is	 taken	up,	most	 likely	
through	the	Isd	pathway,	and	once	 in	 the	cytoplasm	is	bound	by	SbnI	rendering	 it	
“inactive”.	Bound	to	heme,	SbnI	does	not	upregulate	genes	in	the	sbn	operon,	resulting	
in	decreased	SB	secretion.		
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nucleoprotein	 complexes	 that	 can	 consist	 of	 >20	 dimers	 that	 loop	 and	 bridge	 large	
segments	of	DNA,	referred	to	as	ParB	spreading	(19,	20).	Techniques	such	as	protein-
induced	fluorescence	enhancement	(PIFE),	have	been	previously	used	to	examine	DNA-
binding	by	ParB	proteins.	 In	brief,	 this	 technique	 immobilizes	cyanine	3	(Cy3)	labeled	
DNA	in	a	microfluidic	 flow	cell	and	measures	the	 fluorescence	of	Cy3	with	addition	of	
ParB,	where	fluorescence	is	enhanced	with	each	DNA	and	protein	interaction	(20,	21).	
The	power	of	this	technique	is	that	it	does	not	require	any	modification	of	the	protein,	
can	be	used	for	both	DNA	and	RNA,	and	measures	both	binding	of	protein	to	DNA	and	
formation	of	DNA	secondary	structures,	such	as	looping	(21).	In	the	case	of	SbnI,	I	would	
be	interested	to	determine	if	there	are	additional	SbnI	binding	sites	on	the	sbn	operon,	
using	the	entire	operon	fragment	as	the	binding	template,	and	additionally	determine	if	
SbnI	conforms	the	DNA.	These	binding	experiments	could	be	done	in	the	presence	of	L-
DAP,	a	pathway	intermediate	in	SB	synthesis,	or	in	the	presence	of	heme,	where	I	have	
already	observed	changes	to	SbnI	oligomerization.				
Further	experiments	are	needed	to	identify	the	residues	in	SbnI	that	are	responsible	for	
heme	binding.	Magnetic	circular	dichroism	elucidated	that	SbnI	bound	to	heme	through	
a	histidine	residue.	In	addition	to	S.	aureus,	I	have	looked	at	SbnI	in	a	different	species,	
Staphylococcus	 pseudintermedius,	 a	 coagulase-positive	 staphylococci	 that	 is	 known	 to	
cause	severe	skin	infections	in	domesticated	animals	(22).	SbnI	from	S.	pseudintermedius	
is	 also	 capable	 of	 binding	heme,	 as	 determined	 through	UV-vis	heme	 titration	 assays	
(work	 unpublished).	 SbnI	 sequence	 alignment	 of	 S.	 aureus	 and	 S.	 pseudintermedius	
showed	a	69%	sequence	similarity,	and	four	conserved	histidines,	H19,	H42,	H61,	and	
H91.	Listed	in	Table	4-1	are	12	additional	Staphylococcal	species	that	contain	SbnI.	SbnI	
in	each	species	contains	the	same	4	conserved	histidine	residues.	Therefore,	future	work	
will	begin	by	mutating	H19,	H42,	H61,	and	H91	to	alanines	and	testing	for	heme-binding	
both	in	vitro	with	purified	protein,	and	inside	the	cell,	by	expressing	the	mutated	SbnI	
protein	on	 a	 plasmid	 in	 the	 sbnI	mutant,	 and	 then	 looking	 at	 SB	 production	 via	 disc-
diffusion	assays.						
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Table	4-1.	Sequence	alignment	of	SbnI	from	twelve	staphylococcal	species	aligned	to	SbnI	
from	S.	aureus.	
Species	 Identity	(%)a	 Similarity	(%)a	 e-value	
Coagulase	Positive	 	 	 	
S.	agnetis	b	 66	 75	 2e-125	
S.	argenteus	 98	 98	 0.0	
S.	delphini	 61	 70	 1e-114	
S.	EGD-HP3	 63	 75	 3e-120	
S.	HGB0015	 64	 74	 2e-124	
S.	hyicus	 66	 75	 3e-125	
S.	intermedius	 60	 69	 1e-113	
S.	OJ82	 65	 78	 1e-128	
S.	pseudintermedius	 60	 69	 1e-113	
Coagulase	Negative	 	 	 	
S.	arlettae	 63	 75	 1e-120	
S.	equorum	 65	 78	 2e-127	
S.	schleiferi	 64	 74	 2e-123	
a. Representative	of	overall	identity	or	similarity	across	the	entirety	of	the	protein.		
b. Coagulase-variable	staphylococci.	
	
Additionally,	I	demonstrated	that	the	sbnI	mutant	had	increased	sensitivity	to	reactive	
oxygen	species	(ROS).	This	finding	corroborated	with	previous	work	that	showed	that	a	
S.	aureus	sirA	mutant	(a	strain	incapable	of	SB	uptake)	was	more	sensitive	to	oxidative	
stress	 than	WT,	 although	 the	 reason	 for	 this	was	 not	 characterized	 (23).	Therefore,	 I	
propose	that	SB	works	to	either	chelate	intracellular	iron,	thereby	reducing	intracellular	
Fenton	chemistry,	or	carries	iron	to	enzymes	involved	in	the	oxidative	stress	response.	
Future	 work	 on	 this	 finding	 is	 to	 see	 if	 the	 sbnI	mutant	 has	 decreased	 survival	 in	
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neutrophils	 compared	 to	 WT,	 due	 to	 the	 heightened	 oxidative	 burst	 utilized	 by	
neutrophils	in	bacterial	clearance.			
4.1.5 Significance of this study 
The	regulatory	model	of	SB	synthesis,	mediated	by	the	DNA-	and	heme-binding	protein	
SbnI,	 is	 the	 first	 characterized	 system	 in	 bacteria	 to	 demonstrate	 a	 regulatory	 link	
between	siderophore-mediated	iron	acquisition	and	heme	uptake.	The	importance	of	SB	
in	 vivo	 has	 previously	 been	 demonstrated,	 where	 an	 sbnE	mutant	 had	 a	 significant	
reduction	 in	CFUs	 in	a	murine	kidney	abscess	model	of	 infection	(24).	Therefore,	as	a	
regulator	of	the	sbn	operon,	SbnI	is	a	key	virulence	factor	that	may	play	a	critical	role	in	
bacteremia	 model	 of	 infection.	 The	 discovery	 of	 SbnI	 also	 explains	 why	 heme	 is	 the	
preferred	iron	source	of	S.	aureus	(25),	where	I	demonstrate	that	siderophore-mediated	
uptake	is	turned	off	in	response	to	heme.		
4.2 The role of copper detoxification systems in S. aureus 
Unlike	iron	that	is	actively	sequestered	away	from	invading	pathogens,	copper	is	found	
at	 the	 host-pathogen	 interface	 in	 excess.	 Cells	 of	 the	 innate	 immunity,	 namely	
macrophages,	transport	copper	into	bacteria-containing	phagosomes	through	the	efflux	
pump	 ATP7A	 (26).	 Excess	 copper	 in	 the	 phagosome	 causes	 membrane	 damage	 to	
bacteria	and	forms	ROS,	resulting	in	damage	to	lipids,	nucleic	acids,	and	proteins	(27).	
S.	aureus	 is	 capable	 of	 flourishing	 inside	 macrophages;	 however,	 the	 mechanisms	
involved	 in	 this	 process	 have	 not	 been	 fully	 delineated	 (28).	 All	 sequenced	 S.	 aureus	
strains	encode	for	a	copper	efflux	ATPase,	copA,	and	on	the	same	operon	a	cytoplasmic	
copper	 chaperone,	 copZ	 (29).	 CopA	 has	 been	 shown	 to	 be	 critical	 for	 copper	
detoxification	in	vitro;	however,	prior	to	this	study,	its	role	in	the	context	of	intracellular	
survival	in	the	phagosome	had	previously	not	been	investigated.		
CA-MRSA	 strain	 USA300	 carries	 the	 ACME	 cassette,	 which	 is	 thought	 to	 confer	
heightened	virulence	to	this	strain.	On	the	ACME	cassette	is	encoded	a	putative	copper	
efflux	pump,	herein	named	copB,	and	downstream	lipoprotein,	designated	copL.	Prior	to	
this	 study,	 the	 roles	 of	 these	 genes	 in	 heavy	 metal	 detoxification	 were	 unknown.	
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Therefore,	the	goals	of	this	study	were	to	determine	i)	the	function	of	the	putative	copper	
detoxification	genes	on	the	ACME	cassette	and	their	role	in	USA300	copper	resistance,	
and	ii)	if	copper	detoxification	mechanisms	are	required	for	intracellular	survival	of	S.	
aureus	inside	the	macrophage.						
4.2.1 The contribution of copBL in copper resistance 
Through	MIC	growth	analysis,	I	demonstrate	that	CopB	and	CopL	are	involved	in	copper	
resistance.	USA300	had	a	one-fold	higher	copper	MIC	(MIC	of	2	mM)	compared	to	seven	
other	MRSA	and	MSSA	S.	aureus	strains	(MIC	of	1	mM).	Furthermore,	I	determined	that	
it	was	largely	CopL,	and	not	the	efflux	pump	CopB,	that	was	essential	for	this	increased	
resistance.	This	was	unexpected	as	the	role	of	surface	associated	lipoproteins	in	heavy	
metal	 resistance	 has	 been	 largely	 undefined.	 However,	 in	 M.	 tuberculosis,	 LpqS	 is	
described	as	a	putative	lipoprotein	that	is	regulated	in	response	to	copper	and	has	been	
shown	 to	 aid	 in	 both	 copper	 resistance	 and	 Mtb	 survival	 in	 the	 macrophage	 (30),	
although	the	mechanism	behind	this	is	not	known.	Lipoproteins	are	found	in	the	regulon	
of	many	copper-responsive	regulators	(31),	and	thus	the	involvement	of	lipoproteins	in	
defense	against	metal	toxicity	may	be	greatly	underappreciated	and	could	represent	a	
new	area	of	interest	in	understanding	bacterial	mechanisms	of	metal	resistance.			
In	this	study,	I	discovered	that	the	copBL	operon,	like	copAZ,	is	regulated	by	the	copper-
responsive	 transcriptional	 regulator,	CsoR.	Additionally,	 as	determined	by	qPCR,	both	
cop	loci	are	also	regulated	in	response	to	zinc,	where	I	saw	a	notable	increase	in	cop	gene	
expression	 in	 the	 presence	 of	 zinc.	 Although	CsoR	 in	Corynebacterium	 glutamicum	 is	
capable	of	binding	to	both	copper	and	zinc	resulting	in	upregulation	of	cop	genes		(32),	
EMSA	results	 in	 this	study	 suggested	 that	 this	may	not	be	 the	 case	 in	S.	aureus:	CsoR	
interaction	with	the	copA	and	copB	promoter	fragments	was	unaffected	in	2:1	molar	ratio	
of	 zinc	 to	 protein.	 This	 raises	 an	 interesting	 question:	 is	 there	 is	 an	 additional	 zinc-
responsive,	transcription	factor	that	regulates	the	cop	loci?				
4.2.2 cop genes are needed for full virulence inside the phagosome   
Through	gentamicin	protection	assays	in	murine	macrophages,	I	demonstrate	that	the	
copAZ	 and	 copBL	 loci	 are	 important	 for	 growth	 in	 the	macrophage,	 where	 a	 copAZB	
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mutant	 strain	 had	 a	 significant	 decrease	 in	 recoverable	 CFUs	 10	 h	 post-infection,	
compared	to	WT.	This	is	the	first	study	to	demonstrate	a	need	of	copper	detoxification	
pathways	in	S.	aureus	survival	inside	the	macrophage.	This	has	previously	been	observed	
in	E.	coli	(33),	M.	tuberculosis	(34–36),	Salmonella	enterica	sv.	Typhimurium	(37–39),	and	
Listeria	 monocytogenes	 (40),	 where	 strains	 containing	 mutations	 to	 central	 copper	
detoxification	 pathways	 had	 severe	 reduction	 in	 macrophage	 survival	 compared	 to	
isogenic	WT.	In	S.	aureus	USA300,	strains	that	lacked	only	one	cop	loci,	either	copBL	or	
copAZ,	had	a	similar	growth	phenotype	to	WT,	indicating	that	the	presence	of	one	cop	
detoxification	system	is	sufficient	for	survival.				
4.2.3 Future experiments to examine the role of cop genes in intracellular survival 
Future	work	on	this	project	will	examine	the	expression	of	the	copAZ	and	copBL	genes	
during	intracellular	growth	using	qPCR.	Transcriptome	analysis	of	intracellular	bacteria	
following	macrophage	 infection	has	been	performed	 in	other	species,	 such	as	Listeria	
monocytogenes	 (41),	 Salmonella	 enterica	 sv.	 Typhimurium	 (42),	 Francisella	 tularensis	
(43),	and	Streptococcus	gallolyticus	subspecies	gallolyticus	(44).	I	will	 look	at	cop	gene	
expression	in	S.	aureus	following	infection	in	both	WT	and	ΔATP7A	RAW624.7	cells.	This	
will	allow	me	to	confirm	that	cop	genes	are	turned	on	in	the	phagosome,	and	looking	at	
multiple	time-points	during	infection	I	can	observe	their	expression	at	different	growth	
stages	in	the	macrophage.		
Additionally,	further	experiments	are	needed	to	look	at	the	biological	relevance	of	the	
upregulation	of	the	copAZ	and	copBL	genes	in	the	presence	of	zinc.	MIC	growth	analyses	
and	kill	curves	with	increasing	concentrations	of	zinc	will	allow	examination	of	the	zinc	
sensitivity	 of	 the	 copAZB	 mutant	 compared	 to	 WT.	 Previous	 work	 has	 shown	 that	
macrophages	 also	 efflux	 zinc	 into	 the	 phagosome	 following	 phagocytosis,	 and	
furthermore,	the	bacterial	zinc	efflux	pump,	ZntA,	is	important	for	intracellular	survival	
of	 E.	 coli	 (45–47).	 Therefore,	 along	 with	 looking	 at	 cop	 gene	 expression	 following	
macrophage	infection,	I’ll	also	examine	the	expression	of	other	zinc	regulated	genes	in	
the	 phagosome.	 This	 will	 be	 particularly	 interesting	 in	 the	 ΔATP7A	 RAW624.7	 cells,	
where,	 if	 I	 see	 upregulation	 of	 zinc-responsive	 genes	 and	 cop	genes,	 despite	minimal	
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copper	concentrations	in	the	phagosome,	I	can	infer	that	S.	aureus	encounters	a	high	zinc	
environment	in	the	phagosome	and	may	use	CopA	and	CopB	to	efflux	excess	zinc.		
Although	the	murine	macrophage	cell	line	RAW264.7	functions	as	a	consistent	model	for	
gentamicin	protection	assays	with	S.	aureus,	future	work	will	also	explore	the	ability	of	
the	copAZB	mutant	to	replicate	in	clinically	relevant	cells,	primary	human	macrophages.	
S.	 aureus	 infections	 in	 primary	 human	macrophages	 have	 been	 performed	 in	my	 lab	
previously	(28),	and	serve	as	important	model	to	look	at	the	role	of	virulence	genes	in	a	
more	accurate	representation	of	human	infection.		
Lastly,	the	role	of	copper	detoxification	systems	is	generally	investigated	in	the	context	
of	macrophages	and	intracellular	pathogens,	and	thus	the	role	of	these	pathways	in	other	
infection	models,	such	as	 in	skin	colonization,	is	poorly	defined.	Virulence	 factors	that	
contribute	to	skin	colonization	and	infection	are	of	particular	interest,	as	S.	aureus	is	the	
most	common	agent	of	skin	infections	(48).	Moreover,	the	strain	USA300	is	considered	
hypervirulent	as	a	skin	pathogen,	due	to	the	ACME	cassette	that	is	generally	regarded	as	
an	acquired	element	 that	 enhances	virulence	primarily	 in	 skin	 infection	and	bacterial	
transmission	(49).	Of	interest	to	this	study,	the	Latin-American	variant	of	USA300,	also	
known	for	causing	severe	skin	infections,	lacks	the	ACME	cassette,	and	instead	possesses	
the	mobile	genetic	element,	COMER;	this	cassette	carries	genes	that	are	thought	to	aid	in	
copper	 and	 mercury	 resistance	 and	 thus	 contains	 both	 copB	 and	 copL	 genes	 (50).	
Therefore,	the	retention	of	the	copBL	genes	in	two	hypervirulent	skin	pathogens	suggests	
that	they	play	an	important	role	in	skin	infections.	Thus,	future	areas	of	interest	with	the	
copAZB	mutant	would	be	to	examine	its	fitness	in	a	murine	skin	abscess	model.							
4.2.4 Significance of this study 
In	this	study,	I	identify	a	novel	copper-detoxification	mechanism,	CopBL,	encoded	on	the	
ACME	 cassette	 in	 S.	 aureus	 strain	 USA300.	 CopBL,	 in	 concert	 with	 CopAZ,	 works	 to	
detoxify	copper	in	the	cytoplasm	and	decrease	the	copper	sensitivity	of	USA300.	I	show	
that	the	cop	genes	are	required	for	full	virulence	inside	the	macrophage.	This	finding	has	
important	implications	for	the	copAZ	and	copBL	loci	for	S.	aureus	survival	in	vivo	and	its	
escape	from	innate	immune	cells	following	phagocytosis.		
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Outside	of	 the	 innate	 immunity	context,	 there	 is	an	 increase	use	of	copper-coating	on	
hospital	 surfaces	 and	 medical	 devices.	 Preliminary	 work	 that	 looked	 at	 the	 role	 of	
copper-coating	in	hospitals	to	limit	microbial	spread	showed	a	significant	decrease	in	the	
overall	microbial	population;	however,	only	nominally	worked	against	highly	antibiotic	
resistant	 strains,	 such	 as	 ciprofloxacin-resistant	S.	 aureus	 (51,52).	 Therefore,	 copper-
coated	surfaces	in	the	medical	care	environment	may	select	over	time	for	highly	resistant	
strains,	 like	USA300,	and	thus,	understanding	the	mechanisms	of	copper	resistance	 is	
critical	in	order	to	design	copper-based	surfaces	that	are	effective	for	contact	killing.	
4.3 Iron and copper interplay 
In	 this	 work,	 I	 describe	 two	 different	 mechanisms	 by	 which	 S.	 aureus	 maintains	
homeostasis	of	essential	 transition	metals,	 iron	and	copper.	Despite	 the	similarities	of	
iron	 and	 copper	 usage	 by	 bacteria,	 the	 host	 uses	 two	 completely	 different	 facets	 of	
nutritional	 immunity	to	restrict	bacterial	proliferation.	 Iron	 is	actively	sequestered	by	
the	host	to	restrict	the	access	of	free	iron	to	microbes	to	concentrations	far	too	low	to	
support	bacterial	growth	(53).	Therefore	S.	aureus	relies	on	iron-uptake	strategies,	like	
SB	utilization,	to	scavenge	for	iron.	The	mechanism	of	nutritional	immunity	by	the	host,	
with	 respect	 to	 copper,	 is	opposite	 to	 that	 of	 iron.	 In	 the	macrophage,	 free	 copper	 is	
transported	 into	 bacteria-containing	 phagosomes	 where	 excess	 copper	 causes	
membrane	damage	to	bacteria,	and	readily	causes	the	formation	of	ROS.	Thus,	in	contrast	
to	siderophores	that	are	needed	to	bring	in	iron	that	is	scarce	in	the	host,	S.	aureus	inside	
the	phagosome	encounters	a	surplus	of	copper	that	requires	detoxification	systems.	
These	two	pathways	of	metal	homeostasis	in	S.	aureus,	although	discussed	separately	in	
this	study,	do	have	some	points	of	convergence.	In	B.	subtilis	and	E.	coli,	copper	toxicity	
is	largely	due,	not	to	the	formation	of	ROS,	but	to	the	irreversible	displacement	of	iron	by	
copper	 from	 iron-sulfur	 (Fe-S)	 clusters	 (54–56).	 Iron-sulfur	 clusters	 are	 essential	
cofactors	 to	 many	 enzymes	 in	 the	 cell,	 many	 of	 which	 are	 involved	 in	 amino	 acid	
biosynthesis,	and	the	irreversible	exchange	of	Fe	to	Cu	renders	these	enzymes	inactive.	
In	E.	coli,	the	addition	of	excess	branched	chain	amino	acids	to	the	medium	significantly	
decreased	the	copper	sensitivity	of	a	copper-detoxification	pathway	mutant	(56).	I	have	
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observed	indications	of	this	in	the	study,	where	the	copper	MIC	of	WT	and	copAZB	mutant	
are	greatly	increased	in	nutrient-rich	media,	such	as	TSB	or	RPMI	with	the	addition	of	
casamino	acids	(data	not	shown).	The	differences	in	MIC	could	be	due	to	the	addition	of	
excess	amino	acids	or	excess	free	iron,	and	thus	future	work	should	look	the	contribution	
of	iron	and	amino	acids	to	copper	resistance	and	possible	regulation	of	cop	genes.		
A	recent	discovery	in	iron	homeostasis	is	how	bacteria	use	promiscuous	siderophores	
for	uptake	of	metals	other	than	iron,	such	as	copper	(57).	One	of	the	best	examples	of	this	
is	yersiniabactin	(Ybt),	a	siderophore	produced	by	many	Enterobacteriaceae,	 including	
some	 strains	 of	 uropathogenic	 E.	 coli,	 which	 binds	 both	 iron	 and	 copper.	 LC-MS/MS	
analysis	of	urine	from	patients	suffering	from	a	urinary	tract	infection	by	E.	coli,	revealed	
Ybt-Cu(II)	 complexes	 in	 the	 urine	 sample.	 This	 finding	 demonstrated	 that	 Ybt	 binds	
copper	during	infection,	as	a	way	to	either	transport	copper	into	the	cell,	or	perhaps	to	
sequester	extracellular	copper	and	reduce	the	formation	of	ROS	and	membrane	damage	
(58).	In	S.	aureus	the	nicotianamine	siderophore,	staphylopine,	has	a	higher	affinity	for	
copper	 than	 iron,	 as	 determined	 in	 vitro	 (59).	 Biologically,	 staphylopine	 has	 been	
observed	to	bind	to	zinc,	and	as	such	is	considered	a	zincophore	(60);	its	role	in	copper	
transport	 or	 sequestration	 during	 growth,	 or	 inside	 the	 phagosome,	 has	 not	 been	
characterized.	 Thus,	 further	 work	 is	 needed	 to	 investigate	 the	 potential	 role	 of	
staphylopine	in	copper	metabolism	and	copper	resistance.		
Overall,	this	study	has	important	implications	in	understanding	S.	aureus	pathogenicity,	
as	 both	 SB	 and	 copper	 detoxification	 are	 key	 pathways	 linked	 to	 virulence.	 Many	
instances	 have	 been	 observed	 for	 a	 copper-iron	 interplay	 in	 both	 bacterial	 and	
mammalian	metal	homeostasis	(61,	62),	and	thus	future	work	is	needed	to	investigate	
the	potential	crosstalk	of	these	two	complex	systems	in	S.	aureus.		
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